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This thesis focuses on designing and synthesis of novel molecular imaging 
probes based on non-covalent funtionalisation of pure single-walled carbon nanotubes 
(SWNTs). Several synthetic strategies for the supramolecular chemistry 
functionalisation of SWNTs, cytotoxicity measurements and cellular imaging of 
supramolecularly functionalised carbon nanotube probes are discussed.  
Chapter one is a literature review as the thesis Introduction. This describes 
aspects of the physical and chemical properties, structural importance and synthesis 
methods of single-walled carbon nanotubes (SWNTs), also opens the discussion of 
the different functionalisation methods to enhance the solubility and biocompatibility 
of SWNTs for biomedical applications. Several approaches for the design of 
functionalisation SWNTs for molecular imaging reported in the current literature are 
highlighted. Techniques and facilities for accessing cell imaging ability and behavior 
of these synthesized molecular imaging probes, including confocal laser scanning 
microscopy (CLSM) and fluorescence-lifetime imaging microscopy (FLIM) are 
described briefly.     
Chapter two explores the synthesis of specifically designed naphthalene 
diimide (NDI). These molecules are known to form 3 dimensional (3D) helical 
organic nanotubes through hydrogen bonding. In this work an iodine-tagged NDI was 
allowed to self-assemble onto the surface of SWNTs. The cavities of the NDI organic 
nanotubes can accommodate SWNTs strands in their hydrophobic interior as observed 
high-resolution transmission electron microscopy (HR TEM). A new hybrid material, 
NDI@SWNT, was prepared and characterised as dispersed in organic solvents and 
aqueous media and in the solid state by HR TEM, tapping mode atomic force 
microscopy (TM AFM), scanning electron microscopy (SEM), circular dichroism, 
 ii
Raman and fluorescence spectroscopies (steady-state single and two-photon 
techniques). 
These measurements indicate that amino acid-functionalised NDI interacts 
strongly with SWNTs in dispersions and forms a donor-acceptor complex denoted 
NDI@SWNT. The interaction of this nanohybrid with cancer cells was explored 
using fluorescence microscopies. 
Chapter three describes the synthesis of series of molecular imaging agents 
based on two cancer targeting peptides (bombesin and RGDfK). Two types of NDI-
peptide conjugates (Iodine-tagged NDI-Bombesin and Tryptophan-NDI-RGDfK) 
were designed and synthesized through EDC-coupling method. New compounds 
synthesized were characterised by mass spectroscopy and also HPLC. Fluorescence 
lifetime imaging microcopy and confocal laser scanning microscopy were utilised for 
investigating cellular behaviors (stability, fluorescence intensity and localization) of 
these molecular imaging probes. 
Chapter four describes the synthesis of amphiphilic conjugated thiophenes 
(dodecathiophene, denoted as T12). In this system, the thiophene backbone structure 
was chosen as a biocompatible coating for carbon nanotubes as simple molecular 
mechanics modeling suggested that it would be perfectly fitted to the curvature of 
SWNTs. T12 showed very good capability for debundling of SWNTs and forming 
corresponding solution dispersions of T12@SWNTs describes the potential of 
T12@SWNTs as a stable fluorescent bioimaging nano-probe for tracking cancer cells. 
  Chapter five describes the successful filling of SWNTs with Cu2+ by 
radiochemistry methods (using “hot” 64Cu ions anchored onto NaOAc) and also by a 
“cold” optimised procedure for excess Cu(OAc)2. Filling with other metal ions was 
also tested, for example KReO4 and Zr(OAc)4. The filling experiments with Zr(OAc)4 
 iii
in solution did not prove successful at normal pH but results were promising when pH 
was adjusted to ca. 2  by adding H2SO4.  Any significant leakage of metal ions from 
open SWNTs was avoided by a simultaneous encapsulation of C70 molecules at the 
ends of SWNTs. Functionalisation of SWNTs by the supramolecular wrapping the 
surface of SWNTs in aqueous media with a naturally occurring glucan (β-1,3-1,4-D-
glucan, denoted here as β-D-glucan) was also explored. Several boronic acid 
fluorophores were successfully synthesized and tested for the labeling of β-D-glucan 
@SWNTs by molecular recognition between boronic acids and this polysaccharide. 
Their cellular translocation behaviour and fluorescence properties were investigated 
by confocal fluorescence imaging and fluorescence lifetime imaging. Both methods 
show that localisation in sub-cellular (MCF-7 cells) regions and that the glucan 
coating significantly enhances the cell membrane translocation of SWNTs.  
Chapter six reports an efficient and economical strategy of supramolecular 
complex formulation of thermally reduced graphene. Naphthalene diimide (NDI) was 
used to form a stable and energy transfer complex which showed efficient quenching 
and significant red-shift of fluorescence of NDI when adsorbed onto graphene 
surfaces. The effect of thermally reducing annealing procedure to convert graphene 
oxides in graphene-nanoflake like materials was investigated. A new hybrid material 
(denoted here as NDI@TRG) synthesized was characterised by transmission electron 
microscopy (TEM), Raman spectroscopy, thermogravimetric analysis (TGA) and 
fluorescence microscopy in the dispersed phase 
Chapter seven contains full experimental details for the work described in this thesis.  
The Appendix contains details of the crystallographic data and supplementary 
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a.u.    Arbitrary units
ACN                                                                                                              Acetonitrile 
AFM Atomic force microscopy
BB3-R                                                                               Bombesin subtype-3 receptor
BBN                                                                                                                 Bombesin
CD                                                                                                      Circular dichroism
CVD    Chemical vapour deposition
D band “Diamond” band characteristic of sp3 carbon
DCC 1,3-Dicyclohexylcarbodiimide
DFT                                                                                        Density functional theory 
DMF                                                    N,N-Dimethylformamide
DMF N,N-Dimethylformamide
DMSO                                                                                               Dimethyl Sulfoxide 
ECM                                                                                                 Extracellular matrix 
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride
EDS                                                                     Energy-dispersive X-ray spectroscopy
EMEM                                                                       Eagle's minimal essential medium
FBA                                                                                          Fluorescein boronic acid
Fek-4                                                                           Normal human dermal fibroblasts
FLAB                                                                  Biotin-tagged fluorescein boronic acid 
FLIM                                                            Fluorescence lifetime imaging microscopy
FMCA Ferrocene monocarboxylic acid
FTIR                                                                 Fourier transform infrared spectroscopy
G band “Graphite” band characteristic of sp2 carbon
GRP-R                                                                       Gastrin-releasing peptide receptor 
HiPco High pressure CO
HOPG Highly oriented pyrolytic graphite
HRTEM                                           High-Resolution transmission electron microscopy
IR Infrared
MBHA                                                                                      Methylbenzhydrylamine 
MCF                                                                  Human breast adenocarcinoma cell line   
MI50            Concentration that reduces cell metabolism to half that of untreated cells 
MTT                             3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
MWNT     Multi-walled carbon nanotube
NDI                                                                                                  naphthalene diimide
NHS N-Hydroxysuccinimide
NMR Nuclear magnetic resonance
NMR Nuclear magnetic resonance
PBS                                                                                         Phosphate-buffered saline
PET                                                                                  Positron emission tomography  
RBM Radial breathing mode
RGD                                                                                Arginine-glycine-aspartic acid 
SAED                                                                           Selected area electron diffraction
SDS Sodium dodecyl sulfate
 viii
SEM                                                                             Scanning Electron Microscopy  
SFM                                                                                                  Serum free medium 
SIESTA           Spanish Initiative for Electronic Simulations with Thousands of Atoms
SPG                                                                                   β-1,3-D-glucan schizophyllan
SWNT Single wall carbon nanotube
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Chapter 1 Introduction to functionalised carbon 
nanotubes 
1.1 Introduction 
The first objective is to introduce single walled carbon nanotubes (SWNTs) and 
discuss their physical and chemical properties, structural importance and synthesis methods. 
The applications of SWNTs in biomedicine with particular focus on their use as targeted 
drug delivery and molecular imaging will be highlighted. Several different functionalisation 
methods used to enhance the solubility and biocompatible of SWNTs for biomedical 
application are also discussed. The final goal of this chapter is introduce several 
biocompatible compounds related to those used for encapsulating SWNTs within this 
research. 
1.2 Single walled carbon nanotubes (SWNTs) 
   Since the discovery of carbon nanotube (CNT) by Iijima,1 many researchers and 
scientists from different groups all over the world have been attracted to this material and a 
large number of studies have been carried out to forward potential applications in electricity, 
advanced material and medicine.  
  CNTs were first synthesized as a by-product in the synthesis of fullerenes by using 
an arc-discharge method, and from this method also several other procedures were then 
derived,1-7 including laser ablation8-10 and catalytic decomposition of hydrocarbon.11-14 
Considering the great effort scientists spent on studying on these materials and given the 
distinctive electrical, mechanical and chemical properties, CNTs could become one of the 
most important and promising materials in the 21st century. CNTs can be classified into two 
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categories: One is multi walled carbon nanotubes (MWNTs)1,7and the other single walled 
carbon nanotubes (SWNTs).1 The MWNTs had been discovered first. An MWNT is 
comprised of 2 to 30 concentric graphitic layers, diameters of which range from 10 to 50 nm 
and length of more than 10 pm. On the other hand, SWNTs are much thinner, with the 
diameters from 1.0 to 1.4 nm. However, the low solubility and the rapid formation of 
bundles when dispersed in most common solvents have been the obstacle of forwarding for 
industrial applications. Indeed, as-produced CNT are insoluble in all organic solvents and 
aqueous solutions. They can be dispersed in some solvents by sonication, but precipitation 
immediately occurs when this process is interrupted. On the other hand, it has been 
demonstrated that CNT can interact with different classes of compounds on the aromatic 
surface of CNT. The formation of supramolecular complex gives the hope for fabricating 
innovative nanodevices.  
1.3 Structure  
1.3.1 Bonding of carbon atoms 
    To understand the structure and properties of nanotubes, the bonding structure and 
properties of carbon atoms are discussed hereby. A carbon atom has six electrons with two of 
them filling the 1s orbital. The remaining four electrons fill the sp3 or sp2 as well as the sp 
hybrid orbital, responsible for bonding structures of diamond, graphite, nanotubes, or 
fullerenes. A SWNT can be visualised as a hollow cylinder, formed by rolling over a 
graphite sheet by specified as vector C in terms of a set of two integers (n, m) corresponding 
to graphite vectors a1 and a2 (Figure 1.1) , 
21 aa mnC +=                                                                    (1.1) 
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 Where C is the chiral vector, n and m are integers, and a = |a1| = |a2| is lattice 
constant of graphite. The tubes with m = n are commonly referred to as armchair tubes and m 
= 0 as zigzag tubes. Others are called chiral tubes in general with the chiral angle, θ is 
defined as the angle between the vector C and the zigzag direction a1, 
)]2/(3[tan 5.01 nmm += −θ                                                    (1.2) 
θ  ranges from 0 for zigzag (m = 0) and 30° for armchair (m = n) tubes.  
 
Figure 1.1.  A nanotube (n, m) is formed by rolling a graphite sheet along the 
chiral vector 21 aa mnC +=  on the graphite where 1a  and 2a  are graphite lattice 
vector. The picture is reproduced from the paper.15 
 
 
Figure 1.2. Different types of SWNT formed by rolling a graphite sheet in 
different directions, two typical nanotubes can be obtained: zigzag16, armchair (m, m) 
and chiral (n, m) where n>m>0 by definition. In the specific example, they are (10, 10) 
(a), (12, 7) (b) and (15, 0) (c) nanotubes. The picture is reproduced from the paper.15 
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 The tube chirality parameter (n, m) significantly affect the electronic, optical, 
magnetic, and other properties of a nanotube. Scanning Tunneling Microscopy (STM) can be 
used to measure tube geometry charactersied by (d, θ) which, in turn, can be used to derive 
the (n, m) parameters. 
1.4 Synthesis  
  Carbon nanotubes are normally synthesized by three main methods. These are arc 
discharge, laser ablation and chemical vapor deposition (CVD). Scientists are still searching 
for more economic routes for scale up synthesis and purification of the new material. In the 
arc discharge method, carbon nanotubes are created through arc-vaporization of two carbon 
rods placed end to end with or without catalyst. The rods are separated by approximately 1 
mm, in an enclosure that is usually filled with inert gas at low pressure. In the laser ablation 
technique, a high-power laser beam vaporises a graphite target in a high-temperature reactor 
filled with inert gas in the chamber. At the moment, laser ablation produces a small amount 
of clean nanotubes, whereas arc discharge methods generally produce large quantities of 
impure material. In general, chemical vapor deposition (CVD) results in MWNTs or poor 
quality SWNTs. The SWNTs produced with CVD have a large diameter range, which can be 
poorly controlled. But on the other hand, this method is very easy to scale up, shows the 
most promise for industrial-scale production.15 
1.4.1 Arc discharge 
   The carbon arc discharge method initially used for producing C60 fullerenes by 
using a current of 100 amps. However the first macroscopic production of carbon nanotubes 
using this method was made in 1992 by two researchers at NEC's Fundamental Research 
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Laboratory.17 In this method, the carbon in the negative electrode sublimates in the high 
temperature caused by discharge (Figure 1.3). This technique produces a mixture of 
components. It is required to separate carbon nanotubes from the soot and also the catalytic 
metals in the crude product. Because nanotubes were initially discovered using this 
technique, it has been the most widely-used method of nanotube synthesis. This method 
produces carbon nanotubes by arc-vaporising of two carbon rods also filled with inert gas 
(helium, argon) at low pressure (50-700 mbar). Recent research also indicates that producing 
nanotubes by arc-discharging in liquid nitrogen.18 A direct current of 50 to 100 A driven by 
approximately 20 V creates a high temperature discharge between the two electrodes. The 
discharge vaporises one of the carbon rods and forms a small rod shaped deposit on the other 
rod. Producing nanotubes in high yield depends on the uniformity of the plasma arc and the 
temperature of the deposit formed on the carbon electrode.17 
  
                (a)                                           (b) 
Figure 1.3. Schematic drawings of arc-discharge apparatus (a) for producing 
SWNTs. Small diameter, single-wall nanotubes can be synthesized in arc chamber (b) 
using an arc welder to maintain the optimal settings between two horizontal electrodes 
in helium or argon atmospheres.  
(http://www.personal.psu.edu/faculty/p/c/pce3/facilities/arc.htm) 
 
Nanotubes were observed in 1991 in the carbon soot of graphite electrodes during an 
arc discharge, by using a current of 100 amps, that was intended to produce fullerenes.16 
However the first macroscopic production of carbon nanotubes was made in 1992 by two 
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researchers at NEC's Fundamental Research Laboratory.19 During this process, the carbon 
contained in the negative electrode sublimates because of the high discharge temperatures. It 
has been the most widely-used method of nanotube synthesis, since nanotubes were initially 
discovered by this technique. The yield by using this method is up to 30% by weight, 
including both SWNTs and MWNTs. 
1.4.2   Laser ablation for the production of CNTs 
   This process was developed by Dr. Richard Smalley and co-workers at Rice 
University in 1995, who at the time of the discovery of carbon nanotubes, were blasting 
metals with a laser to produce various metal molecules. Upon observation of CNTs 
formation, they replaced the metals with graphite to create multi-walled carbon nanotubes.20 
The laser vaporisation apparatus used by Smalley's group is shown in Figure 1.4. The 
graphite target in an oven at 1200 °C is vaporised by a pulsed or continuous laser. The oven 
is filled with helium or argon gas in order to keep the pressure at 500 Torr. Very hot vapors 
expand and cool rapidly, and then small carbon molecules and atoms quickly condense to 
form larger clusters including fullerenes. At the same time, the catalyst also condenses but 
this process takes place more slowly than the condensation of carbon. Catalysts may form 
cage structures when they are attached to carbon, then stop carbon nanotube growth. It is 
believed that tubular carbon structures form around the cage structures and grow into 
SWNTs, until the whole catalyst particles become too large or there are no carbon atoms that 
can sufficiently cover the surface of catalyst on cooling. The SWNTs formed in this case are 
bundled together by van der Waals forces.21 
 








The optimum gas and catalyst mix is the same as in the arc discharge process, 
therefore the laser ablation process is similar to the arc discharge: since similar reaction 
conditions are needed, the chemical transformations probably occur with the same 
mechanism. 
1.4.3   Chemical vapour deposition (CVD) for CNTs synthesis 
  Carbon nanotubes formed by vapour phase deposition method was first reported in 
1993.22 For CVD method, a layer of metal catalyst particles (nickel, cobalt, iron or a 
combination) is prepared as a substrate. Also the diameters of nanotubes grown using this 
method are related to the particles size. Before filling with carbon containing gas, the 
substrate is heated to approximately 700 °C. Then two types of gases are bled into the reactor: 
a process gas (such as ammonia, nitrogen or hydrogen) and a carbon-containing gas (such as 
C2H2, CH4, C2H4 and C2H6). The carbon-containing gas is broken apart at the surface of the 
catalyst particle, and the carbon is transported to the edges of the particles, where it forms the 
nanotubes. In order to promote the yield of carbon nanotubes, scientists mixed the metal 
nanoparticles with a catalyst support (MgO or Al2O3). CVD method has become the most 
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commercial production of carbon nanotubes because of its low price/unit ratio, and because 
CVD is capable of growing nanotubes directly on a desired substrate, whereas the nanotubes 
must be collected in the other growth techniques. Carbon nanotubes products from Baytube 
Company are produced in a high-yield catalytic process based on chemical vapour deposition. 
Figure 1.5 shows a schematic diagram of a typical plasma CVD apparatus with a parallel 
plate electrode structure. 
 
Figure 1.5. Schematic diagram of plasma CVD apparatus 
(http://students.chem.tue.nl/ifp03/synthesis.html) 
1.5   Chemically functionalised carbon nanotubes 
SWNTs can severely bundle with each other due to strong van der Waals forces and 
the resulting materials are very difficult to solubilise essentially in any solvent. Insolubility 
has become the major roadblock forward the potential application of SWNTs due to the 
difficult to process carbon nanotubes in the liquid state forming devices or complex. Though 
they can be dispersed in some solvents by using sonication, precipitation happens after a 
while if there is no continuous sonication applied. Oxidation processing of SWNTs in 
mixture of concentrated nitric and sulfuric acid is a very important and essential treatment of 
carbon nanotubes. The final products from this treatment are nanotube fragments. Ends and 
sidewalls of these 100-300 nm length nanotubes are attached with lots of carboxyl groups. 
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These abundant carboxyl groups present on carbon nanotubes can be modified again through 
forming amide and ester bonds for attaching with different functional moieties. The presence 
of carboxyl groups leads to a reduction of van der Waals interactions between the CNTs, 
which strongly facilitates the separation of nanotube bundles into individual tubes.23 
Additionally, the attachment of suitable groups enhances the solubility in aqueous or organic 
solvents. A high water solubility of a few tenths of a gram per milliliter has recently been 
achieved on the basis of the carboxyl-based coupling of hydrophilic polymers such as 
poly(ethylene glycol) (PEG).24 
  The study of SWNTs and their interaction with different kinds of compound to form 
supramolecular complexes has been a matter of intense investigation. The most common 
routes used for modification of these one-dimensional structures can be grouped into two 
types: The covalent attachment of chemical groups on the aromatic surface of SWNTs. 
Different kinds of functional molecules (such as polymers) can be non-covalently attached 
on carbon nanotubes surface through aromatic interactions.  
1.5.1  Covalent chemistry methods for surface modification  
     Direct coupling of functional groups on to the π-conjugated carbon structure are 
available by thermally activated reactions. Several addition reactions have been published, 
and these are represented schematically in Figure 1.6. 
 





Figure 1.6. Overview of possible addition reactions for the functionalisation of the  
                           nanotube sidewall. 
 
Reactions of graphite with elemental fluorine yield several different types of 
fluorides mainly depending on fluorination temperature. Graphite fluorides (CF)n and (C2F)n 
with covalent C–F bond are prepared at high temperatures of 350–600 °C.25 Two possible 
fluorinated patterns forming two isomers were proposed. One pattern is called the 1,4 isomer 
which the fluorine atoms occupy the 1,4 positions on every other row of hexagons. Another 
one is called the 1,2 isomer, i.e. the fluorine atoms occupies the 1,2 positions of the hexagons 
of alternate rows while the double bonds form a conjugated system along the tube. It has 
been reported that the 1,4 isomer is more stable than the 1,2 addition pattern.26 Fluorinated 
SWNTs can be solvated as individual tubes in various alcohol solvents via ultrasonication. 
The solubility limit of the solvated fluorinated SWNTs in 2-propanol is at least 1 mg/mL.27 
Terminal alkylidene diamines and OH group-terminated moieties were attached with 
fluorinated SWNTs through nucleophilic substitution reactions. FTIR, Raman, UV−vis−NIR, 
SEM/EDS, TEM and TGA analyses were used to determine the sidewall attachment of the 
N-alkylidene amino groups and hydroxyl groups.28,29 Hydrogenated SWNTs and MWNTs, 
as well as graphite were prepared by dissolved metal reduction method in liquid ammonia. 
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Hydrogenated carbon nanotubes can maintain stable up to 400 °C. Also glow discharge 30-32 
or proton bombardment33 was used for functionalisation of CNT with atomic hydrogen.  
Dichlorocarbene has been attached on the surface of carbon nanotubes by stirring in a 
CHCl3/NaOH mixture or using a phenyl (bromodichloro methyl) mercury reagent (Figure 
1.6). The dichlorocarbene-functionalised SWNTs [(s-SWNT)CCl2] have good solubility in 
organic solvents such as tetrahydrofuran and dichlorobenzene. The degree of 
dichlorocarbene functionalisation was from 12% to 23%. The chlorine atoms can be 
removed by heating treatment above 300°C.34-36 Organic functionalised of Carbon 
Nanotubes was described using the 1,3-dipolar cycloaddition of azomethine ylides, prepared 
remarkably soluble bundles of nanotubes supported by TEM analysis.37,38 The microwave-
induced pyrazoline-modified SWNTs by thermal 1,3-dipolar cycloaddition of nitrile imines 
was reported by Yubing Wang et al.39 The 1,3-dipolar cycloaddition of SWNTs was carried 
out in 15 min under microwave conditions. The final products were characterised by UV−vis, 
NMR, and FT-IR spectroscopies. The solubility of the functionalised SWNTs in different 
organic solvents was also observed in Yubing Wang’s research work.39 Molecular dynamics 
simulations indicated that radicals can be attached on the surface of carbon nanotubes 
through carbon radicals forming. Diazonium salts have been used to covalently functionalise 
the sidewall of carbon nanotubes.37,39,40 Electrochemical reduction of substituted aryl 
diazonium salts in organic media was used for modification of CNTs.37,40,41 Electron transfer 
between CNTs and the aryl diazonium salts leads to the formation of aryl radicals on the 
surface of CNTs. Confirmation of this type of functionalisation was made easily according to 
UV−vis spectroscopy. Also Raman spectroscopy and TGA methods suggested that tubes are 
heavily functionalised. This modification method significantly increased the solubility of 
CNTs in DMF (0.8 mg/mL). Substituted phenyl groups were attached on the surface of CNT 
by electrochemical method, in which two types of coupling reactions were proposed, one 
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was reductive coupling of aryl diazonium salts (Figure 1.10) and another was oxidative 
coupling of aromatic amines (Figure 1.6).42-44 The lithium ions were reduced and intercalated 
with the surface of CNTs in ammonia atmosphere or in polar aprotic solvents.45,46 Transient 
alkyl radicals were attached covalently on the surface through electron exchange between 
negatively charged tubes and long chain alkyl iodides. The successful covalent attachment 
was confirmed by FT-IR, Raman, and TEM. 
1.5.2   Covalent attachment of polymers onto CNT  
   Polymer covalently wrapping can enhance the solubility CNTs in CHCl3, DMSO, 
MCB, DCM, H2O and DMF. Long chain polymer can wrap the tubes uniformly and decrease 
the CNTs form bundles. According the polymerization before wrapping or after interaction 
with CNTs, there are two methods for this modification, which are defined as “grafting to” 
and “grafting from” methods. The former one, polymer chain is synthesized with a specific 
molecular weight before attached to the surface of CNT. The latter one, polymer precursors 
are immobilised on the surface of nanotubes first and then propagating the polymer chain by 
adding monomeric species.  
1.5.2.1  “Grafting to” Method 
    Ultrasonication of SWNTs in a monochlorobenzene (MCB) solution of 
poly(methyl methacrylate) (PMMA) followed by filtration is an effective way to  obtain 
discrete and single dispersed carbon nanotubes. The damages of ultrasonication to SWNTs 
can be controlled to the least. The FT-IR spectra indicate that MCB and PMMA were 
attached with SWNTs chemically.47 The SWNTs wrapped with poly(vinyl-pyrrolidone) 
(PVP-1300) was reported by Richard E. Smalley.48 PVP-1300 forms a monomolecular ~2.5 
nm thick layer which is wrapping individual SWNTs by coiling and forming nanotube 
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bundles. Preparation of polystyrene-wrapped SWNTs using the high-speed vibration milling 
technique was reported which can help disperse SWNTs in various organic solvents.49   
1.5.2.2   “Grafting from” Method 
  CNT-polymer composites were first fabricated by an in situ radical polymerisation 
process. Poly(methyl methacrylate)/carbon nanotube (PMMA/CNT) composites prepared by 
using an in situ process was reported.50-54 CNTs can be initiated by AIBN 
(Azobisisobutyronitrile) to open their π-bonds. In turn, this is then forming strong 
interactions between the aromatic surface of CNT and in the presence of the PMMA matrix, 
at the same time when PMMA polymerization occurs. Carbon nanotubes can be grafted with 
polystyrene molecules using an in situ radical polymerisation reaction also enhanced their 
solubility and their suitability for nanocomposite applications. A uniform thin polystyrene 
wrapping was formed on the wall surface of CNTs. Complexes denoted 
polystyrene@MWNTs were soluble in dimethylformamide and tetrahydrofuran.55-58 SWNTs 
was grafted with poly (4-vinylpyridine by using in situ free radical polymerization of 4-
vinylpyridine was reported by Shuhui Qin et al.59 After centrifugation and ultrafiltration 
treatment, catalyst particles and unattached polymer were removed.  SWNT−PVP can 
maintain stable in DMF, methanol, and 2-propanol at least 8 months. Raman spectra analysis 
confirmed that discrete SWNT having PVP covalently attached. MWNTs grafted with a soft 
shell of brush-like polystyrene was successfully prepared by in situ atom transfer radical 
polymerization (ATRP), using Cu(I)Br/N,N,N’,N’’,N’’’-pentamethyldiethylenetriamine 
(PMDETA) as the catalyst, at 100°C in diphenyl ether solution. The thickness of the shell 
layer can be controlled by controlling the molecular weight of polystyrene.60  
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1.5.3  Non-covalent interactions for SWNTs wrapping 
  CNTs’ surfaces adsorb strongly with each other and they can easily form big 
bundles in solution: this is due to the fact that CNTs have strong surface energy. Non-
covalent wrapping of the tubular structure by various species of polymers, polynuclear 
aromatic compounds, surfactants and biomolecules are also an important method to prepare 
separated carbon nanotubes. Non-covalent wrapping method is very interesting as this 
method modifies the CNTs without affecting the electronic network or the tubes. The non-
covalent interaction between CNT and shell wrapping material is based on van der Waals 
forces and aromatic stacking.  
   Nanotube−polymer composites have been be widely used in different kinds of 
applications. The most important issue for nanotube−polymer composite preparation is 
efficient and uniform wrapping the core carbon nanotubes with shell species. The efficient 
load of wrapping species requires homogeneous dispersion and strong interfacial bonding 
between the host and guest. Chemists have developed several approaches for synthesis of 
such composites, including physical mixing in solution, in situ polymerization of monomers 
in the presence of nanotubes, surfactant-assisted processing of composites, and chemical 
functionalisation of the incorporated tubes. Carbon nanotubes were functionalised with 
polyethylene oxide (PEO) chains for biosensor by immobilizing a wide range of proteins 
with PEO.61 It has been reported that zinc protoporphyrin IX (ZnPP) binds non-covalently to 
SWNTs and renders them solubility in DMF or DMSO.62,63 Jinyu Chen et al. used water-
soluble porphyrin molecules [meso-(tetrakis-4-sulfonatophenyl) porphine dihydrochloride] 
to wrap SWNTs, resulting in soluble SNWTs@porphyrin solutions that were stable for 
several weeks.64 
Earlier work in the Pascu group described a strategy for coating SWNTs by using 
tripodal porphyrin receptors. These two tripodal porphyrin hosts can solubilise SWNTs in 
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DMF–toluene mixtures. Also this supramolecular coating material showed intense 
fluorescence, promise photovoltaic properties and biocompatibility whilst helping to disperse 
carbon nanotubes in organic solvents.65 The Soret and Q-bands of porphyrin moieties in the 
porphyrin@SWNTs composites are significantly broadened and their fluorescence was 
almost quenched as the strong aromatic stacking between host and guest. Hongjie Die’s 
group reported the use of fluorescein−polyethylene glycol (Fluor-PEG) to noncovalently 
functionalise SWNTs to enhance water-soluble of Fluor-PEG/SWNT and also afford the 
fluorescent labeling to nanotubes.66  
 Their interesting physicochemical properties make CNTs good candidates for 
nanomedicines design, especially for drug delivery applications. These are, for example, 
ordered structure with high aspect ratio, ultra-light weight, high mechanical strength, high 
electrical conductivity, high thermal conductivity, metallic or semi-metallic behaviour and 
high surface area. 
  However, CNT toxicology to human body and the environment is a big concern for 
application forward in medicine and industry. Certain experiments in vivo and in vitro have 
shown that there is no apparent toxic effect of CNT in the short term if modified in a suitable 
way.67 In vitro and in vivo studies focused on the impact of functionalised carbon nanotubes 
on cells and animals. There is no size cut-off below which diameter suddenly becomes 
harmful. There are two factors that act together to induce harm:  
(a)  Large surface area of CNT  
(b) CNTs’ reactivity or intrinsic toxicity of the surface.  
Additionally, the smaller the diameter of CNT, the more surface area they have per 
unit mass; therefore the more toxic the CNT. A dispersed CNT phase contains a huge 
number of tubular, high lengths/diameter ratio particles of even milligrams quantity as the 
nanometer-scale dimensions, with a concurrent very high total surface area. The total surface 
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area depends on their degree of bundling and aggregation of nanotubes in solution. Toxicity 
studies showed that there would be less cytotoxic effects than aqueous dispersions of pristine 
SWNT stabilised with a surfactant-1% of Pluronic F108 if SWNT are functionalised by 
phenyl-SO3H or phenyl-(COOH)2 groups covalently.68  
In vitro studies indicated that two types of f-CNTs (functionalised through 1, 3-
dipolar cycloaddition reaction and the oxidation/amidation treatment) can be  taken up by B 
and T lymphocytes as well as macrophages without affecting cell viability as the solubility of 
f-CNTs seems high in cell culture medium.69 Gene delivery using CNTs as a carrier can 
increase expression up to 10 times higher than the DNA alone. Hongjie Dai’s group 
(Stanford) used CNT as a drug carrier to load anticancer doxorubicin.70 The anticancer 
effects evaluation indicated this carrier had ultrahigh loading capacity of doxorubicin while 
targeted delivery of it selectively to cancer cell lines. The popularly used lipid vesicles for 
drug delivering can only carry doxorubicin in quantities up to one-eighth of their weight. 
Covalent binding with biocompatible molecules is an efficient way for bio-functionalisation 
of CNTs and enhance the possibility of applying CNTs in biomedical research areas. 
1.5.3.1 Glucans as coating materials for SWNTs 
        β-1,3-D-Glucans are polyglucose complexes which can be isolated and purified 
from yeasts, mushrooms and other fungi. They are normally prepared by enzymatic 
extraction treatments of yeast cell walls. Curdlan is the simplest β-1,3-glucan. β-1,3-glucan 
has been attracting interest from phytochemical research scientists and health professionals 
since in 1940s, Dr. Louis Pillemer and his colleagues first isolated an immunity activating 
compound from a yeast cell-wall named  'Zymosan'.71,72 The active component of Zymosan 
was not identified. The β-1,3-glucan has shown to be able to fortify and magnify the all-
important 'primary' immune response in humans and animals. X-ray diffraction patterns of β-
Chapter 1 Introduction to functionalised carbon nanotubes 
  
 17
1, 3-glucans in the anhydrous form showed that it adopts a right-handed  triple helix.73,74,75  
In the triple helix structure, three glucoses containing different chains are bound together 
through the hydrogen bonds among the three O-2 atoms, forming the one-dimensional 
hydrogen-bonding network in the triple helix.76 (1→3)-linked β-D-glucose molecules 
arranged in a linear polymer backbone with a side glucose group linked at every third main-
chain glucose forms schizophyllan (SPG).   
   The helical structures of β-1,3-glucans helical structure are quite similar with those 
of double-stranded DNA, but larger than DNA helical tube. There is not enough space in the 
triple helix structure as it stands to accommodate even small molecular guests.  The only way 
for β-1,3-glucans to encapsulate molecules is to dissociate the original triple helix structure 
into single strand by losing the hydrogen-bonding network, and dissociated  β-1,3-glucan 
chains can have the ability to include guests and to form nanotubes. Norisuye et al. have 
reported the interesting solution properties of β-1,3-glucans where denaturing and re-
naturing of the triple helix can take place reversibly. In the reported experiment β-1,3-
glucans adopted a triple helix in nature, but can be dissociated into a single chain by 
dissolving in DMSO. When DMSO is exchanged by water, the changes in β-1,3-glucan 
intermolecular structure are promoted, resulting in the formation of the original triple helix 
structure.77  
As mentioned above, since the discovery of SWNTs by lijima, SWNTs have attracted 
scientists’ attention and have been regarded as very ideal materials due to their unique 
electronic, photochemical and mechanical properties.1,2 But the strong cohesive nature and 
poor solubility of SWNTs in the absence of functionalisation is the major obstacle in their 
application in bioimaging fields. Synthetic or biological polymer solutions can be used for 
wrapping SWNTs to promote dissociation of the SWNT bundle to give a well dispersed 
SWNTs solution without damaging SWNT surface.  Natural polysaccharide schizophyllan 
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was found by Shinkai78 to be an excellent dispersing agent for SWNTs. In addition, 
polysaccharides do not absorb in the UV-Vis wavelength region, therefore the photochemical 
properties of the resulting complex composites are not affected by SPG. Hydrophobic 
interaction and the hydrogen-bonding interaction are main driving forces for the 
reconstruction of the triple-stranded β-1,3-glucans from the single-stranded ones. On the 
basis, SWNTs might be encapsulated in the hollow of the β-1,3-glucans helical structure 
mainly owing to hydrophobic interaction. However the natural β-1,3-glucans do not have 
enough cavity to accommodate SWNT larger than 1–2 nm diameters. Thus, some 
conformational change is needed in the β-1,3-glucan main-chain after wrapping the guest, 
probably with the weakness of the H bonds.  
1.5.3.1.1 Interactions between boronic acids and diols   
 A method for rapid functionalisation of  β-D-Glucans such as curdlan (an analogue 
of SPG, used widely) demonstrated by Prof Tony James group.79 This group also pioneered 
the rapid tagging and recognition of polysaccharides by boronic acids.80-82 
A number of research works examined the properties and the synthesis of boronic 
acids 83,84 and quantitative investigate into the interactions between boronic acids and polyols 
in 1959.85 The dissociation of a hydrogen ion from phenylboronic acid occurs from the 
interaction of the boron atom with a molecule of water. As the phenylboronic acid and water 
react, a hydrated proton is liberated, thereby defining the acidity constant Ka. 86 The Scheme 
1.1 depicts the association between water molecule and the Lewis acidic boron.  
 
Scheme 1.1. The acid–conjugate base equilibrium for phenylboronic acid in water,   
                        diagram reproduced from paper.87 





Scheme 1.2. Interaction of the phenylboronate anion with 1,2 diol to form diol–
phenylboronate complexes with five membered rings, respectively, diagram reproduced from 
paper.87 
 
Simultaneously, boronic acids have been reported to rapidly and reversibly88 interact 
with dicarboxylic acids89,90 α-hydroxy carboxylic acids and diols to form esters in aqueous 
media.91 The most common interaction is with 1, 2 diol to form five-membered ring (Scheme 
1.2). From experimental observations, it has been demonstrated that the kinetics of this inter-
conversion is fastest in aqueous basic media where the boron is present in its tetrahedral 
anionic form. Therefore, boronic acids seem to be ideal candidates for rapid and stable 
functionalisation of polysaccharides such as β-D-Glucans. 
Early findings by Shinkai for curdlan and SPG clearly showed that β-1,3-D-Glucan 
maintains its inherent ability as a one-dimensional host and can change the cavity to 
accommodate SWNT. The wrapping of β-1,3-D-Glucan provided a novel strategy to create 
functional polymer composites in a supramolecular manner. Considering a general difficulty 
in introducing functional groups into the functional polymer backbones without damaging 
the helical network, the use of boronic acids in combination with the present system may be 
a new potential path to develop functional polymeric materials formed by SWNT (filled or 
empty), glucan and targeting/monitoring tag.  
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1.5.4 Introduction to filling of SWNTs 
   A number of laboratories in the UK and world-wide are involved in the research of 
endohedral filling of SWNTs. The first endohedral filling of SWNTs with inorganic 
compounds was published in 1998,92 therefore starting the new area of filling SWNTs to 
give new composite materials. Throughout this work we denoted the SWNT-based hybrid 
nanocomposite as X@SWNTs (where X is an atom, a molecule, or a chemical compound 
encapsulated into the cavity or around onto the surface).  
The main interest in filling SWNTs was to enforce the filling materials to adopt 1D 
morphology. Filling SWNTs with 1D metallic wires was expected to promote the synthesis 
of future electronic devices.93 Another application of filling SWNTs was to use this SWNT 
as a container for nano-sized catalysts with delayed action.94 SWNTs may be partially filled 
with short nanorod or nanoparticles of catalysts. The carbon shell can protect catalyst from 
its release to the surrounding medium and help control the reaction due to the chemical and 
thermal inertness of the carbon layer. After the reaction conditions become oxidising (e.g. an 
oxidising agent is introduced into the mixture) the carbon layer would be oxidised and 
broken, then nano-size catalysts are released and activated for reaction. The catalyst 
efficiency was thus enhanced greatly due to the nano-size effect.  
The first successful SWNT filling work with exogenous material was using RuCl3, 
which was subsequently reduced into metallic Ru by using a heat-treatment (45 °C) under 
gaseous hydrogen. The group of Professor Malcolm L.H. Green (Oxford Nanotube Group) 
pioneered in the filling SWNTs with different kinds of halides so far, including ThCl4,95 
CdCl2,95 TbCl3, TiCl4 and PbI2, lanthanide halides LnCl3,96 KI, 97,98 ZrCl499 and silver 
halides.100  
Most metallic filling proceeded via a melting route, where very harsh condition were 
needed (T>400 °C) over prolonged periods of time.  
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The preparation of C60@SWNTs (‘peapods’) was reported in 1998, the same year as 
Ru/RuCl3@SWNT. The peapods were synthesized unexpectedly during purification and 
annealing treatments which were applied at Rice University on raw SWNT materials 
produced from the pulsed laser vaporisation method (PLV). Both carbon nanotubes and C60 
molecules are produced when using pulsed laser vaporization of graphite in the presence of 
certain metallic catalysts. But C60 is still trapped inside a nanotube during this rather 
elaborate synthetic sequence.  
We envisage that heavy-elements or radio-elements can be trapped inside the 
encapsulated fullerene under mild conditions and used as whole body markers for 
radiography. The application may be promoted for medical trials because fullerenes have 
been demonstrated to be biologically in active. They would eventually be eliminated from 
the body while the complex containing the markers (otherwise not very welcome in the body) 
will be imaged.101-103  
The synthesis of ‘endotubular metallofullerenes’ (such as [Gd@C82]@SWNT,104,105 
[La@C82]@SWNT, [La2@C82]@SWNT and [Sm@C82]@SWNT and [La2@C80]@SWNT 92 
have been achieved already. 
  The first method for filling SWNTs with molecular species under harsh conditions 
was by mixing SWNT and the material to be inserted into a glass ampoule sealed under 
vacuum, and then heat the ampoule beyond the filling material sublimation temperature. 
Thus the filling materials become gas-phase atoms and enter into the cavity of SNWTs 
which can open simultaneously. This method has been used widely for preparing peapods 
and related materials,106-108 due to the rather low sublimation temperature of fullerenes (～
350 °C) added to the exceptional thermal stability of the isolated C60 and C70 molecules (～
3000–4000 K109). Using this method a successful filling of nearly 100%, makes SWNT 
surfaces adequately clean. In situ filling is another similar method, which SWNTs are 
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synthesized while the filling material is sublimed, typically during the electric arc process, 
e.g., by using graphite anodes doped with both Co and Bi.110 This resulted in the product of 
Bi@SWNT or resulted with the peapods by using various carbon anodes doped with C60. The 
yield of this method is very low because of the high speed of the transient phenomena and 
the restricted volume where SWNT formation occurs in the plasma. Filling via liquid phase 
is another most common route used for preparing SWNT-based nano-complex. In addition to 
the above filling procedure, solution phase method is another simple and efficient filling 
method,94,110-112 with the advantage that filling temperature is close to the room temperature. 
In this procedure, the SWNT material is suspended into a solution of the filling material 
using the suitable solvent depending on the filling material and the specific requirements of 
the procedure, e.g. HCl for CrO3,94 HNO3 for Bi(NO3)3,110 AgNO3 111,112 and H2O for 
RuCl3.113 After filling, encapsulated metallic SWNTs can be obtained by reducing the 
inserted salts using a heat treatment under gaseous hydrogen.110,112 It was reported that 
Ag@SWNT can be obtained from the heat-treatment of AgNO3@SWNT at 350 °C in air.111 
This method has not yet been exploited a biomedical context.  
1.6 Application of functional SWNTs in molecular imaging  
    The molecular imaging is a new discipline in which probes known as biomarkers 
are used to visualise, characterise and measure biological processes at the molecular and 
cellular level in humans and other living systems without perturbing them. This new 
technique is applicable for diagnosis of diseases such as cancer, and neurological and 
cardiovascular diseases. The development and improvement of new ideas and methodology 
in molecular imaging discipline have enhanced the possibility of earlier and more precise 
diagnosis of various cancers. Generally, molecular imaging modalities include molecular 
magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), optical 
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bioluminescence, optical fluorescence, targeted ultrasound, single photon emission computed 
tomography (SPECT), and positron emission tomography.99,114 Molecular imaging methods 
use chemically synthesized probes to target molecular markers at different stages of diseases. 
These can also give whole-body readout of molecular changes of different diseases which is 
much more reliable and scientific than popular used in vitro/ex vitro assays. Non-invasive 
detection of various molecular makers can allow for precise and in time diagnosis and earlier 
treatment in early development stage of most of diseases.   
   Functionalised SWCNTs have been studied in the context of every single molecular 
imaging modality, including magnetic resonance (MR), optical, SPECT, and PET imaging.9  
SWNTs were loaded with aquated Gd3+n-ion clusters which may occur through the side-wall 
defects or end-of-tube openings to give linear super-paramagnetic molecular magnets with 
MRI efficacies 40 to 90 times larger than any Gd3+-based contrast agent (CA) in current 
clinical use. These ultrasound systems denoted Gd3+n@US-tubes led to a new paradigm for 
high-performance MRI CA design115. Michael S. Strano et al.116 reported that complexes 
formed by magnetic iron oxide nanoparticles and near-infrared117 fluorescent SWNTs can be 
utilised as dual magnetic and fluorescent imaging agents. The iron oxide particle-enriched 
(Fe-enriched) and iron oxide particle-depleted (Fe-depleted) DNA-SWNT solutions 
contained 35 wt % of magnetic particles, had a magnetization saturation of 56 emu/g, and a 
magnetic relaxation time scale ratio (T1/T2) of approximately 12 and also a longer spin−spin 
relaxation time (T2 :164 ms) than typical ferromagnetic particles. Gd3+n@US-tubes was 
confirmed as ultrasensitive pH-smart probes from pH 7.0−7.4. It indicated that Gd3+n@US-
tubes might be very good candidates for detecting of early stage of cancer where the 
extracellular pH value can drop to pH = 7 or below.118 Hongjie Dai et al. reported the 
utilization of PL-PEG-NH2 functionalised and semiconducting SWNTs as near-infrared 
fluorescent tags for probing of cell surface receptors and simultaneous cell imaging.119 
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Phospholipid-PEG-NH2 functionalised semiconducting SWNTs were attached to the 
antibody Rituxan to recognise CD20 cell surface receptor on B-cells and Herceptin aiding 
the recognition of HER2/neu positive breast cancer cells.  
1.6.1 Optical imaging using functionalised SWCNTs 
Fluorescent labeling of SWCNTs has been exploited for optical imaging applications. 
Massimo Bottini et al. reported the application of streptavidin-conjugated quantum dot 
decorated SWNTs in both optical and confocal fluorescent microscopies.120 The 
supramolecular luminescent nano-complex can form stable dispersions under physiological 
conditions. Complexes were internalized by Jurkat T leukemia cell by multivalent CD3 
receptor-mediated endocytosis (adsorption by cell).  
Hongjie Dai et al. reported that SWNTs conjugated with various targeting ligands 
including Herceptin (anti-Her2), Erbitux (anti-Her1), and RGD peptide exhibited distinct 
Raman G-band peaks which have been used for multiplexed multicolour Raman imaging of 
biological systems (Figure 1.7).121 An optimised noninvasive Raman microscope was used to 
evaluate targeting effects and localization of RGD-SWNT and compare to plain-SWNTs. 
Results of imaging indicated that increased accumulation of RGD-SWNTs in tumour (p < 
0.05) compared to plain-SWNTs over the next 72 h was observed. Antibody-functionalised 
SWCNTs have recently been used as multicolor Raman labels for highly sensitive, 
multiplexed protein detection in an arrayed format.122 




Figure 1.7.   (a) Merged Ultrasound (grey) and photoacoustic (green) images of 
one vertical slice (white dotted line) through the tumour. Injection with SWNT-RGD 
induces a significantly higher photoacoustic signal than injection with plain SWNT in 
tumour site. (b)SWNTs tagged with different isotope compositions show distinct 
Raman single walled carbon nanotubes (SWNTs) with different isotope compositions 
show distinct Raman G-band peaks and accordingly show different Raman colours. 
This can be used for multicolour imaging of biological systems. [Image adapted 
from121,123,124] 
 
1.6.2 PET and SPECT imaging using functionalised SWCNTs 
 PET uses positron emitter-labeled molecules in very low concentrations (<10-9 M) to 
image and measure the function of biological processes with minimal disturbance.125,126 
Normally the sensitivity of PET is significantly higher than SPECT. After the development 
of micro-PET scanners, scientists can use small-animal imaging studies (which can provide a 
similar in vivo imaging capability in mice, rats, and monkeys) to facilitate and prove clinical 
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translation of lab derived PET agents.127 The SPECT images emerge from gamma-ray 
emissions. 3D images can be obtained from radioisotope decays and emitted gamma rays 
detected by a gamma camera. Carbon nanotubes are promising candidates for PET or SPET 
imagines in vivo. Haifang Wang et al. studied the distribution of 125I  labeled water-soluble 
hydroxylated carbon single-wall nanotubes in mice.128 This study, for the first time, affords a 
quantitative analysis of carbon nanotubes accumulated in animal tissues. Later, 111In labeled 
DTPA functionalised water-soluble SWNTs were used for PET imaging purposes (DTPA= 
Diethylene-triamine-pentaacetic acid, Figure 1.8). After intravenous administration of 
functionalised SWNTs, radioactivity tracing study revealed that SWNTs were not retained in 
any of the reticulo-endothelial system (RES) organs (liver or spleen) and were rapidly 
cleared from systemic blood circulation through the renal excretion route.129 The whole body 
biodistribution in mice was studied using 64Cu- labeled SWNTs by in vivo PET. 
 
 
Figure 1.8. Synthesis of 111In-labeled CNT (top diagram) and SPECT imaging 
applications (bottom diagram). [Image adapted from Reference130. ] 
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The SWNTs used in this report were non-covalently functionalised with 
phospholipid–PEG (PL–PEG) and were surprisingly stable in vivo (Figure 1.8 a).  
PEGylated SWNTs exhibited relatively long blood circulation time and low uptake 
by the RES. DOTA was attached to the termini of the PEG chains and used to conjugate 
positron emitting radionuclide 64Cu (radio decay half-life t1/2 = 12.7 h). The conjugation of 
SWNTs to both 64Cu and Cyclo-(RGDyK), a potent integrin αvβ3 antagonist, aimed at in vivo 
targeting of integrin αvβ3-positive tumours in mice via specific RGD–integrin αvβ3 binding 
was reported.123,124  In order to evaluate the potential application of SCNT scaffold for 
tumour targeted radioisotope drug delivery. Covalently-attached DOTA chelates attached 
and 86Yttrium labeled SWNT constructs were synthesized from amine-functionalised, water-
soluble CNT (Figure 1.9).131 The whole-body distribution and clearance of yttrium-86 was 
studied at 3 and 24 hours post-injection using PET. The 86Yttrium disappeared from the 
blood within 3 hours and accumulated predominantly to the kidneys, liver, spleen and to a  
less extent in the bone.  
Novel radionuclide filled and carbohydrate functionalised SWNTs were prepared and 
used as radioprobes by Sung You Hong et al. (Figure 1.10).67 Metal halides (Na125I) were 
encapsulated inside SWNTs by a molten phase method under harsh conditions. The surface 
of carbon nanotubes was covalently modified with ‘biantennary’ carbonhydrates for 
improving dispersibility and biocompatibility. Intravenous administration of Na125I-filled 
glyco-SWNTs in mice was tracked by SPECT. High lung accumulation and zero leakage of 
isotopes to high-affinity organs (thyroid/stomach or excretion) of these radioprobes were 
demonstrated in vivo experiment. It remains the case that the synthetic method applied here 
was extremely time consuming in the biomedical radioimaging   
 









































Figure 1.9. Synthetic scheme to prepare 86Y-CNT and fused PET and CT images 




Figure 1.10. Molecular structure of GlcNAcD–X@SWNTs (X=CuBr, NaI or 
Na125I) (Middle). Whole-body SPECT/CT imaging of mice after immediately tail-vein 
and 7 days post-injection of the GlcNAcD–Na125I@SWNTs or Na125I with a scanning 
time of 40–60 min (Left).  [Image adapted  from paper 67] 
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1.7 Fluorescence spectroscopy  
   The use of fluorophores in bioimaging applications is an increasingly approach in 
biological studies. For examples, after the fluorophores are internalised by cells they may 
bind within cellular structures of interest. Upon irradiation with laser light, fluorophores 
inside of cells can absorb energy from photons, a valence electron of this molecule is 
activated to jump to a higher energy orbit. Electrons cannot remain excited at this energy 
level, they return back to the original level of lower energy, ground level and certain 




Figure 1.11. Jablonski diagram illustrates the energy states transfer. Fluorophore 
without absorbing energy stays at the ground state level S0. After it is excited by 
photons with certain wavelength, the excited state S1energy. Normally fluorophore can 
exist in number of vibrational energy levels at each energy state; one energy state has 
multiple lines. The fluorophore can not maintain stable in this excited energy level, it 
will drop back to the stable energy level which gives the emission. The time of 
fluorophore staying in this excited energy level ranges from nano- to picoseconds for 
most standard fluorophors.132,133  
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1.7.1  Confocal laser scanning microscopy (CLSM) 
Confocal laser scanning microscopy (CLSM) is a technique which can acquire in-
focus high-resolution images with depth selectivity. Basically, images are formed by 
collecting signal point-by-point from the sample and mathematically transferring to two-
dimensional or three-dimensional photos. A conventional microscope can collect signals 
from the whole range as far into the specimen as the light can penetrate, but a confocal 
microscope just collect signals from one depth level at a time. CLSM can focus on very 
limited depth level and scan all levels to reconstruct the interior images. This technique can 
let researcher obtain the three-dimensional profile not just surface profile of the objects of 
interest.  The basic principle of this technique can be traced back to Marvin Minsky’s patent 
in 1961.134 This technique became a standard technique until the end of the 1980s after the 
development and utilization of lasers for CLSM. Using laser scanning method for profiling 
3D structure of biological species labeled with fluorescent markers was designed by Thomas 
and Christoph Cremer in 1978.135 Then this technique has become more and more mature 
due to instrument development by academics and industry partners.  
  In a confocal laser scanning microscope, a laser beam enters the system and is 
focused onto certain depth level of specie by objective lens. In biological application, the 
specimens are normally fluorescent or labeled with fluorescent reporter. Fluorescent light 
was generated after excitation by laser light, the emitted signal is collected by the objective 
lens and relayed to the detector. The confocality is achieved by a pinhole blocking in front of 
the detector. This pinhole passes the light from the confocal point while rejecting the 
majority of the light from the outside of the confocal area.  After passing the pinhole, the 
intensity of light is detected by a photodetection device (usually a photomultiplier tube (PMT) 
or avalanche photodiode), transforming the light signal into an electrical one that is used for 
reconstructing images by computer. 





Figure 1.12. The principle of setup of a confocal microscope. Laser light excites 
fluorescence emission from sample which can be collected by the objective lens and 
relayed to the detector. Light from out of the focus lane is rejected by the pinhole and 
the light originating from the focus is detected and transferred to electrical signal. 
132,133 
1.7.2 Fluorescence-lifetime imaging microscopy (FLIM)    
1.7.2.1   Fluorescent lifetime  
 A fluorophore which is excited by a photon following the absorption of energy and 





Focal point of sample  
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average time the molecule remains in its excited state before dropping to the ground state is 
the fluorescence lifetime. 
   The fluorescence emitted will decay with time according to this equation  
F(t) = F0e − t / τ 
Where  
. 
In this equation, τ is the fluorescence lifetime, t is time, F0 is the initial fluorescence 
at t = 0, and ki are the rates for each decay pathway. Fluorescence-lifetime imaging can be 
achieved by forming images with intensity of each pixel representing the lifetime τ, which 
can give the contrast images of objects based on the difference of fluorescence decay rates.  
1.7.2.2 Time-correlated single-photon counting 
 Time-correlated single-photon counting (TCSPC) is a method which can detect 
single photons of a periodical light signal, also measure of the decay time of  the individual 
photos and reconstruct the waveform from each measurements. Usually, TCSPC records 
times of corresponding pulse when individual photons are detected by a photo-multiplier 
tube 136). The recordings can be repeated for the continual pulses and a histogram of all these 
recording times can be generated (Figure 1.13). An exponential function contained the 
lifetime decay function can be fitted based on this histogram. The lifetime parameter can be 
accordingly extracted. 132,133 





Figure 1.13. Measurement Principle of TCSPC.  [Image adapted  from paper137] 
 
1.7.2.3 Applications 
1.7.2.3.1 Calcium Ion Concentration Imaging 
   This application is based on both fluorescence lifetime and fluorescence intensity 
change after calcium ion binds to fluorescent probe. The change amplitude of the intensity 
reflects the change of the calcium concentration influx into the cells because the ratio of 
bound and unbound calcium leads to the change of fluorescence lifetime and the measure 
pixel in the specimen. This principle also can be used to probe the cellular pH change.  
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1.7.2.3.2 Fluorescence Resonance Energy Transfer (FRET) 
   When mapping the lifetime of a population of fluorophores in single cell, a key 
factor will interfere with lifetime of individual fluorophore, in which a second fluorophore 
(acceptor) with the appropriate spectral properties can absorb energy from the first 
fluorophore (donor) by fluorescence resonance energy transfer.138 The decrease of the 
lifetime and fluorescence quenching of the donor, accompanied with an increase in acceptor 
fluorescence emission can be used to judge whether the FRET interaction happen or not 
between donor and acceptor. Also, FRET can be utilised as a tool for measuring distances 
between two biomolecules labeled with an appropriate donor and acceptor fluorochrome.138 
For example labeling two interested biomolecules with two spectrally distinct fluorophores 
and combining with FLIM imaging technique can provide a powerful tool to visualise the 
spatial distribution and also the interaction between these two biomolecules. Fluorescence 
microscope can give a maximum resolution of about 5 μm. Using fluorescence resonance 
energy transfer can increase the spatial resolution of the fluorescence microscope to below 
10 nm. This amazing leap in resolution makes FRET technique so attractive for studying co-
localization of two interesting biomolecules in live cells. 
1.8 Summary   
The introduction provided a brief overview of some recent developments in the fields 
of synthesis, functionalisation and characterization of carbon nanotubes with an emphasis on 
their biomedical imaging applications. Several methods used for the monitoring of the 
interactions between carbon nanotubes and living cells and organisms have been also 
highlighted. The reminder of this thesis describes the synthesis, characterization and cellular 
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imaging of novel nanohybrid materials based on single walled carbon nanotubes with 
potential biological applications. 
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Chapter 2 Interactions between amino acid-tagged 
naphthalenediimide and single walled carbon nanotubes 
for the design and construction of new bioimaging 
probes    
2.1 Introduction 
New synthetic routes to functionalised fullerenes and carbon nanotubes using molecular 
recognition and encapsulation techniques can lead to optoelectronic materials with 
nanotechnological applications ranging from future photovoltaics1 to nanoreactors for 
controlled chemical reactions2 and to  sensors and drug delivery devices.3-7 Single walled 
carbon nanotubes (SWNTs) have been studied for their potential as electronic nanodevices with 
unique electron transport properties on the nano-scale.4,8 The supramolecular encapsulation of 
fluorescent molecules inside the hollow cavity of SWNTs (e.g. polythiophenes9) and their self-
assembly onto the surface of aromatic carbon nanomaterials (e.g. tailor-made porphyrin hosts 10 
or water soluble perylenes11,12) has been a lively area of exploration in the quest for new nano-
hybrids with potential applications ranging from new luminescent materials to molecular 
imaging tools.4,5,7-9,12-33 Naphthalenediimides (NDI) are emerging both as a building block for 
organic nanotube creation34 and as a promising class of chromophores because of their strong 
absorption and fluorescence emission at visible and near IR wavelengths.35 NDI fluorescence 
emissions show maxima between 300-800 nm, including in the spectral region where the 
interference from the autofluorescence of living cells (300-650 nm) may be bypassed; this 
makes them attractive candidates as building blocks for optical imaging probes.35-42 NDI 
derivatives have been recently explored as DNA intercalators by virtue of their aromatic 
stacking with purines and pyrimidines40,43,44 and as fluorescent tags for hypoxia-targeting 
probes such as nitroimidazoles.45-47 Due to their aromatic stacking ability, fluorescence and 




electrochemical properties, NDIs are of interest as building blocks for biomimetic 
supramolecular and functional materials.48-50 Amino acid-functionalised NDI molecules self-
assemble into helical nanotubular, supramolecular structures from weakly polar solvents.51,52 
These dynamic structures are capable of recognising and solubilising fullerenes and ion pairs:53 
the Sanders group has shown that carbon materials such as C60 sense the helicity of the NDI host 
environment54 whereas C70  provoked an entirely unexpected reorganisation to give a hexameric 
receptor.55 The NDI supramolecular nanotubes which have cavities with diameters in the range 
of 1-2 nm created by hydrogen bonding have been shown to act as receptors for aromatic 
molecules including naphthalene-based guests or fullerenes.42,56  
Fluorescence imaging studies on fluorescent carbon nanotubes have thus far focused 
primarily on the measurement of the steady state spatial changes in emission intensity or 
wavelength.3,13-17,19,21,57-64 The use of fluorescence lifetime imaging microscopy (FLIM) in 
combination with multiphoton excitation and near infrared65 femtosecond laser pulses is widely 
used in the study of small molecule fluorophores.66-69 To date FLIM has been used primarily on 
endogenous molecules such as tryptophan and common fluorescent dyes (e.g. GFP-tagged 
proteins and fluorescein-based derivatives),70,71 with recent work exploring lifetime imaging of 
fluorescent platinum complexes permitting for the first time microsecond resolved emission 
imaging microscopy.70 There are, to the best of our knowledge, thus far no reports on 
supramolecular assemblies involving carbon nanomaterials studied by this method. The 
combination of two-photon excitation with fluorescence lifetime imaging techniques (FLIM) 
allows the use of near IR light to provide deeper tissue penetration, reduced cellular cytotoxicity 
and scattering and improved signal detection. Due to the defined nature of the emission lifetime 
and the sensitivity of lifetime measurements, excited state lifetime measurements could provide 
a powerful means by which to study donor-acceptor complexes in cells.  




We have been interested in the design and spectroscopic investigation of new 
nanomaterials with light emitting properties.63 The NDI nanotubular receptor recently 
developed52 has the ability to bind via donor-acceptor interactions to carbon nanomaterials, 
therefore we investigated the formation of a new nano-hybrid, denoted NDI@SWNT, in 
solution and on a preparative scale. We report here for the first time, the recognition and coating 
of the aromatic surface of steam-purified SWNTs (Thomas Swan Ltd, Elicarb SWNTs, free of 
catalytic impurities or carbonaceous materials from the nanotube synthesis, see Experimental 
section Chapter 7) by a new iodine- and amino acid-derivatised NDI. Investigations into the 
properties of the new material synthesized (in bulk and in dispersions in CHCl3, EtOH, DMSO 
and serum free aqueous cell culture media such as EMEM) have been carried out by Raman, 
circular dichroism, FT IR, UV-Vis-NIR and fluorescence spectroscopies and imaged at the 
nano-scale by HR TEM, SEM, EDS and TM AFM. The cellular translocation of the resulting 
NDI@SWNT complex was investigated by a combination of fluorescence microscopy 
techniques including fluorescence lifetime imaging and cytotoxicity assays (MTT) in cancerous 
and non-cancerous cell lines.  Here we have used such techniques to probe the integrity of a 
new nanocomposite denoted NDI@SWNT in vitro. Such an approach could aid the future 
understanding of the mechanism of action of supramolecular materials at the cellular level and 
improve the synthetic design of nano-hybrids for biomedical imaging and therapeutic 
applications. 
2.2 Results and Discussions  
2.2.1 Synthesis, single crystal X-ray diffraction and molecular modeling of new iodine-
tagged naphthalenediimides (NDI)  
 




To facilitate the direct observation of these nanodimensional aggregates by electron 
microscopy techniques coupled with energy dispersive X-ray spectroscopy (EDS) analysis, we 















µW, 5 min, 140 ºC  
Scheme 2.1. Synthesis of iodine-derivatised NDI 
The new amino acid-derivatised and iodine-tagged NDI was synthesized from L-4-
iodophenylalanine and 1,4,5,8-naphtalene-tetracarboxylic dianhydride, using a microwave-
assisted method(Scheme 2.1).51,52  
The molecular structure and supramolecular architecture of NDI was determined in the 
solid state by single crystal X-ray crystallography (Figure 2.1). The NDI molecules are oriented 
face-on and show two amino acid groups placed anti with respect to the aromatic core. No 
aromatic stacking was observed in the unit cell but intramolecular and intermolecular dipole 
interactions link up stacks of NDI molecules, whereby the I…(O)COH dipole interactions have 
rather short (3.184 Å) separations. Thus, the NDI supramolecular structure shows weakly linked, 
hence flexible and likely to act as adaptive, tubular arrangements in the solid state, with cavities 

















      Figure 2.1. a) X-ray structure of NDI: unit cell fragment, view over axis a; b) Proposed 
structure of a fragment of NDI@SWNT composite: molecular mechanics minimised 
representation (Forcite) of NDI stacks self-assembled on the surface of a [10:10] SWNT 
fragment. [Color code: purple: I, grey/green: C, white:H, red:O, blue:N].  
To isolate NDI@SWNT composites on a preparative scale, a solution of NDI dissolved 
in CHCl3: EtOH 4:1 (6 mg/mL) was treated with 1 mg of purified single walled carbon 
nanotubes (Elicarb©, Thomas Swann). The mixture was sonicated for 30 min (340 W), 
followed by centrifugation (1500 rotations/min) and filtration (a 200 nm pore diameter 
membrane). The separated solid material was dispersed in minimum amount of CHCl3: EtOH 
4:1 and the sonication, centrifugation and filtration sequence was repeated at least 3 times 
(stages 1-3 of dispersion experiment). The resulting liquid phases were analysed by UV-Vis, 
UV-Vis-NIR and steady state fluorescence spectroscopies (Figure 2.3, vide infra), which 
confirmed the removal of excess and weakly bound NDI and the presence of dispersible 
SWNTs. After at least 3 cycles of dispersion/filtration, the resulting solid residue denoted 
NDI@SWNT was redispersed in CHCl3: EtOH 4:1 (with 30 min sonication, stage 4) to give a 
transparent dispersion (0.2 mg/mL, Appendix Figure 8.1) which was stable for days without 
precipitation. Formation of stable and clear dispersions was also observed when DMSO or 
aqueous cell medium (EMEM, Eagle’s Modified Essential Medium, phenol-red free) were used 
to ‘solubilise’ the NDI@SWNT hybrid.  
a 
b 




 In an attempt to describe the structure of NDI@SWNT, we propose a molecular 
mechanics (MM+, Forcite) model of SWNT encapsulated within the supramolecular 
nanotubular receptor framework of NDI based on the X-ray structure determination of the NDI 
(Figure 2.1). It has already been shown that certain NDI networks may adjust their adaptable 
tubular cavities in order to encapsulate via aromatic stacking guests with diameters in the range 
of 1 nm (for C60 54 or C70 55). DFT computational modeling was used to aid our understanding of 
the geometry adopted by an isolated NDI molecule in the presence of a SWNT and the nature of 
its interactions with this aromatic guest. Here, the simplified SWNT model used was 1.6 nm 
wide. A hierarchy of DFT-based codes (SIESTA, Spanish Initiative for Electronic Simulations 
with Thousands of Atoms72) allowed the ab initio total energy calculations of these large 
systems, thus aiding investigations of the structural and electronic behavior of NDI absorbed 
onto SWNTs (Figure 2.2). To examine more closely the interaction between an isolated NDI 
molecule and SWNT surface we modeled at the DFT level a simplified capped model of a short 
[10,10] SWNT and two possible geometries for the corresponding NDI:SWNT 1:1 complex:  
(A) NDI decorates the sidewall of the SWNT and  
(B) NDI is bound face-on to the tip of the SWNT.  
Table 2.1 shows calculated distances at the binding of NDI to SWNTs. These compare 
well with the known, simpler model of NDI molecule bound to C60.  The calculated binding 
energies for the NDI interaction with the sidewall of the SWNT and to the tip of the SWNT are 
−0.84 eV and −0.66 eV respectively, indicating a π-orbital interaction between the NDI 
aromatic ring and the aromatic network of the model SWNT. According to the DFT estimated 
binding energies (Table 2.1), it is clear that the interaction between NDI and SWNT is of a 
similar order of magnitude to that between NDI and C60 and these are both of a rather weak 
non-covalent nature. In terms of binding energy values the NDI molecule binds more strongly 
to a single strand of a short and idealised [10,10] SWNT than to a C60 molecule. One of the 




limitations in the DFT model used is the overestimation of the binding energy caused by weak 
interactions.73 This has been first highlighted for the modeling of a supramolecular benzene 
dimer.74 For this simple aromatic stacking model interaction DFT calculations yielded an inter-
ring distance of 3.06 Å and a binding energy of −0.48 eV, whereas higher level modeling 
(CCSD (T)) calculations gave corresponding values of 4.1 Å and −0.05 eV respectively.74 A 
similar computational approach was applied hereby by our collaborator Dr Navaratnarajah 
Kuganathan (UCL) and was detailed in a previous publication by the Pascu group.63 
 
Note: 
a) Defined as described in Appendix Determined by the counterpoise correction (CP) 
method 75 
 
First-principles computational studies using density functional theory (DFT) were 
performed on a naphthalenediimide (NDI) molecule anchored onto a model single strand of a 
[10. 10] SWNT. Table 2.1 lists the binding energies calculated for the NDI@SWNT where the 
configurations shown in Figure 2.2 were optimised. These were compared with the simpler case 
 
Table 2.1. DFT-calculated binding energies Eb(eV) and NDI-aromatic guest distances in the 
optimised composite geometries. For a comparison, the gas-phase DFT estimated charge transfer at 







distances between  
aromatic surface  




Eb (unc) a 
Corrected 
binding 
energy (eV)  
Eb (CP) b 
NDI@C60 0.024 
3.230, 3.294, 3.307, 
3.334, 3.462, 3.484, 
3.523 −0.66 −0.31 
NDI@SWNT  
(Configuration A, 
middle of SWNT) 0.086 
3.150, 3.310, 3.455, 
3.700, 4.020, 4.090, 
4.140 −1.03 −0.84 
NDI@SWNT 
 (Configuration B, 
tip of SWNT) 0.044 
2.926, 3.104, 3.360, 
3.398, 3.587, 3.853, 
3.920 −0.95 −0.66 




of NDI binding to C60 giving a model complex NDI: C60 1:1.The interaction between the NDI 
and C60 molecules is −0.31 eV indicating a π-orbital interaction between the NDI aromatic ring 
and the C-ring of the C60. The calculated binding energies for the NDI interaction with the 
sidewall of the SWNT and to the tip of the SWNT are −0.84 eV and −0.66 eV respectively. 
According to these estimated binding energies, it is clear that the interactions between NDI with 
C60 or SWNT are both of a rather weak non-covalent nature. However, in terms of binding 
energy values the NDI molecule binds stronger to a single strand of a short and idealised [10,10] 
SWNT than to a C60 molecule. The closest C-C distances (Table 2.1) were measured in 
optimised geometries of the NDI@SWNT and NDI@C60 composites to further explore the 
nature of bonding in simplified 1:1 model complexes. Table 2.1 summarises the amount of 
charge transfer between a molecule of NDI and the aromatic guest (C60 or the model SWNT 
considered). Calculations show that the interactions between either C60 or SWNT and a single 
molecule of NDI occur with a negligible charge transfer in the gas phase. For the C60: NDI 
complex, the estimated charge transfer between one NDI and one C60 molecule was 0.024 
electrons. For the NDI@SWNT composite where an NDI molecule is bound to the middle of 
the SWNT strand (configuration A, Figure 2.2), 0.086 electrons were transferred between a 
molecule of NDI and the [10, 10] SWNT model. For the NDI@SWNT composite in the tip-
binding configuration B (Figure 2.2), 0.044 electrons were transferred between NDI and the [10, 
10] SWNT model. In order to investigate the charge transfer between two adjacent NDI 
molecules (in the absence of SWNT) we performed a control calculation on two stacked NDI 
molecules using a fragment of the asymmetric unit for the X-ray structure determination: this 
showed that a negligible NDI-NDI charge transfer occurs.  
Since the DFT-optimised model used for computational studies, considered only a very 
short length for the SWNT modeled (200 nm): this allows maximum 6 NDI molecules to bind 




in configuration A (to the middle part of the SWNT) and a further 4 NDI molecules to bind in 
configuration B (coating the tip of the SWNTs).  
Observations from HR TEM coupled with EDS (vide infra) showed that NDI molecules 
coating both the surface and the tips of the SWNT are giving a monolayer of NDI@SWNTs. 
NDI@SWNT composites with dimensions of 200-500 nm length have been observed by 
microscopy (AFM, SEM and HR TEM, vide infra) in samples deposited on supports from 
CHCl3: EtOH dispersions, Thus, DFT calculations estimate that overall approximately 2 
electrons are transferred between the nano-receptor formed by 10 molecules of NDI absorbed 
onto the outer surface of a 500 nm long capped SWNT fragment. Since fluorescence 
spectroscopy showed a significant quenching of NDI emission in the presence of SWNTs this is 
likely to be due to the donor-acceptor interactions and DFT calculations support this hypothesis. 
Calculations showed that for a model NDI@SWNT composite with configuration A 
(Figure 2.2 c, where an NDI molecule is bound to the middle of the SWNT strand, 0 0.086 
electrons were transferred between a molecule of NDI and the [10, 10] SWNT. For the 
NDI@SWNT composite in the tip-binding configuration B (Figure 2.2 d), 0.044 electrons were 
transferred between NDI and the carbon nanotube. In order to investigate the charge transfer 
between two adjacent NDI molecules we performed a control calculation in the absence of 
SWNT, where only two stacked NDI molecules were modeled. Initial geometries for the NDI-
NDI complex were generated using a fragment of the asymmetric unit for the X-ray structure 
determination. This showed that a negligible NDI-NDI charge transfer occurs in the absence of 
the aromatic guest (C60 or SWNT).  
Our DFT-optimised model used for computational studies considered only a very short 
length for the SWNT modeled (200 nm): this allows maximum 6 NDI molecules to bind in 
configuration A (to the middle part of the SWNT) and a further 4 NDI molecules to bind in 
configuration B (coating the tip of the SWNTs). According to gas-phase DFT modeling, NDI 




and SWNTs are held together by non-covalent interactions whereby approximately 2 electrons 
are transferred between the nano-receptor formed by 10 molecules of NDI absorbed onto the 
outer surface of a 500 nm long capped SWNT fragment. In solution, steady-state fluorescence 
spectroscopy showed a significant quenching of NDI emission in the presence of SWNTs. DFT 
calculations support the hypothesis that donor-acceptor interactions may occur between NDI 
and SWNTs and that these are similar in nature to those found in known  NDI-C60 complexes.54  
 
 
Figure 2.2. DFT-level optimised geometries (SIESTA) of model compounds: (a) a short [10,10] 
capped SWNT; (b) NDI molecule; (c) NDI molecule bound supramolecularly onto the middle 
part of a [10,10] capped SWNT (configuration a); (d) NDI molecule bound to the tip of a [10,10] 
capped SWNT (configuration b). [Colour code: black – carbon, red – oxygen, nitrogen – blue, 









2.2.2 Spectroscopic characterisation of NDI@SWNT composite 
 
Figure 2.3. Solid state FT IR spectroscopy of (a) and (b) NDI@SWNT composite; (c) and (d) 
free SWNT; (e) and (f) free NDI. Images a, c and d represent expansion in the 3400-2400 cm-1 
region of the spectrum, show the presence of –COOH in free NDI and in NDI@SWNT. 
Solid state FT-IR spectroscopy (Figure 2.3) of the solid composite prepared as above 
suggested functionalisation associated with nanotubes, with the spectrum clearly showing the 
carbonyl (C=O) stretching at 1730 cm-1, the C-O stretching at 1100 cm-1 and O-H band at 3300 
cm-1. Thus the presence of carboxylic groups associated with the tubes due to the amino acid 









Raman spectroscopy is a powerful tool for characterising functionalised carbon 
nanomaterials:76,77 spectra shown in Figure 2.4 were recorded for dispersed samples deposited 
from CHCl3:EtOH (4:1) or DMSO using λex= 830 nm, i.e. a region of the emission spectra of 
the NDI@SWNT without interference from fluorescence emission from NDI. NDI@SWNT 
showed features consistent with the occurrence of defects in the tube surface post-
functionalisation with respect to free SWNTs. The G band (which corresponds to a splitting of 
the E2g stretching mode of graphite and reflects the structural intensity of the sp2-hybridised 
carbon atoms) at ~1590 cm-1 and a disordered D band (generally attributed to the disordered 
graphite structure of the nanotubes) at ~1330 cm-1 were observed. For dried samples, deposited 
from CHCl3:EtOH 4:1, an increase in the ID/IG band intensity ratio of the NDI@SWNT solid 
composite (15%) was observed compared to the ID/IG of free SWNTs (9.5%), confirming that 
the supramolecular functionalisation of SWNTs has occurred.78-79. 
Raman spectra of NDI@SWNT also showed a G’ band at ca. 2600 cm-1 as well as the 
radial breathing modes (RBM) between 140-300 cm-1. The latter signal remained largely 
unchanged with respect to that of the starting material steam-purified SWNTs in DMSO or 
EMEM. Several broad peaks centered at 150, 165, 189, 235, 239 and 270 cm-1 are observed for 
pristine SWNTs samples and are also visible in the spectra of NDI@SWNT particles deposited 
on borosilicate glass slides from all  solvents investigated, i.e. CHCl3:EtOH 4:1, DMSO and 
aqueous media EMEM (Figure 2.5). The pristine SWNT sample contains tubes with a broad 
diameter ranging between 1.8 and 0.8 nm. RBM maxima indicate that tubes with diameters of 
1.6, 1 and 0.86 nm are mainly present (Footnote 1) in the starting material used. The spectrum 
of NDI@SWNT showed significant enhancement and sharpening of the RMB peaks at 147.5, 
165 and 240 cm-1 respectively, with respect to the RBMs of the pristine SWNTs used. This 
indicates that in CHCl3: EtOH 4:1, NDI@SWNTs dispersions contain tubes with diameters of 
1.65, 1.47 and 0.93 nm.  
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Figure 2.4. Raman spectroscopy of purified SWNT and NDI-functionalised SWNTs (λex=830 
nm, laser power at the sample 220 mW spot size 100 μm. (a) Full spectra for materials 
deposited on borosilicate glass from CHCl3:EtOH 4:1, 0.2 mg/mL dispersions; (b) expansion 
diagnostic of surface functionalisation of SWNT, showing D and G bands for CHCl3:EtOH 4:1. 
(c) RBM of SWNT upon NDI complexation. Spectra of solid materials were recorded three 
times from different areas of the nanomaterial and the average spectra reported. 
 
 









Figure 2.5. Raman spectrum of solid NDI@SWNT deposited from several solvents (λex=830 
nm) showing the intensity of G and D bands vs Raman shift (cm-1) (a and b) as well as RMB 
frequency modes (c).  
Several broad peaks centred at 150, 165, 189, 235, 239 and 270 cm-1 are observed for pristine 
SWNTs deposited from all investigated solvents (Figure 2.5 c). These signals correspond to 
SWNTs with a rather broad diameter range, from 1.7 to 0.85 nm but the main components of 
the pristine SWNT sample used (steam-purified Thomas Swann Elicarb) have diameters of 1.6, 
1 and 0.86 nm (estimated according to the equation ϖ= [(223.5/dt)+12.5], where constants 
223.5 and 12.5 were taken from literature80). In CHCl3:EtOH 4:1, NDI ‘solubilises’ SWNTs of 
diameters 1.65, 1.47, 0.93 and 0.87 nm, which are only very minor components of the SWNTs 
starting material used. This was evidenced from the significant enhancement of the 




coresponding RMB and the sharpening of the peaks at 147.5, 165 , 240  and 270 cm-1 
respectively. 
  To determine the most reliable NDI:SWNT mass ratio likely to lead to a complete 
binding of NDI to SWNT and stable dispersions (with respect to nanoparticle precipitation over 
24 h) in common solvents, fluorescence and UV-Vis spectroscopic titrations of NDI solutions 
onto SWNTs dispersions were carried out in several common solvents (CHCl3, EtOH, DMSO).  
First, aliquots of 2 μg/mL of NDI were added followed by 5 minutes sonication prior to 
recording each spectrum. The optimum NDI: SWNT mass ratio was obtained when a solution 
of 26 μM of NDI (21 μg/mL) was anchored onto 35 µg/mL SWNTs dispersed in CHCl3: EtOH 
4:1, DMSO or aqueous medium EMEM (containing up to 5 % DMSO) giving the NDI: SWNT 
mass ratio 0.6. The titration experiment was also repeated by the addition of SWNTs (dispersed 
in CHCl3:EtOH, 20 μg/mL aliquots) to a solution of NDI (26 μM). The direct spectroscopic 
observation for the SWNT surface recognition by NDI was thus achieved: NDI@SWNT 
formation on a preparative scale (using excess of NDI and the filtration /redispersion procedure 
described above) as well as titration experiments showed an extremely rapid quenching (with ca. 
80% decrease in fluorescence intensity) of the NDI fluorescence emission in the presence of 
SWNTs. Titration curves obtained were typical of very strong binding, as shown in appendix 
Figure 8.3. The binding of NDI to SWNTs appears to be too tight in solution and did not allow 
an accurate determination of the association constant using standard binding isotherms. 81 
Similar binding curves with extremely sharp end-points were recently observed at the tight non-
covalent binding of porphyrin oligomers to SWNTs: the binding constant was believed to be 
higher than 107 M-1 in such cases.81 
The UV-Vis spectroscopy of NDI@SWNT recorded in aqueous medium (EMEM) or in 
organic solvents CHCl3, CHCl3/EtOH, DMSO and EtOH showed very similar features (Figure 
2.6). UV-Vis spectroscopy showed that both NDI@SWNT and free dye NDI have broad and 




complex excitation spectra with three characteristic maxima in the 300-400 nm region. The 
occurrence of a new band was observed in the UV-Vis spectra of samples containing SWNTs 
(λmax = 280 nm), as well as significant broadening and red-shifting of the bands in the 388 nm 
region. In DMSO or in aqueous cells media (EMEM containing 1% DMSO), NDI@SWNT 
dispersions showed a ca. 6 nm red-shift of the band at 388 nm compared with the organic 
solvents investigated (CHCl3, EtOH). This suggests that the interaction between SWNTs and 
the NDI molecules absorbed is stronger in biocompatible environment (the cell culture media 
EMEM or in DMSO) than in the standard organic solvents investigated (CHCl3, EtOH).  
The fluorescence spectra of NDI@SWNTs were recorded for excitation wavelengths 
between 200-800 nm in CHCl3: EtOH, DMSO or aqueous media (EMEM, of relevance for 
bioimaging investigations) and are broader than those of the free NDI. Both NDI and 
NDI@SWNT show two emission maxima in the range 300-700 nm (Appendix materials). The 
position of these bands seems strongly influenced by the nature of the solvent and concentration. 
As stated above, the severe quenching of the fluorescence emission intensity was observed after 
adding SWNT (Figure 2.6c), indicating the strong absorption of the aromatic coating material 
onto the surface of the nanotube.41 A red-shift in the emission maxima of NDI (20 nm) was also 
observed upon its anchoring onto SWNTs (Figure 2.7 and Figure 2.8). The broadening in the 
UV-Vis spectra as well as decay in the fluorescence emission intensity with time was observed, 
and this behavior stabilises after 24 h presumably as the NDI absorption onto SWNTs reaches 
completion. The presence of the SWNT as the aromatic guest within the NDI supramolecular 
network (which acts as a nano-receptor) makes the dispersion phase determination of the 
fluorescence quantum yield of NDI@SWNT difficult to ascertain with precision. The quantum 
yield of the free dye was estimated as 2.4 % in CHCl3 and 1.6 % in EtOH (relative to 
[Ru(bipy)3][PF6]2 in H2O,82 which is within the range expected for this class of compounds.83  






Figure 2.6.  a) Preparation of NDI@SWNT monitored by UV-Vis spectroscopy in CHCl3: 
EtOH 4:1. (1)-(3): NDI@SWNTs composites during the stages 1-3 of the synthetic 
experiment; (4): redispersed NDI@SWNT composite from stage 4 (0.2 mg/mL) and (5): 
free SWNT (0.35 mg/mL); b) CD spectra of NDI@SWNT composite, recorded in fresh 
dispersions (20 min, followed by filtration through a 200 nm pore PTFE membrane) or 
after storing at r.t. for 24 h (0.2 mg/mL, CHCl3:EtOH 4:1); c) Typical fluorescence 
emission spectra showing the NDI fluorescence quenching upon treatment of a diluted 
solution of NDI (26 μM in CHCl3:EtOH 4:1, λex=280 nm) with SWNT (35 μg/mL); d) 
Emission/excitation map (normalised intensity) showing that the redispersed 
NDI@SWNT composite resulting after the stage 4 of the redispersion experiment retains 
fluorescence (0.2 mg/mL CHCl3:EtOH 4:1). e) UV-Vis spectroscopy of NDI@SWNT (0.2 
mg/mL) in organic and in aqueous cell culture media (EMEM). f) UV-Vis-NIR 











                                                          
Figure 2.7. Fluorescence spectroscopy (2-D excitation/emission wavelengths plots, with 
normalised intensities) for free NDI (26 μM) in CHCl3:EtOH 4:1 (a), CHCl3 (b), EtOH (c) and 
in EMEM: DMSO 99:1 (d), showing significant solvent-dependent behaviour. 
 
Figure 2.8. Fluorescence spectroscopy (2-D excitation/emission wavelengths plot, normalised 
intensity) of NDI@SWNT containing 26 μM NDI anchored onto 35 μg/mL SWNTs (mass ratio 
NDI:SWNT ca 0.6) in EMEM:DMSO 99:1. Fluorescence spectroscopy showed a significant 
red-shifting of NDI@SWNT emission maxima compared with that of the free NDI. 
(a) (b) 
(c) (d) 




The circular dichroism (CD) spectrum at the free NDI absorbance (330 – 400 nm) was 
assigned to interactions between the NDI couplets of sequential interacting NDI 
chromophores.84 Changes in the relative position of these moieties lead to changes in the CD 
fingerprint of the supramolecular assembly. CD spectroscopy showed new features for the 
NDI@SWNT composite which are due to NDI upon absorption onto the carbon nanomaterial, 
i.e. the sequential interacting NDIs change their relative position, leading to changes in the 380 
nm region of circular dichroism spectrum and the appearance of a new signal in the 260-280 nm 
region (Figure 2.6 b). CD spectroscopy shows that the initial aggregation motif of free NDI in 
solution is being altered by the presence of SWNT. The chirality of the amino acid-derivatised 
NDI molecule is also observed in the NDI@SWNT composites: this is consistent with earlier 
reports on DNA@SWNT composites studied by this method, whereby DNA helicity was 
believed to be sensed by carbon nanotubes in dispersions. 20,85,86  
The UV-Vis-NIR spectra of NDI@SWNT (recorded in pure CHCl3 or mixtures of 
CHCl3:EtOH 4:1) shows the lowest-energy van Hove transition S11 for NDI@SWNT (at 1204 
nm), and also typical S22 transitions at in the 960 nm region (Figure 2.6 f). Partially overlapping 
of S22 and metallic M11 transitions characteristic to SWNTs can be seen at 500-1000 nm in 
NDI@SWNT dispersions.  The S22 and S11 band are sharp compared to those observed in other 
supramolecularly functionalised SWNT composites (for example those of peptides78,87,88 or 
porphyrin oligomers81) absorbed onto the SWNTs, and closely similar to those observed in 
perylene-SWNTs composites11,12 Since these transition energies are related to the size of the 
SWNT bundles and the presence of isolated tubes in solution have been reported to give rise to 
sharp, well-resolved peaks,26 UV-Vis-NIR spectroscopy of the NDI@SWNT composite 
suggests that NDI is capable of efficient de-bundling of the SWNT strands in these common 
organic solvents. 




2.2.3 Solid state investigations by HR TEM, AFM and SEM 
High resolution transmission microscopy (HR TEM, JEOL 3000F) provided direct 
evidence for the presence of a monolayer of NDI coating the walls of the SWNTs (Figure 2.69 a 
and Figure 2.69 b). Areas of strong contrast due to heavy elements, attributable to iodine atoms, 
are clearly visible with respect to the lighter regions (due to the lower scattering elements 
present, i.e. carbon, hydrogen, nitrogen, oxygen) and in contrast to the initially clean SWNT 
surface observed for the high purity, SWNTs used (raw Elicarb SWNTs provided by Thomas 
Swann Ltd.). HR TEM also showed that NDI coated the ends of the SWNTs and that the NDI 
layer is less than 2 nm thick, consistent with the qualitative molecular mechanics model 
proposed in Figure 2.1 for a NDI-wrapped single strand of a [10,10] SWNT. The presence of 
amorphous carbon created by beam damage of the soft coating under the HR TEM working 
conditions cannot be fully discounted, but both low resolution TEM and HR TEM coupled with 
EDS allowed us to probe locally the surface of nanotubes where such dark spots were observed 
(Figure 2.9a). Characteristic peaks corresponding to iodine were detected in the EDS spectra in 
the 4 keV region. By contrast with the large bundles typically observed for purified but 
unfunctionalised SWNT starting material the NDI coated nanotubes tended to aggregate into 
















Figure 2.9. (a-c): Typical HR TEM images of the NDI@SWNT composite showing the 
uniform coating of SWNTs, including its tips (a and b), and the presence of ‘dark dots’ 
assignable to the heavy element iodine (Z = 53) in uniform layers on the aromatic surface; (d): 
TEM of free, purified, SWNT used. The EDS spectrum of NDI@SWNT composite deposited 
on glass support (e) and control EDS spectrum (f). 
a b 
c d 






























Figure 2.10. SEM and TM AFM imaging of NDI and NDI@SWNT deposited from 
CHCl3:EtOH. Aggregates of free NDI formed upon spin-coating onto a mica substrate, imaged 
by SEM (a) and TM AFM (b) showing formation of nanodimensional tower-like objects on 
mica; SEM micrographs showing a small bundle of NDI-coated SWNTs (c) and the 
morphology of NDI@SWNT (d); TM AFM imaging of NDI@SWNT (e). All SEM 
measurements were carried out on samples coated with ca. 2 nm gold layer. Concentrations: 
free NDI 26 μM; NDI@SWNT composite dispersion containing 21 μg/mL NDI (26 μM) 
anchored onto 35 μg/mL SWNT.  
The morphology of these new aggregates was confirmed by SEM and tapping mode 
AFM (TM AFM) (Figure 2.10). The coating with NDI was uniform and covered the entire 
aromatic surface of SWNTs. TM AFM of free NDI (spin-coated on mica surfaces from 0.2 
mg/mL solutions in CHCl3:EtOH 4:1) showed formation of tower-like aggregates with heights 
of ca. 10 nm and diameters of ca. 2 nm. TM AFM of the NDI@SWNT composite (spin-coated 









coating of the SWNTs and formation of small NDI@SWNT bundles with lengths of ca. 500 nm, 
and heights ranging from 10-50 nm, without free (unbound) NDI aggregates on the mica surface. 
2.2.4 Multiphoton fluorescence imaging of the NDI@SWNT complex in solution and in 
vitro   
To probe the potential of NDI@SWNT somposite as a precursor for future applications 
towards traceable imaging probes inside living cells, two-photon emission lifetime decay 
spectra were recorded by time-correlated single photon counting using pulsed laser excitation 
(λex= 910 nm in DMSO). DMSO was chosen as the solvent of use here for both NDI and 
NDI@SWNT showed minimum scattering due to aggregation within the experimental timescale 
in this solvent and due to its low volatility. Both systems exhibited more than one lifetime 
component: calculations (SPC Image analysis software) indicated a long component on the 
order of several nanoseconds and a much shorter component on the order of several hundred 
picoseconds. There are several differences between the lifetime decay spectra profiles of free 
NDI and NDI@SWNT (Figure 2.11), i.e. the lifetime of the long component drops by ca. 10%, 
from 2.67 ns (36 % weighting) in free NDI to 2.33 ns (27 % weighting) in NDI@SWNT. Only a 
slight increase in the short component lifetime and weighting was found for the dominant 
component, from 0.43 ns (64 % weighting) in free NDI to 0.41 ns (73 % weighting) for 
NDI@SWNT dispersions. The decrease in fluorescence lifetime of NDI upon immobilisation 
onto the SWNT (in DMSO) confirmed the fluorescence quenching by the SWNT surface via 
non-radiative pathways, in agreement with earlier reports on polythiophene-SWNTs nano-
hybrids.89  
For the high resolution laser scanning confocal fluorescence imaging of NDI@SWNT 
fresh dispersions (0.2 mg/mL in CHCl3:EtOH 4:1) were dropcast on a borosilicate glass cover 
slip and the solvent evaporated under air. High-resolution confocal imaging under single-photon 




(488 nm) or two-photon excitation (910 nm), using a mode-locked Ti-sapphire laser (see 
Appendix), generated images of the solid NDI@SWNT film by the raster scanning of the laser 
spot in the xy plane.  
 
Figure 2.11. Two-photon fluorescence spectroscopy: fluorescence decay traces and 
corresponding fitted curves for the lifetime determinations (λex = 910 nm, NDI 26 μM, pure 
DMSO, NDI@SWNT composite dispersion containing 21 μg/mL NDI or 26 μM anchored onto 
35 μg/mL SWNT).  
Two photon fluorescence imaging and emission lifetime measurements were carried out, 
using FLIM in solid state composite (deposited on borosilicate glass from CHCl3:EtOH 4:1 
dispersions) and in HeLa and MCF-7 cell lines (vide infra) for NDI and NDI@SWNT. Single 
photon laser scanning confocal fluorescence imaging showed solid NDI@SWNT particles 
retaining some fluorescence emission under single photon excitation (λex=488 nm) but this 
composite is a rather weak fluorophore with respect to standard organic dyes and the signal to 
noise ratio is normally dramatically improved when using 2-photon excitation. Within the 
NDI@SWNT film, fluorescent aggregates with irregular shapes and sizes ranging from ca. 200 
nm to 1 μm were observed in the differential interference contrast (DIC) micrographs, in the red 
(λem = 606 nm) and green (λem = 516 nm) channels of the single photon fluorescence emission 
images (λex=488 nm), as well as by two-photon fluorescence intensity and lifetime imaging 




(λex=910 nm). Intensity images of NDI@SWNT obtained from two-photon fluorescence 
excitation gave better signal to noise than one-photon excitation and fluorescence lifetime 
imaging and corresponding data fitting was obtained when 2-photon FLIM measurements were 
used (Figure 2.12). The fluorescence lifetime imaging shows lifetime emission maps for 
NDI@SWNT together with intensity maps showing the spatial variations in fluorescence 
emission and the lifetime distribution plots for the major lifetime component. For NDI@SWNT, 
the maximum fluorescence lifetime in the solid state of the major component (0.42 ns, with 
width at half-height WHH of +/-0.12 ns) is similar to the fluorescence lifetime measured in pure 

























Figure 2.12. Single photon confocal imaging (scale-bar 100 μm, λex = 488 nm) of solid 
NDI@SWNT composite drop-cast on borosilicate glass from a CHCl3:EtOH 4:1 mixture  
showing: (a) bright-field micrograph  (b) red channel emission (606 nm); (c) green channel 
emission (516 nm)  and d) overlay of (a)-(c) micrographs  
a b 
c d 




To test the biocompatibility and in vitro stability of the NDI@SWNT composite, 
cancerous (breast carcinoma MCF-7 and cervical carcinoma HeLa) and healthy (fibroblast Fek-
4) cells were treated with the composite dispersed in cell medium EMEM over a range of 
concentrations. Despite the strong quenching observed with respect to the free NDI fluorescence 
emission, some residual emission of the NDI absorbed onto SWNTs was sufficient to enable the 
observation of the nanocomposite in living cells (Figure 2.13, Figure 2.14, Figure 2.15 and 
Figure 2.16). Cell uptake was monitored in living cells by epi-fluorescence microscopy 
(following 30 min, 2 h, 3 h or 5 h incubation with NDI@SWNTs at 4 °C and 37 °C, λex 450 nm) 
and by single-photon laser scanning confocal fluorescence imaging (λex = 488 nm, 30 min, 1 h 
and 2 h incubation at 37 °C, Figure 2.13). The composites penetrate cell membranes at 37 °C 
but not at 4 °C, suggesting active uptake, possibly endocytosis, as the likely uptake 
mechanism.20 Colocalisation experiments showed some nuclear uptake for free NDI in all cell 
lines and this seems to increase in cells after 1 h incubation, as indicated by co-staining with 
Hoechst nuclear stain and fluorescence lifetime imaging (vide infra). To verify whether the 
supramolecular NDI@SWNT composites remain stable in vitro with respect to NDI loss, 
fluorescence emission lifetime measurements were carried out using 2-photon FLIM in HeLa or 
MCF-7 cell lines (1 h incubation, 37 °C, using 910 nm excitation from a mode locked Mira 
titanium sapphire laser, 180 fs pulse, 75 MHz) and data was compared with FLIM of the free 
NDI under identical conditions (Figure 2.15, Figure 2.16). Similar to the case of FLIM of the 
solid NDI@SWNT composite, data fitting for FLIM measurements of NDI@SWNT in cells 
was significantly more reliable for 2-photon excitation than compared to the 1-photon 
measurements. Figure 2.165 shows lifetime emission maps for NDI and NDI@SWNT in HeLa 
cells together with 2-photon intensity maps showing the spatial variations in fluorescence 
emission, the lifetime imaging maps and corresponding distribution plots for the predominant 




lifetime component (τ1) for either free NDI or NDI@SWNT composite. Similar images are 
included for the FLIM of NDI and NDI@SWNT in the MCF-7 cell line (Figure 2.16). 
 
 
Figure 2.13. Single Photon Laser scanning confocal imaging of  cancerous (HeLa) cells 
incubated at 37 °C where λex = 488 nm with: (a-l) NDI imaging (26 μM or 21 μg/mL in 1: 99% 
DMSO:EMEM) - 30 min incubation showing DIC (a), DIC-green-red channel overlay (b), 
green channel (515-530 nm) (c) and red channel (605-675 nm) (d); (e-h) 1 h  incubation 
showing DIC (e), DIC-green-red channels overlay (f), green channel (515-530 nm) (g) and red 
channel (605-675 nm) (h);  (i-l) 2 h incubation showing DIC (i), DIC-green-red channels 
overlay (j), green channel (515-530 nm) (k) and red channels (605-675 nm) (l); (m-p) 
NDI@SWNT composite dispersion (in 1:99% DMSO:EMEM) containing 21 μg/mL NDI 
anchored onto 35 μg/mL SWNT: DIC (m), DIC-green-red channels overlay (n), green channel 
(515-530 nm) (o) and red channel (605-675 nm) (p). Scalebar 20 μm.  
a b c d
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The lifetime distributions measured inside cells are within the same order of magnitude 
with the values acquired from studies in pure DMSO (Figure 2.12) for both the NDI and the 
NDI@SWNTs and compare well with the FLIM of the solid NDI@SWNT. The major lifetime 
components measured in cells incubated for 1 h (37 °C) were 0.65±0.15 ns for free NDI inside 
cells and 1.10±0.10 ns for NDI@SWNT in HeLa cells. A much broader lifetime distribution 
inside the cells than in solution or solid state was observed, and images of NDI@SWNT in 
HeLa cells showed regions of extremely high fluorescence intensity, corresponding to particles 
of ca 4 μm with extremely short emission lifetimes by 2-photon FLIM (0.07 ns or less). As 
expected, the relative weightings of the lifetime components obtained were somewhat different 
under the different conditions employed for cellular vs. solution lifetime estimations.90 An 
inspection of the DIC and confocal images suggest that these large aggregates contain SWNTs 
coated in fluorescent materials and are concentrated in the proximity of the cell membrane and 
also bound on the outer surface of the cell.  
Initial tests on the colocalisation of NDI and NDI@SWNT with the mitochondrial stains 
Mitotracker Red, and lysosome stain Lysotracker Red (Invitrogen) were carried out but results 
did not show any conclusive mitochondrial or lysosomal colocalisation (Figure 2.17). There was 
evident nuclear uptake both in the HeLa and in Fek-4 cell lines and this seems to increase in 
cells after 2 h incubation, as indicated by co-staining with Hoechst and fluorescence lifetime 
imaging. Further colocalisation tests using alternative stains to fully identify the specific sites of 
cellular localisation for these compounds and their effect on the cellular organelles are 
underway.  

























Figure 2.14. Single Photon Laser scanning confocal imaging of Fek-4 cells incubated for 2 h at 
37 °C in cells incubated for 2 h at 37 °C with: (a-d) NDI@SWNT composite dispersion (in 1: 
99% DMSO :  EMEM) containing 21 μg/mL NDI (26 μM) ‘anchored’ onto 35 µg/mL SWNT; 
(e-h): 21 μg/mL (26 μM) NDI in 1: 99% DMSO:  EMEM (i-l): 35 µg /mL free SWNT scaffold 
(dispersed in 1: 99% DMSO: EMEM). (m-p):  Control experiment where the cell nucleus was 
stained with Hoechst (λex 405 nm) prior to the experiment. Images (i-l) and 91 show significantly 
more damage to the cell morphology upon treatment than (a-d); images (a-d) and (e-h) show 
significant localisation of probe within the cell nucleus. Images show nuclear uptake for free 
NDI and significant deterioration of cells morphology. Scalebar 10 μm. 
 






Figure 2.15. Two-photon laser confocal fluorescence (λex= 910 nm):(a-c) solid NDI@SWNT 
composite (drop-cast on borosilicate glass from a CHCl3:EtOH 4:1 mixture): intensity image (a), 
lifetime mapping and scalebar (b) and corresponding lifetime distribution curve (c); (d-f) 
Typical micrograph of adherent cancerous cells (HeLa) incubated for 2 h at 37 °C with NDI (26 
μM or 21 μg/mL in 1: 99% DMSO EMEM) showing NDI uptake throughout cytoplasm and cell 
nucleus, intensity image (d), lifetime mapping and scalebar (e) and corresponding lifetime 
distribution curve (f); (g-i) Typical micrographs of adherent cancerous cells (HeLa) incubated 
for 2 h at 37 °C with NDI@SWNT composite (dispersions in 1: 99% DMSO : EMEM 
contained 21 μg/mL NDI (26 μM) ‘anchored’ onto 35 μg/mL SWNT. Intensity image (g), 
lifetime mapping and scalebar (h) and corresponding lifetime distribution curve (i). Bright spots 
show fluorescent NDI@SWNT composites translocated into cells as intact objects (Scalebar / 
Micrographs width = 100 μm). A key is provided for direct correlation between the lifetime 










      NDI 20 min incubation                  NDI  1 h incubation         NDI@SWNT  1 h incubation 
Average lifetime (WHH): 
                1562 ps                                          1568 ps                                    1224 ps 
Figure 2.16. Two photon intensity images (a-c) and FLIM (d-f) for NDI and NDI@SWNT in 
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Figure 2.17. (a):  INDI alone (no dye imaged in ex. 488 nm channel,); (b): NDI 
colocalised with mitotracker red. Only mitotracker emission visible in the red channel (ex. 
543 nm) without NDI emission in this channel; (c): NDI colocalised with lysotracker red. 
Only lysotracker emission in the red channel (ex. 543 nm) without NDI emission visible 
on this channel; (d) NDI@SWNT alone (no dye imaged in  ex. 488 nm channel). Scalebar 
20 μm. 




2.2.5 Cellular translocation monitoring of NDI@SWNT by MTT assays 
The different spatial distributions observed by DIC imaging coupled with fluorescence 
imaging and FLIM for the free NDI and NDI@SWNT in vitro suggests that the nanocomposite 
translocates into cells as a distinct intact entity and remains largely intact in the cellular 
environment within the timescale of these imaging experiments, i.e. is kinetically stable with 
respect to de-complexation by loss of NDI in vitro within the timescale of this experiment. 
Since the naphthalene diimides and structurally related monoimides are known to show cell 
toxicity and potent antitumour activities by virtue of their DNA binding38,92 standard MTT 
assays were used here to verify the cell viability in the presence of NDI, SWNT and 
NDI@SWNT under conditions similar to those used in the fluorescence microscopy 
studies(Figure 2.18). Assays showed that the materials investigated (free SWNTs, free NDI and 
NDI@SWNT hybrid) had only a moderate impact on cell viability at the 1 h time point at the 
same concentration used in the fluorescence studies. In separate experiments, cell metabolism 
MI50 values (the concentration that reduces cell metabolism to half that of untreated cells) were 
also determined via MTT assays over the traditional 24 h period. Dispersions of NDI, 
NDI@SWNT and free SWNT  (1% DMSO in  Eagle’s Modified Essential Medium EMEM 
containing 15% foetal calf serum FCS) were incubated with HeLa cells for 24 h at 
concentrations of 1 nM, 100 nM, 1 μM, 10 μM, 50 μM, 100 μM and 250 μM for NDI or NDI-
anchored onto SWNTs (whereby the mass ratio of NDI:SWNT was kept at 0.6, consistent with 
observations from fluorescence titrations) and concentrations ranging from 1 μg/mL to 250 
μg/mL for the pristine SWNT. MI50 values were estimated in each case from five repeat 
experiments (see Appendix Figure 8.9). It was interesting to note that after 24 h incubation at  
37 °C the pristine SWNTs seem to be significantly more cytotoxic than the NDI-functionalised 
SWNTs. MI50 values for free and functionalised SWNTs are within the same order of 
magnitude with earlier reports of the uptake of functionalised carbon nanotubes in 




vitro.7,30,58,60,93,94 Confocal imaging experiments already showed that both free NDI and 
NDI@SWNTs localise in the cell cytoplasm and partially in the nucleus too. Interestingly, an 
inspection of the cell morphology of free NDI treated cells suggested that these are significantly 
more damaged than of those treated with the NDI@SWNT composite or free NDI within 2 h 
incubation time. MTT assays suggest that NDI@SWNTs has a somewhat lower cytotoxicity 
compared to that of the free SWNTs and free NDI healthy cells (Fek-4) vs in cancerous (MCF-
7).  Interestingly, MI50 data estimated by MTT assays over the traditional 24 h observation 
period showed significantly lower toxicity of NDI@SWNT towards FEK4 when compared to 
MCF-7. Cell viability tests support the hypothesis from imaging experiments  that that free NDI, 
NDI@SWNT and free SWNTs all act upon healthy (Fek-4) and cancerous cells (Figure 2.13, 
Figure 2.14) over a wide range of concentrations, but that the NDI modulates the 
biocompatibility of the SWNTs and the resulting composite localises in the cell cytoplasm as an 
intact object. The NDI@SWNT composite has a higher cytotoxicity to cancer cells MCF-7 than 
to normal cells Fek-4, as shown both by MI50 determinations (Table 2.2, Figure 2.19 and in 
Appendix Figure 8.9) and via time-lapse MTT experiments(Figure 2.18). Both free NDI and 
SWNT-supported NDI (NDI@SWNT) exhibit low toxicity up to 6 h incubation in Fek-4 cells, 
with cell viability higher than 89% and 96% respectively. After 24 h incubation with NDI and 
NDI@SWNT, Fek-4 cells showed lower viability by comparison to that of controls, of 25% and 
45% respectively. Cell viability for the group treated with NDI@SWNT was 5% higher than for 
the case when free SWNTs were used, suggesting an increase of the SWNT biocompatibility 
upon wrapping and the significantly altered behavior of NDI@SWNT composite in vitro with 
respect to its individual components, i.e. free NDI or SWNT. In MCF-7 cells, free NDI as well 
as SWNT-supported NDI showed notable cytotoxicity at shorter time points. Cells treated with 
the NDI@SWNT composite show 53% viability after 6 h incubation for MCF-7 vs 96% 
observed for Fek-4. Pristine SWNTs showed cytotoxicity after 1-3 h incubation for both cell 




lines, with the faster inhibition observed in Fek-4 cells. The cell viability after 6 h incubation 
with NDI@SWNT was higher than that of pristine SWNT (96 % vs 63 %, Figure 2.18). Further 
investigations are underway in our laboratories to fully establish the precise mechanism for 
these differences, and whether size and/or shape of this new nanoparticle are influencing the 
biolocalisation and ultimately their toxicity in vivo.31,94-98  
 
a                                                                        b 
Figure 2.18. Cell viability is expressed as the percentage of viability measured for untreated 
cells (control) for MCF-7 (left) and Fek-4 cells cultured with purified SWNT, free NDI and the 
NDI@SWNT composite. Data were recorded after 1, 3, 6 and 24 hours incubation time (37 oC). 
In control experiments the cells were cultured in SFM (phenol-red free EMEM with 1% DMSO 
and also without DMSO). Concentrations (in 1: 99 % DMSO :serum free medium EMEM): a) 
0.70 μg SWNT dispersed in 100 μL solvent b) 0.42 μg free NDI dispersed in 100 μL solvent  
(5.15 μM); c) NDI@SWNT composite, formed in situ by anchoring 0.42 μg NDI onto 0.70 μg 
SWNT and dispersed in 100 μL medium. Two control groups were used consisting of 100 μL 
solvent / well, i.e. 1:99 % serum free medium, as well as 100% serum free medium. Each 
bar/value corresponds to the average result from three repeated experiments with three culture 
wells for each experiment.  
We observed that the surface functionalisation of carbon nanotubes with NDI reduces 
the SWNT toxicity behavior significantly both in cancerous and non-cancerous cell lines and 
mediates the biocompatibility of pristine SWNTs. Supramolecular wrapping is rapid and 
uniform thus bypassing the need for complex covalent synthetic procedures to be performed 
directly on the SWNT surface.99-101 The new NDI reported hereby is a biocompatible nano-
receptor that may be derivatised further by virtue of the carboxylic groups: this method of 
SWNTs wrapping could facilitate the rapid incorporation of targeting peptides onto the surface 




of SWNTs for precise cancer cell delivery in vitro. Future experiments are underway in our 
laboratories to construct and test in vitro and in vivo future nanotherapeutics based on this 
optically traceable NDI@SWNT scaffold.  
 
Figure 2.19. A comparison of MI50 values (μg/mL, shown on Y axis) for free NDI, NDI@ 
SWNT and free SWNT in healthy (Fek-4) and cancerous cells (MCF-7).  Cells were cultured in 
EMEM % FCS containing was 15% for Fek-4 and 10% for MCF-7 as this is standard for these 
cell lines ;  each experiment was repeated five times. 
Table 2.2. Calculated MI50 (± SEM values, μg/mL, the concentration that reduces cell 
metabolism to half that of untreated cells, 24 h MTT assay) for free NDI, NDI@ SWNT and 
free SWNT. Cells were cultured in EMEM each experiment was repeated five times.  
MI50 µg/mL MCF-7  
Breast carcinoma 
Fek-4 
Normal human fibroblast cell line 
NDI 13.76 ± 1.00 12.21 ± 1.17  
NDI@SWNT 34.08 ± 3.46 73.79 ± 3.87  
SWNT  17.81 ± 2.71 23.66 ±3.90 
2.3 Conclusions to Chapter 2 
In summary, we have developed a rapid and reliable method for the surface 
functionalisation of SWNTs via encapsulation by a new nano-receptor, NDI, which acted as a 
supramolecular host. A new supramolecularly functionalised fluorescent nanomaterial was 




synthesized on a preparative scale. Iodine atoms featured as a key design motif in the NDI 
structure to aid the identification by TEM of the uniform coating of the surface of the carbon 
nanotubes. 2,101 The ‘host’ is tightly wrapped around the carbon nanotube, forming a monolayer 
of NDI held to the aromatic surface by aromatic stacking reinforced by solvophobic effects. The 
NDI network adapts its geometry in order to accommodate a guest with diameters as wide as 
1.6 nm (i.e. a [10,10] SWNT). Charge transfer interactions are likely to occur between host 
(NDI) and guest (SWNT) in these composites in dispersions as suggested by significant 
quenching in fluorescence emission and DFT calculations in the gas phase. 
The NDI@SWNT hybrid is biocompatible, translocates in cells as an intact object and 
shows fluorescence emission in the visible range. Confocal fluorescence imaging showed that 
localisation in sub-cellular (Fek-4 and MCF-7) regions and that the NDI coating significantly 
enhances the biocompatibility of SWNTs and mediates its intracellular localisation. The excited 
state lifetime of the probes in cells versus solution phase indicates that the probes are not 
affected by the change in their chemical environment. The new amino acid functionalised NDI 
is amenable for further rapid derivatisation with functional groups and/or biomolecules92 via 
simple peptide coupling chemistry. Supramolecular coating led to the controlled and uniform 
functionalisation of the whole of SWNTs surface, including the coating of the SWNTs ends in a 
manner analogous to the fullerene binding by similar NDI-based nano-receptors and without the 
disruption of the aromatic network. This new nano-hybrid showed a significant output in the 
visible spectrum, opening up future possibilities for its incorporation in the next generation 
optoelectronic devices for both photovoltaic and biomedical imaging applications. We are now 
investigating further amino acid- and targeting peptide-derivatised NDI molecules as key 
components for the rapid assembly of imaging and drug delivery devices based on carbon 
nanomaterials.  
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Chapter 3 Synthesis of tumour targeting peptide tagged 
naphthalenediimide derivatives and their 
supramolecular complexes with SWNTs  
3.1 Introduction 
Fluorescence imaging technologies have become powerful research tools for cellular 
imaging and diagnosis as a result of the development of modern epifluorescence, confocal, 
and multiphoton microscopes. With the aid of these modern imaging facilities and in 
combination with fluorescent probe development, fluorescent-labeled organelles, molecules, 
and enzymes can be visualised with precision in vitro. The further chemical modification 
with specific targeting molecules attached to the fluorescent label is usually needed to 
localise specific targets in vivo and in vitro.  
In the past decades, synthetic peptide-based targeting fluorescence probes have been 
developed for diagnostic imaging and therapy. This is because of their advantages compared 
with large-sized antibodies: specific peptides are easily synthesized and modified, and they 
are less likely to be immunogenic, also they have rapid blood clearance.1-5 Bombesin 
peptides have attracted lots of research groups to investigate since many types of human 
cancer have been found to over-express bombesin receptors.6 This receptor family comprises 
three members in humans: the neuromedin B receptor (NMB-R), the gastrin-releasing 
peptide receptor (GRP-R), and the orphan bombesin subtype-3 receptor (BB3-R).7 GRP-R is 
the prominent subtype because its high expression has been detected on prostate, non-small 
cell lung carcinoma, breast and gastrointestinal stromal tumours.8 NMB-R and BB3-R also 
have been found over-expressed in intestinal carcinoids and small cell lung carcinomas.9 The 
same type of carcinoma even co-expresses two bombesin receptor subtypes. This suggests 
that bombesin peptide is a very good candidate for visualising these tumours in earlier 
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diagnosis. It is more and more important to develop GRP receptor targeting agents including 
the bombesin peptide for both diagnostic imaging and therapeutic application. Previous 
research studies have revealed that bombesin, a 14-amino-acid analogue of mammalian 
gastrin-releasing peptide, binds to the GRP-R with very high affinity and specificity. This 
compound, BBN (7−13) NH2 is the most popular peptide sequence used for designing 
tumour-specific radiotracers for early diagnosis or systemic radiotherapy of the GRPR-
positive tumours.   
Tumour angiogenesis is the process of growing new blood vessels that can assist 
cancerous growths through supplying nutrients and oxygen also removing waste 
products.10,11 Angiogenesis is an important mechanism involved in the of spreading of a 
tumour, and in a simplified explanation, cancer cells can invade into the blood vessel, and 
also can then be transported to a distant site.12-14 A secondary tumour will grow once cancer 
cell invade the normal tissue in this new site. Angiogenesis is a potential target for 
combating tumour as it plays a key factor in tumour metastasis and growth. Application of 
specific compounds that may inhibit new blood vessels at tumour site may help switching off 
the metastasis.  
The biomolecule called αvβ3 integrin is one of important molecular markers which 
involved in the mechanism of cell adhesion to the extracellular matrix (ECM). They are 
highly expressed during angiogenesis and playing an important role of transferring signals 
from extra-cellular environment to the intracellular compartment.15 αvβ3 integrin is absent in 
resting endothelial cells and most normal organ systems, rendering it a very potential target 
for anti-angiogenic cancer therapy. Tumour progression, invasion and metastasis of breast 
cancer, glioma, melanoma and ovarian carcinoma are all linked to αvβ3 integrin 
overexpression during tumour angiogenesis. It has been found that several proteins like 
vitronectin, fibrinogen and fibronectin can bind with αvβ3 integrin via the same amino acid 
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sequence arginine-glycine-aspartic acid or RGD.16-19 Based on this finding, pentapeptide 
cyclo(-Arg-Gly-Asp-DPhe-Val-) was developed by Kessler and co-workers and shows high 
affinity and selectivity for αvβ3 integrin.20-22 It has shown that cyclo-(RGDfK) is one the 
most prominent structures for development of molecular imaging agents for the assessment 
of αvβ3 expression.  
As described in Chapter 2, amino acid tagged naphthalene diimide (NDI) has 
attracted particular attention because of its electron accepting properties and good solubility 
properties.23 NDIs and their derivatives are relatively easily-functionalised materials24,25 
which have strong absorption and fluorescence emission at visible and near IR wavelengths. 
These make NDI-based derivatives attractive candidates as building blocks for optical 
imaging probes.  
In this chapter, two types of promising NDI-peptide imaging probes incoparating 
naphthalene fluorophore core, cancer specific targeting peptide (RGDfK and Bombesin[7-
13]) and an amino acid linking the NDI core with peptide chain were designed and 
synthesized through a EDC-mediated coupling (EDC=1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide. (Scheme 3.1) 
The rational reason that these probes were designed to incorporate cyclo-(RGDfK) or 
Bombesin[7-13] is that these are known to selectively bind to breast cancer cells and prostate 
cancer cells that overexpress specific receptor aiming to perform in vitro experiments. 
Furthermore, in this work, the conjugates of NDI dye with cyclo-(RGDfK) or Bombesin[7-
13] was used to image cancer cells in vitro in preliminary tests. 
The application of two-photon fluorescence microscopy has become a very potential 
tool for studying biological function in living cells and tissue as their many advantages 
compared with conventional imaging microcopies.26,27 Neuroscientists in particular prefer to 
use two-photon fluorescence microscopy to investigating subcellular neural structures and 
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their physiological function as this technique can image deep tissue with spatial resolution 
and reduced photodynamic tissue damage and fluorophore photo-bleaching effect.28,29   
Two photon excited fluorescence spectroscopy is a method that differs from single 
photon excited fluorescence in the first stage of normal fluorescence process (three stage 
process, normally consisting of: (1) excitation, (2) internal conversion, and (3) emission).30 
For two photon excitation, the transition of fluorophore from its ground state to an excited 
state happens by the near-simultaneous (~10-16 s) absorption of two photons. One photon 
excites the fluorophore to a ‘virtual’ intermediate state while the second photon further 
excites the fluorophore to the excited state before the virtual state decays (dephases), hence 
highly focused, very fast pulsed lasers are required (< 1 ps) so that instantaneous irradiation 
in the focal volume is high. Two photon excitation uses half of the energy needed for one 
photon excitation to excite a fluorophore in a one-quantum event.  
 Two photon absorption has already been extensively used for developing a new 
technique: two photon excitation microscopy, which allows the imaging of living tissue up to 
a very high depth (up to about one millimeter) and also allows the imaging of targeting 
processes to specific cells or tissue, making it possible to obtain the imaging of delicate sites, 
such as the retina and avoiding damage to healthy tissue.31  
In addition, exciting the fluorophore by two photon absorption requires photons with 
half the energy and double wavelength for the transition. This allows the diagnosis and 
treatment of deeper tissue with spectral windows between 800-1100 nm. Two photon 
excitation can be a potential and powerful alternative to confocal microscopy technique due 
to its deeper tissue penetration, efficient light detection and reduced phototoxicity.32 
 Until now, very few studies investigated small molecule fluorophores in cells using 
two photon fluorescence lifetime microscopy (FLIM). For example, cell uptake behaviour of 
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BODIPY (for boron-dipyrromethene) conjugates and diethynyl dipyrromethene- boron dyes 
were studied in HeLa cells using two photon excitation lifetime microscopy.33,34  
The potential of two photon fluorescence imaging technique combined with single 
photon confocal imaging provide powerful tool to study the peptide-derivatised fluorescence 
probes for cellular targeting applications. The potential of this technique for providing 
information on the stability under in vitro conditions of the peptide-based targeting NDI 
probes was discussed here.  
 
Scheme 3.1. Schematic representation of the methods applied for synthesis of peptide-
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3.2 Results and Discussion 
3.2.1 Synthesis of NDIBBN 
3.2.1.1 Bombesin [7-13] analogue 
The peptide analog used here is a GRP-receptor binding peptide, bombesin[7–13], 
(denoted BBN, 2). This amino acids sequence has been studied broadly and shown to bind to 
all four GRP receptor sub-types with high affinity.6 These GRP receptors are over-expressed 
in a variety of tumours, including prostate cancer, making BBN a potentially important 
labeling tag for both cancer diagnosis and therapy.  
    The targeting BBN peptide 2 was synthesized using standard Fmoc solid phase 
synthesis, cleavage, deprotection and purification on an insoluble polystyrene Rink amide 4-
methylbenzhydrylamine (MBHA) resin. The resulting BBN peptides 2 used in this study 
were characterised by electrospray ionisation-MS and HPLC (Table 3.1, Figure 3.2).  
3.2.1.2 Two routes for synthesizing the NDIBBN conjugate 
  A new naphthalene diimide-bombesin conjugate was synthesized by coupling NDI 
(synthesized as described in Chapter 2 and in appendix) to the amino group of glutamine 
residue of the conjugates. In here, two routes were designed to couple NDI with BBN.  
In the first route (Method 1), peptide 2 was attached to NDI in one reaction with 
EDC.HCl, HOBt·H2O in DMF. In the second route (Method 2), the NHS-activated NDI 
intermediate, the NDI succinate ester (NDI-OSu, 4) was synthesized in the first step. This 
intermediate is stable enough to be purified and stored at low temperatures in the absence of 
water. The success synthesis of 4 was confirmed by 1H NMR and HPLC characterisation. 
For the next step, 4 can react with amino group of glutamine residue of BBN peptide in DMF.  
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 All of the intermediate and resulting NDIBBN conjugates were purified by 
semipreparative HPLC and characterised by electrospray ionisation-MS (Table 3.1). ESI/MS 
and HPLC traces reveal that only mono-substituted NDIBBN (3) was produced in the 
Method 1 while double-substituted NDIBBN (compound 5) can be seen from the Method 2 
(see Experimental Details).  
We propose that in the Method 1 reaction, the steric crowding induced by BBN 
peptide when attached to one side carboxylic acid group of NDI leads prevents the effective 
activation of the second carboxylic acid group of NDI, which in turn cannot be effectively 
activated by NHS and this results in the production of only compound 3.   
However, a double NHS activated NDI intermediate was synthesized firstly in the 
second route, in which it is likely to avoid this steric hindrance by the peptide chain.  
Figure 3.1 shows the UV/Vis absorption and fluorescence emission profile of 
compounds 5 and 3 in pure DMSO (1 mg/mL concentration). Absorbance spectra show no 
significant differences between these two dyes which both have two maxima absorption 
around 360 nm and 378 nm.  
Compound 5 (resulting from Method 2) shows a small red-shift (1 nm) compared 
with compound 3 which may arise from the significant structural differences. Accordingly, 
the fluorescence emission spectra show no apparent difference of these two NDIBBN dyes 
with maxima emission peak at 396 nm (mono-substituted NDI, compound 3) and 400 nm 
(double-substituted NDI, compound 5), in which compound 5 has a 4 nm red-shift compared 
with compound 3.  
The formation of compound 5 and their intermediates were confirmed by 1H and 13C 
NMR wherever the solubility allowed this, and by ESI-MS and HPLC (Table 3.1, Figure 3.2, 
Figure 3.3).  
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                            （a）                                                                       （b） 
Figure 3.1. Normalised absorption and emission spectra of compounds 5 and 3 recorded 
in DMSO at 37 °C.  
 
Figure 3.2. HPLC chromatogram comparing of compound 3 with their starting materials 
(Mobile phase for column: 95 % 0.01 % water; 5 % CH3CN. Loading solvent for HPLC: 
DMSO. RP-column flow rate: 0.300 μL min-1.) 
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Table 3.1. Mass spectroscopy and HPLC analysis (reverse phase) of NDIBBN derivatives 
and their starting materials 
Molecule  Molecular formula [M+H]+ 
calculated
MS observed m/z RP-HPLC 
retention 
time(min) 
1 C32H20I2N2O8 814.93 813.9251 [M-] 10.94 
2 C38H56N12O8 809.44 809.44 [M + H]+ 









1643.0 [M+ K]+ 
8.31 




5 C108H128I2N26O22 2395.78 2434.43 [M+ K]+ 8.71 
 
 
Figure 3.3.  HPLC chromatogram compare of compound 5 with their starting materials 
(Mobile phase for column: 95:5, (0.1% TFA in water): (0.1% TFA in CH3CN, Loading 
solvent for HPLC: DMSO. RP-column flow rate: 0.300  μL/min.) 
 
3.2.1.3 Confocal fluorescence microscopy imaging 
Confocal fluorescence microscopy images showed that both compounds studied 
mono-NDIBBN (Compound 3) and double-NDIBBN (compound 5) were internalised by 
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PC-3 cancer cells after 25 minutes of incubation at 37 °C (Figure 3.4).  Both dyes mainly 
localise in the cytoplasm without penetrating the nuclear membrane. 
 
  
Figure 3.4. Single Photon Laser scanning confocal imaging (λex =543 nm) of PC-3 cells 
incubated for 25 mins at 37 oC with 38.9 µM mono-NDIBBN (Compound 3) in 5: 95 % 
DMSO: serum free medium (a-c) and 38.9 µM compound 5 in 5: 95 % DMSO: serum free 
medium (e-h). Scalebar 10 µm 
 
3.2.1.4 Cytotoxicity of NDIBBN derivatives (compounds 3 and 5) on fibroblast cells and 
prostate cancer PC-3 cell line  
In order to evaluate the cytotoxicity of compounds 3 and 5, the typical MTT assay 
was used here, in which the conversion of soluble MTT into formazan is directly related to 
mitochondrial activity and subsequently to cell viability. As shown in Figure 3.5 and Figure 
3.6, both compounds 3 and 5 show high cytotoxicity to prostate cancer PC-3 cells with IC50 
value of 22.53±3.1 µM and 6.38±0.9 µM, while they show low cytotoxicity to fibroblast 
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The selective inhibition behavior observed seems to suggest that both peptide-substituted 
NDIBBN have anticancer activity to PC-3 cells. Data indicates that these compounds have 
significant potential towards prostate cancer therapeutic applications. Moreover, data 
indicates that the double peptide functionalisation of the NDI core reduces the cytotoxicity 
towards a healthy cell line (Fek-4) and simultaneously shows increased growth inhibition 
towards prostate cancer PC-3 cells.  
 
Figure 3.5. Cell viability (fibroblast cell line Fek-4 and Prostate cell line PC-3) as a 
function of compounds 5 and 3 by typical MTT assay. Cells were cultured in 96-well plates 
for 24 h the day before the experiment at a density of 7×103 cells/well. Then the cells were 
treated with NDIBBN compounds with varying concentrations for 24 h, respectively. Error 
bars represent the standard deviation of three measurements. [NDIBBN]= 0-1000 μM, 
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Figure 3.6. IC50 (µM) of compounds 5 and 3 towards fibroblast cells Fek-4 and prostate 
cancer cells PC-3. 
3.2.1.5 Fluorescence lifetime microscopy imaging 
We are also interested of the lifetime distribution and fluorescence intensity of both 
NDIBBN dyes in cancer and healthy cells. Figure 3.7 shows lifetime emission maps for 
compounds 3 and 5 in PC-3 cells together with 2-photon intensity maps showing the spatial 
variations in fluorescence emission, the lifetime imaging maps and corresponding 
distribution plots for the predominant lifetime component (τ1) for both dyes. Lifetime 
analysis indicates that both compounds 3 and 5 show two components in PC-3 cells. The 
long lifetime decay component of compounds 3 and 5 in PC-3 cells are 1.92 ± 0.92 ns and 
1.66 ± 0.81 ns, separately (Table 3.2), in which compound 5 shows less lifetime compared 
with compound 3 but not too much.  The FLIM mapping of compound 5 shows a 
homogenous distribution of the fluorescence lifetimes throughout the cytoplasm area but not 
penetrating the nuclear membrane.   
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Figure 3.7. Two-photon laser confocal fluorescence (λex = 910 nm): fluorescence lifetime 
(a), fluorescence intensity (b) and corresponding lifetime distribution curve (c) of PC-3 cells 
incubated with compound 5 (38.9 µM in 5: 95 % DMSO: EMEM). Lifetime mapping and 
scalebar (d), intensity image (e), and corresponding lifetime distribution curve (f) of PC-3 
cells incubated with compound 3 (38.9 µM   in 5: 95 % DMSO: EMEM).  
 
Table 3.2. Lifetime decay constants for compounds 3 and compound 5 in PC-3 cell  
 
Compound τ1 / ns  WHHM / ns τ 1  % τ 2 / ns WHHM / ns  τ 2  %  χ2 
3 0.31 0.16 77.5  1.66   0.81 22.5 1.43 
5 0.71   0.18  84.9 1.92 0.92 15.1 1.20 
3.2.2 Synthesis and characterisation of 3@SWNTs supramolecular hybrid 
One important strategy for tracing the early stage of cancer cells is to using highly 
luminescent nano-vectors for qualitative or even quantitative in vitro detection of tumour 
cells. Quantum-Dot and gold rods decorated luminescent carbon nanotubes have been made 
for cancer cell imaging.35 The shortage of these methods is the high cytotoxicity of the 
decorated luminescent QD and gold rods.  Even overcoming the cytotoxicity of popular 
CdSe/ZnS quantum dots is a major problem of this material application.36  In this research, 
a b c 
d e f 
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we report a novel strategy to develop fluorescent tracers with the properties of precise 
detecting and low cytotoxic by wrapping carbon nanotubes with NDIBBN conjugate. We are 
aiming to use coat the entire aromatic surface of nanotubes by benign materials in order to 
decrease the toxicity of SWNTs, and render it traceable in vitro. Bombesin-derivatised NDIs 
were synthesised as described in Experimental section (Chapter 7) and used for the 
supramolecular functionalisation of carbon nanotubes.  
Upon mixing the peptide-NDI compounds with solid SWNTs in ethanol (0.125 mg/mL), we 
observed the formation of clear carbon nanotube dispersions. Since the peptide-NDI 
complexes are fluorescent they were also chosen to act as fluorescent tags for tracing the 
dispersed SWNTs hybrid in cells. The fluorescence emission was expected to be quenched 
by carbon nanotubes. As discussed in Chapter 2, some residual NDI fluorescence is retained 
and allows the tracing of the composite in cells.  The protocol involving in the use of 
bombesin as a peptide coupled to naphthalene diimide was investigated with a view to 
exploring its possible function as a vehicle for delivering this complex to tumour sites. The 
design engages to introduce the amino acid group of bombesin peptide to imide position of 
NDI and therefore reduce the cytotoxicity of carbon nanotubes. It is hoped that, as shown in 
Chapter 2, the NDI will cover the entire area of carbon nanotubes avoiding the exposure of 
aromatic surface to biomolecules in vitro and thus reducing the SWNTs’ cytotoxicity.    
3.2.2.1 High purity single carbon nanotubes for biomedical funtionalisation 
Different methods have been exploited to remove amorphous carbon, catalyst, such 
as gas phase reaction, acid oxidation, electrochemical oxidation, filtration, and 
chromatography.37 In this work, the objective was to use carbon nanotubes of highest purity 
as a vector for cellular delivery. Then the clear aromatic surface of carbon nanotube can be 
functionalised with biomolecules to decrease their cytotoxicity. Briefly, the cytotoxicity of 
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SWNTs can be due to several factors: metal impurities, surface area, dispersion and 
aggregation status, coating or functionalisation.38 Metal catalysts used in synthesis can be 
removed by acidic oxidising and converting to Fe(II), then washing with water at neutral pH. 
As also discussed in previous chapters, in this chapter we also used carbon nanotubes from 
Thomas Swann, purified by a steam-based method to remove the amorphous carbon and 
open the end of tubes, pioneered by the research group of Prof Malcolm Green (Oxford 
Nanotube Group).39,40 During the steam purification the graphitic shells which are normally  
coating the catalytic metal particles and amorphous carbon on the surface of carbon 
nanotubes are known to be removed without introducing further defects on the nanotubes 
walls. 39,40  Further purification gives SWNTs characterised by clear outer surfaces, as shown 
by HRTEM (see Chapter 5 Figure 5.1). This substrate, available from Thomas Swann Ltd 
(Elicarb), was used for all supramolecular functionalisation methods described hereby.  
3.2.2.2 Complex of compound 3 with SWNTs 
   In this report, mono-NDIBBN (compound 3) was selected for functionalising 
SWNTs forming imaging probes due to its high solubility and because it was available in 
highest yield. The 3@SWNT complex was prepared by mixing compound 3 water solution 
(2.4 mg, 1 μmol, 2 mL) with SWNT (0.25 mg, 2 mL) EtOH dispersion, then sonicating 20 
mins, solution was stirred at room temperature for 2 days. Dialysis of compound 3 and 
SWNTs mixture against phosphate-buffered saline (PBS, 50 mM, pH 7.4) was carried out at 
27 oC which can results in removal of unbound compound 3. Centrifuging was performed to 
remove the aggregate since the large, insoluble aggregates (> 1 μm size) are unlikely to be 
suitable for biomedical imaging applications.  
Approximately, 90% of the initial SWNTs sample was dispersed in aqueous media as 
described above in the presence of NDIBBN based on the UV-vis-NIR absorption analysis. 
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The UV-visible absorption spectra of NDIBBN in a DMSO solution (ca. 1mg/mL), 
compound 3@SWNT DMSO suspension and SWNT are presented in Figure 3.8. This shows 
that the lowest energy absorption band of compound 3@SWNT solution in DMSO is red-
shifted from 378 nm to 383nm relative to the spectrum of the pure compound 3 solution (1 
mg/mL dispersions). The red-shift of π- π* transition band of ca. 5 nm was observed: this 
was due to the possibility that charge-transfer interactions may occur between compound 3 
and SWNT.  
      Severe quenching of the fluorescence emission intensity and a large red-shift in 
the emission maxima of compound 3 were observed after compound 3 anchoring onto 
SWNT from the 2D fluorescent contour plotting and fluorescence spectroscopy (Figure 3.8 b 
and Figure 3.9, emission shifts observed were from λem max=396.5 nm to λem max = 417 nm).   
Compared with the sharpness of the maxima emission peak of compound 3, the 
emission peak of compound 3@SWNT is much broader. The maxima emission peak of 
compound 3 around 396 nm was not seen in 2D fluorescence contour plotting of 
functionalised SWNTs. These observations confirm that free, unattached, compound 3 
coating can be successfully removed after 3 cycles of the filtration/dispersion procedure 
described in Chapter 2 and above.  
This red-shift behaviour observed in the spectrum of compound 3@SWNT 
dispersions can be rationalised by the mechanism of fluorescence resonance energy transfer 
(FRET) a physical process resulting from induced dipole-induced dipole interactions at a 
close proximity (< 10 nm) between SWNTs and absorbed compound 3.  
The red-shift of emission suggests that more photon energy is required for compound 
3 fluorescence excitation due to SWNT absorption. The broadening of compound 3@SWNT 
emission spectrum was possibly due to the non-homogeneity of isolated or small bundled 
SWNTs present in dispersions.  
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Despite this quenching of fluorescence by SWNT, the residual fluorescence of bound 
compound 3 adequate for cell imaging, as described below. 
 
(a)                                                                    (b)  
Figure 3.8.  UV-Vis spectrum comparison of compound 3 and 3@SWNT (a), 
Fluorescence spectrum compare of compound 3 and 3@SWNT (b) (Dispersions 
concentration of ca. 1 mg/mL).  
 
Raman spectroscopy is a powerful tool in the study and characterisation of 
functionalised carbon nanotubes.  The Raman spectra (excitation 830 nm) of compound 3, 
steam purified SWNT and compound 3@SWNT are shown in Figure 3.11. The expected G 
band at ca. 1585 cm-1, disordered D band at ca. 1287 cm-1 and radial breathing modes (RBM) 
at 232 cm-1. The D-band is known from disordered sp2 carbon structure and has been 
considered as probe for C-atom vacancies, amorphous carbon stacking on the surface of 
nanotubes, chemical groups’ substitution and other symmetry-breaking phenomena.41 The 
dramatic decrease of the D-band intensity in compound 3@SWNT compared to the starting 
material, indicating that the covalent functionalisation route reported here can efficiently 
remove defects formed during purification. This represents an advantage compared to 
chemical modification on the sidewall which can cause a partial destruction of SWNTs. The 
significant peaks observed in NDIBBN  Raman Spectrum (303-380 cm-1, 609-694 cm-1, 
1038 cm-1, 1415 cm-1 and 2117 cm-1) are all present in compound 3@SWNT spectrum. This 
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indicates that SWNTs remain successfully functionalised by compound 3 after removing 
excess 3.  
 
(a)                                                               (b) 
Figure 3.9. 2D Emission/excitation contour plotting (normalised intensity) of free 
compound 3 (a) (38.9 µM in DMSO) and re-dispersed 3@SWNT composite (b) resulting 
after the stage 4 of the re-dispersion experiment (38.9 µM compound 3 binding with 60 
µg/mL SWNTs in DMSO). 
 
  Steam purified SWNTs used here were dispersed in EtOH by ultrasonication and 
deposited onto a lacey carbon coated TEM grid. Figures 3.10 a shows a typical HRTEM 
image of an individual debundled SWNTs with pretty clean wall surface. To examine the 
successful wrapping of 3 on SWNTs, 3@SWNTs composites were dispersed in EtOH using 
ultrasonication and deposited onto a lacey carbon/copper grid. Figure 3.10b shows a typical 
TEM image of a bundle of CNTs with 3 attached on the outside of the SWNTs compared to 
Figure 3.10a. The presence of 3 attached on surface of SWNTs was also can be confirmed by  
energy dispersive X-ray spectroscopy (EDS) analysis, Figure 3.10c clearly shows the iodine 
atom peaks are present in the 3@SWNTs EDS spectrum compared with  control EDS 
spectrum.  









Figure 3.10. Representative images from TEM (recorded as supported on lacey 
carbon/copper grids) of steam purified SWNTs (a) and compound 3@SWNT composites (b). 
The EDS spectrum of compound 3@SWNT composites deposited on glass support (c) and 
control EDS spectrum (d). 
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Raman spectroscopy was carried out to probe the presence of compound 3@SWNTs 
in cells. MCF-7 cells were incubated with compound 3@SWNT for 20 min, washed with 
3×PBS.  Cells were suspended in 2 mL PBS prior to the measurement. Raman scattered light 
was collected using an ISA Triax 550 spectrometer equipped with a 41 liquid-nitrogen 
cooled CCD. Intense G-bands centred around 1590 cm-1 and RMB range from 100 cm-1 to 
350 cm-1 were easily observed from spectrum collected from cytoplasmic region area of 
MCF-7 cells incubated with compound 3@SWNT. This measurement confirmed that this 
SWNTs-peptide hybrid was indeed translocated into MCF-7 cells (Figure 3.12).  
Several regions “black dots” can be observed in cytoplasm region from this optical 
image of MCF-7 cells. Control cells incubated in medium (without SWNTs) had no 
detectable SWNT Raman signatures under the same conditions. The higher noise level in the 
Raman spectrum in MCF-7 cells is possibly due to the Rayleigh and Raman scatterings of 
lipids and cell organelles. 
From this optical image of MCF-7 cells, black dots can be observed within cytoplasm 
region. Control cells incubated in medium (without SWNTs) had no detectable SWNT 
Raman signatures under the same conditions. The higher noise level in the Raman spectrum 
in MCF-7 cells is possibly due to the Rayleigh and Raman scatterings of lipids and cell 
organelles. 
 




Figure 3.11. Raman spectroscopy of compound 3 (a), purified SWNT (b) and compound 3 





Figure 3.12. Raman spectra acquired from cytoplasmic regions of the live MCF-7 cells 
alone and MCF-7 cells that were incubated at 37°C for 20 mins with compound 3@SWNT. 
The arrows in the optical micrographs denote the specific regions of the MCF-7 cells where 
spectra were acquired.  
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3.2.2.3 Laser scanning confocal imaging and life-time imaging of compound 3@SWNTs 
in cells 
Despite the strong quenching of the compound 3 by SWNTs, the residual emission of 
the absorbed compound 3 was sufficient for mapping the distribution of SWNT in living 
cells using single- and two-photon fluorescence microscopy.  
Cell uptake was monitored in PC-3 (Figure 3.13 and Figure 3.14) and HeLa cells 
(Figure 3.15) by single-photon laser scanning confocal fluorescence imaging (λex= 488 nm, 
25 min incubation at 37 °C). The luminescent nanocomposites mainly localise in the 
cytoplasm (for both PC-3 and HeLa cells) without entering into the nucleus which can be 
confirmed by the fluorescent mapping. 
 
Figure 3.13.  Single Photon Laser scanning confocal imaging (λex =488 nm) of PC-3 cells 
incubated for 25mins at 37 oC with: (a-d) compound 3 38.9 µM in 5: 95 % DMSO: serum 
free medium; (e-h): compound 3@SWNT in (38.9 µM compound 3 binding with 60 µg/mL 
SWNTs in 5: 95 % DMSO : serum free medium); (i-l): 5: 95 % DMSO : serum free medium 
control.  Scalebar 5 µm 





Figure 3.14. Single Photon Laser scanning confocal imaging (λex =543 nm) of PC-3 cells 
incubated for 25 mins at 37 oC with: (a-c) Compound 5   38.9 µM in 5: 95 % DMSO : serum 
free medium,  Scalebar 5 µm 
 
 
Figure 3.15. Single Photon Laser scanning confocal imaging (λex =488 nm) of HeLa cells 
incubated for 25 mins at 37 oC with: (a-d) compound 3  38.9 µM in 5: 95 % DMSO : serum 
free medium; (e-h): 3@SWNT (38.9 µM compound 3 binding with 60 µg/mL SWNTs) in 5: 
95 % DMSO: serum free medium (i-l): 5: 95 % DMSO : serum free medium control.  
Scalebar 5 µm 
 
(a) (b) (c) 
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To probe the potential of NDI@SWNT as a precursor for future applications as 
traceable imaging probes inside living cells, two-photon emission lifetime decay spectra 
were recorded by time-correlated single photon counting using pulsed laser excitation (λex = 
910 nm in DMSO). To compare the lifetime of NDI and compound 3, two-photon emission 
lifetime decay spectra of these two solid was recorded in DMSO by time-correlated single 
photon counting using pulsed laser excitation (λex= 910 nm). Clearly, the lifetime of 
compound 3  (1.23 ns) is significantly shorter than that of NDI (lifetime 2.67 ns) under the 
same condition and can be rationalised due to NDI fluorescence quenching by neighboring 
peptide chain, causing additional non-radiative pathways for the loss of fluorescence, 
perhaps through additional H bonding involving the peptide chain. 
To verify the cellular behaviour of the supramolecular compound 3@SWNT 
nanohybrid in terms of stability, fluorescence intensity and biolocalisation, fluorescence 
emission lifetime measurements were carried out using 2-photon FLIM in HeLa and PC-3 
cell lines (20 min incubation, 37 oC, using 910 nm excitation from a mode locked Mira 
titanium sapphire laser, 180 fs pulse, 75 MHz) and data was compared with FLIM of the free 
compound 3 under identical conditions.  
Figure 3.16 shows lifetime emission maps for compound 3 and 3@SWNT in PC-3 
cells together with 2-photon intensity maps showing the spatial variations in fluorescence 
emission, the lifetime imaging maps and corresponding distribution plots for the 
predominant lifetime component (τ1) for either free compound 3 or 3@SWNT composite.  
Similar images are included for the FLIM of compound 3 and 3@SWNT in the HeLa 
cell line (Figure 3.17). Lifetime imaging shows that both compound 3 and 3@SWNT have 
two lifetime components in HeLa and PC-3 cells (long component and short component).  
The long lifetime component of free compound 3 measured in PC-3 cells, HeLa cells and 
DMSO are 1.66 ± 0.81 ns, 1.93 ± 1.28 ns and 1.23 ± 0.19 ns respectively. These values are 
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rather close in terms of order of magnitude and suggest that the cellular environment does 
not interfere significantly on the lifetime of this compound.   
The short and long lifetime components of 3@SWNT are 0.24±0.11 ns (83 %) and 
1.45±0.72 ns (17 %) for PC-3 cells, while 0.56±0.38 ns (81.7 %) and 1.47±1.03 ns (18.3 %) 
for HeLa cells (Table 3.3 and Table 3.4).    
The short lifetime component is believed to be a contribution from intact 3@SWNT 
composite, which is due to the fluorescence of the NDIBBN (Compound 3) coating which 
was quenched by SWNTs.  Also It was found that the long lifetime component is present - 
this is supposed to be from NDIBBN (compound 3) dissociation, breaking free from 
composite in the cell. Based on the above analysis, we postulate that the “host” and “guest” 
components of compound 3@SWNT composites are separated to a certain degree during this 
incubation time inside of cell, but this level of dissociation was estimated at only ca. 20% 
within 20 minutes incubation.   
 
 
Figure 3.16. Two-photon laser confocal fluorescence (λex= 910 nm):(a,c,e) Typical 
micrograph of PC-3 cells incubated for 20 min at 37 oC with compound 3 (38.9 µM in 5: 95 
% DMSO:  EMEM showing NDIBBN mainly stay in cytoplasm surrounding nucleus, 
lifetime mapping and scalebar (a), intensity image (b), and corresponding lifetime 
distribution curve (c); (b, d, f)  Typical micrographs of PC-3 cells incubated for 20 min at 37 
oC with compound 3@SWNT composite dispersion (5: 95 % DMSO: EMEM contained 38.9 
µM compound 3 binding with 60 µg/mL SWNTs). Lifetime mapping and scalebar (d), 
Intensity image (e), and corresponding lifetime distribution curve (f).  
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Table 3.3. Lifetime decay constants for compounds 3 and 3@SWNT in PC-3 cell  
 
Compound τ1 / ns WHHM / ns τ 1  % τ 2 / ns WHHM / 
ns 
τ 2  % χ2 
3 0.31 0.16 77.5 1.66 0.81 22.5 1.43






Figure 3.17. Two-photon laser confocal fluorescence (λex = 910 nm):(a,c,e) Typical 
micrograph of HeLa cells incubated for 20 min at 37 oC with compound 3 (38.9 µM in 5: 95 
% DMSO:  EMEM showing NDIBBN mainly stays in cytoplasm surrounding nucleus, 
lifetime mapping and scalebar (a), intensity image (c), and corresponding lifetime 
distribution curve (c); (b, d and f) Typical micrographs of PC-3 cells incubated for 20 min at 
37 oC with compound 3@SWNT composite dispersion (5: 95 % DMSO : EMEM contained 
38.9 µM compound 3 binding with 60 µg/mL SWNTs. lifetime mapping and scalebar (b), 
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Table 3.4. Lifetime decay constants for compounds 3 and 3@SWNT in HeLa cell 
Compound  τ1 / ns  WHHM 
/ ns  
τ 1  % τ 2 / ns  WHHM 
/ ns  
τ 2  %  χ2 
3 0.49 0.29 77.5  1.93  1.28 22.5 1.19
3@SWNT 0.56  0.38  81.7 1.47 1.03 18.3 1.03
3.2.3 Synthesis of tryptophan-NDI-cyclo-(RGDfK) conjugate for biomedical 
imaging  
3.2.3.1 Synthesis, single crystal X-ray diffraction determination of tryptophan-
NDI(TrypNDI, 9) 
A new compound, tryptophan substituted NDI (TrypNDI, 9), was synthesized from L-
Tryptophan and 1,4,5,8-naphtalenetetracarboxylic dianhydride, using a microwave-assisted 
method as described in Experimental section (Chapter 7). The molecular structure and 
supramolecular architecture of compound 9 was determined in the solid state by single 
crystal X-ray crystallography (Figure 3.18). Single crystal X-ray diffraction data was 
obtained for tryptophan-NDI by Dr Gabriele Kociock-Köhn. Crystals suitable for analysis 
were grown from DMSO.  
A typical crystal was mounted using the oil drop technique, in perfluoropolyether oil at 
150(2) K with a Cryostream N2 open-flow cooling device. Single crystal X-ray diffraction 
data were collected using graphite monochromated Mo-Kα radiation (λ = 0.71073 Å) on a 
Nonius KappaCCD diffractometer. The structures were solved by direct methods and refined 
using the program WinGX42 and representations drawn using CCDC Mercury 3.0. In general, 
coordinates and anisotropic displacement parameters of all non-hydrogen atoms were refined 
except where this was not possible due to the presence of disorder.  
Abbreviated crystal data and structure refinement parameters are included in in 
Experimental section.  The cif file is available in the appended CD. 
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The new tryptophan NDI-RGDfK conjugate (TrypNDI-RGDfK, 11) was also 
synthesized by coupling compound 9 to the amino group of lysine residue of peptide RGDfK 
(compound 8). The formation of compound 11 and their intermediates were confirmed by 




Figure 3.18. a) X-ray structure of TrypNDI (Compound 9)– view over axis c 
 
Table 3.5. Mass spectrometry and RP-HPLC analysis of TrypNDI-RGDfK (Compound 11) 
and relevant starting materials 
Molecule Molecular formula  MS 
calculated  
MS observed m/z RP-HPLC 
retention 
time(min) 
8 C27H41N9O7    603 604.3910 [M+H]+ 7.95 
10 C44H30N6O12   834 857.45 [M+Na]+,  
873.46 [M+K]+,  
893.33 [M+K+NH4+2H]4+ 
10.63 
11 C90H102N22O20 1810.76 1812.75 [M+2H]
2+ 8.62 
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3.2.3.2 Confocal fluorescence microscopy imaging 
Figure 3.19 and Figure 3.20 give the confocal laser scanning microscopy images of 
compound 9 and 11 in PC-3 cells (λex =543 nm). Compound 9 shows emission in all 
channels after excitation at either 405 nm, 488 nm or 543 nm. By contrast, 11 only shows 
emission in the red channel after exciting at 543 nm. This indicates that after the compound 9 
tagging with two c(RGDfK) peptide groups, the excitation wavelength range narrows 
significantly. 
 
Figure 3.19. Single Photon Laser scanning confocal imaging (λex =543 nm) of PC-3 cells 
incubated for 25mins at 37 oC with: (a-c) Compound 9 (10 μM in 5: 95 % DMSO: serum 
free medium); (d-f): Compound 11 (10 μM in 5: 95 % DMSO: serum free medium).  
Scalebar 5 µm 
(a) (b) (c) 
(d) (e) (f) 
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Figure 3.20. Single Photon Laser scanning confocal imaging of PC-3 cells incubated for  
25 mins at 37 oC with Compound 9 (10 μM in 5: 95 % DMSO: serum free medium): (a-d) 
(λex =405 nm); (e-h) (λex =488 nm); 
 
3.2.3.3 Fluorescence lifetime microscopy imaging 
To demonstrate the potential of compound 9 and its RGDfK derivative compound 11 
for imaging applications, two photon fluorescence lifetime imaging microscopy technique 
was used here for mapping cellular distribution of compounds.  
Experiments were carried out at the Rutherford Appleton Laboratory with assistance 
and supervision from Dr. S Botchway.  
Lifetime measurements were recorded using time-correlated single photon counting 
with an excitation wavelength of 810 nm and the emission measured at 360-580 nm. The 
measurements of compounds 9 and 11 were carried out in DMSO solvent with concentration 
of 10 μM. Emission spectral detection was carried out using an Acton Research Component 
275 spectrograph and an Andor iDus 740-BU CCD camera.  
Cell uptake studies were performed using HeLa cells and PC-3 cells. Cells were 
plated on Petri dishes incorporating a glass cover slip and left to adhere for 12 h. Background 
(a) (b) (c) (d) 
(e) (f) (g) (h)
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lifetime images were recorded before the addition of compound. Cell dishes were then 
mounted on the microscope stage and kept at 37 °C.  
Compounds were dissolved in DMSO as solvent and added to the cells to achieve a 
final concentration of 10 μM dye in EMEM medium containing 5 % DMSO (v/v). Cell 
uptake was monitored after 25 min incubation, in which dyes reached a maximum after this 
time. Measurements were recorded for the complete field of view.  
The fluorescence lifetime images (FLIM) obtained for compound 9 and its RGDfK 
derivative compound 11 are displayed in Figure 3.21 and Figure 3.22 including an intensity 
map showing spatial variations in fluorescence emission, the lifetime map which displays the 
distribution of different fluorescence decay lifetimes over the cell and also the profile of 
corresponding lifetime distribution. Lifetime decay data (Table 3.6) shows that both 
compounds 9 and 11 have two lifetime components.  
Compound 11 shows relatively poor uptake in PC-3 cells considering the lifetime 
distribution. It is apparent from confocal fluorescence microscopy studies that both NDIBBN 
(compounds 3 and 5) and compound 11 predominantly localise in the cytoplasm with 
negligible nuclear uptake. It is clear from the lifetime distribution maps that the distribution 
of lifetimes over the cells is not homogeneous.  
  
         (a)                                                      (b)                                                  (c) 
Figure 3.21. Two-photon laser confocal fluorescence (λex = 810 nm):(a, b and c) Typical 
micrograph of HeLa cells incubated for 20 min at 37 oC with compound 9(10 μM in 5: 95 % 
DMSO: EMEM) showing: lifetime mapping and scalebar (a), intensity image (b), and 
corresponding lifetime distribution curve (c). 
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            (a)                                                 (b)                                                 (c)                    
Figure 3.22.  Two-photon laser confocal fluorescence (λex = 810 nm):(a, b and c) Typical 
micrograph of PC-3 cells incubated for 20 min at 37 oC with compound 11 (10 μM in 5: 95 
% DMSO:  EMEM showing compound 11 mainly stays in cytoplasm surrounding nucleus, 
lifetime mapping and scalebar (a), intensity image (b), and corresponding lifetime 
distribution curve (c). 
 
Table 3.6. Lifetime decay constants for compounds 9 and 11 in cell 
Compound Cell line τ1 / ns WHHM / ns  τ 1  % τ 2 / ns  WHHM / 
ns  
τ 2  % χ2 
9 HeLa  0.56   0.10   62.4 2.46  0.71 37.6 1.21 
11 PC-3 0.27  0.12  75.7  1.94  0.73 24.3 1.00
 
Figure 3.23 gives an overlay of the two photon emission lifetime decay spectra for 
compounds 9 and 11 with lifetime decay values provided in Figure 3.7 for each compound. 
The data profile includes the goodness of fit of the decay curves as χ2 the lifetime of each 
component and their weighting of each component. The χ2 value of 1.0 corresponds to an 
optimal single exponential fit of this measurement. χ2 value of more than 1.3 means an 
incomplete single exponential fit of this measurement. High χ2 values (>1.5) means either 
significant noise within the TCSPC setup (electronics and/or excitation source) or more than 
one component decay profile. Lifetime components data were processed using SPCImage 
analysis software (Becker and Hickl, Germany) or Edinburgh Instruments F900 TCSPC 
analysis software.  
The fluorescence lifetimes of both compounds 9 and 11 measured in the solution 
phase (DMSO) were found to decay as two component systems, with a long component on 
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the order of several nanoseconds and a much shorter component on the order of several 
hundred picoseconds. Compound 11 shows a longer lived component with 3.21ns (44.6 %) 
compared with 2.83ns (54.1 %) for compound 9.  However compound 11 shows a decreased 
shorter component with 0.55 ns (55.4 %) compared with 0.61 ns (45.9  %) for compound 9. 
The presence of the short components in such high percentage was attributed to aggregation 
in solution and scattering due to the possibility that organic NDI nanotubes or related 
nanodimensional objects may form in solution, as demonstrated by Dan Pantos and Jeremy 
Sanders.43 
 
Figure 3.23. Two-photon fluorescence spectroscopy: fluorescence decay traces and 
corresponding fitted curves for the lifetime determinations of compounds 9 and 11 (λex = 810 
nm, 10 μM, pure DMSO). 
 
Table 3.7. Lifetime decay constants for compounds 9 and 11 point decay 
Compounds τ1 / ns  τ1  %  τ2 / ns τ2  %  χ2 
9 0.61    45.9 2.83 54.1 1.66  
11 0.55  55.4  3.21 44.6 1.40 
3.3 Conclusion for Chapter 3 
In summary, we explored the development of a new series of molecular imaging 
agents based on using cancer targeting peptides (bombesin and RGDfK) coupled to NDI. 
Firstly, specific peptides bombesin[7-13] and RGDfK were synthesized using standard Fmoc 
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solid phase synthesis protocol. The resulting peptides were characterised and confirmed by 
ESI/MASS, MALDI and HPLC. Then, two type of NDI-peptide conjugates (NDI–bombesin 
and Tryp-NDI-RGDfK) were designed and synthesized through EDC-coupling route. Two 
routes were designed to couple NDI with bombesin, compound 3 was prepared from the 
Method 1 when compound 5 was formed from the Method 2. Also, compound 3@SWNT 
supramolecular complex was prepared through non-covalent interaction between NDIBBN 
with SWNTs by mixing compound 3 water solution with SWNT in EtOH dispersed phase. 
Fluorescence quenching and significant red-shift in the emission maxima of NDIBBN were 
observed after anchoring compound 3 onto SWNT in the 2D fluorescent contour plotting, 
which suggests that the charge-transfer interaction between compound 3 and SWNT and a 
successful binding between these two components occurs. The quenching is too strong to 
allow the successful determination of a binding constant by fluorescence titrations 
suggesting that the binding interaction is likely higher than 109 M-1.44 Raman spectroscopy 
probing the presence of intracellular carbon nanotubes also confirms the membrane 
translocation of NDI@SWNTs in MCF-7 cells.  
Tryptophan-NDI-RGDfK was also synthesized based on an analogous procedure to 
that applied in the NDIBBN synthesis. Both NDI-Peptide conjugates were purified and 
collected by semipreparative-HPLC and characterised by MALDI mass spectrometry. 
Fluorescent lifetime imaging and confocal laser scanning microscopies were utilised as 
spectroscopic tools for investigating cellular behaviour (e.g. stability, fluorescence emission 
and biolocalisation) of these new molecular imaging probes. Fluorescent lifetime mapping, 
fluorescence intensity profile, lifetime components and lifetime decay profile were all 
employed in an attempt to qualitatively estimate the integrity of these molecular imaging in 
cancer cells (HeLa, MCF-7 and PC-3 cell lines).   
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Chapter 4 Synthesis of individual polythiophene 
functionalised single walled carbon nanotubes as 
prominent fluorescent nanoprobes for cellular imaging  
4.1 Introduction 
In comparison with the widely used fluorescent proteins and dyes in biology, 
nanotechnology imaging probes have the potential to substantially improve the specificity 
and sensitivity of diagnostic imaging. They could, under correct conditions, provide non-
invasive and targeted detection in vivo.1  Nanotechnology-based bioimaging probes are 
predicted to generate a new era in molecular imaging.   
 Carbon nanotubes can be classed as one-dimensional nanomaterials possessing 
unique electronic and mechanical properties because of their very high length-to-diameter 
ratios. The application of CNTs for potential bioimaging tools has seen very promising 
progress in recent years.2-5  CNTs’ high length-to-diameter ratio of up to 132000000:1 and 
also a tremendously high surface area (~1000 m2/g) which are ideal constructs for coupling 
biomolecules and drugs. They are also naturally photo-luminescent in the near-infrared 
region.  However, CNTs also form aggregates which inhibit their usage in advanced 
biomedical applications.  Separating nanotube bundles to form individual nanotubes in 
solution and then forming stable CNT suspensions is a key factor for their usage as 
bioimaging agents.6 As discussed in Chapter 1, surface functionalisation is a popular method 
for dispersing CNTs. The known methods for CNTs’ functionalisation are normally divided 
into two types, covalent functionalisation and noncovalent functionalisation as descriped in 
Chapter 1.7   
Non-covalent functionalisation is an ideal route for enhancing CNT solubility without 
damaging its sp2 molecular structure as covalent functionalisation involves local destruction 
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of the sp2 hybridization. Non-covalent functionalisation includes polymer wrapping,8,9 the 
use of biocompatible surfactants,5 the encapsulation by supramolecular systems of small 
molecules such as surfactant micelles,10 and π-stacking by rigid, conjugated 
macromolecules.11  Hongjie Dai’s group at Stanford University reported an alternative, 
gentler technique of making a multimodal imaging probe for fluorescence, Raman and 
photoacoustic imaging by coating the CNT with a layer of phospholipids coupled with 
fluorescent molecules.12 Carbon dots are a type of emerging carbon substrate for cell 
imaging, individually as bright as quantum dots.13  According to preliminary work carbon 
dots14,15 can be internalized into cells much more easily than quantum dots.  However, 
quantum dots have advantages over carbon dots in terms of brightness and the ability to emit 
a range of colors while the fluorescence of carbon dots is exclusively in the green range. 
 An ideal class of fluorophores should have large differences from absorption, high 
absorbance values and photoluminescence frequencies (Stokes shifts), and high fluorescence 
(quantum yields).  Oligothiophenes with more than two thiophene rings or a substituted 
thiophene ring have interesting optical and electronic properties such as: fluorescence, 
semiconductance, and light emission if excited with light at the appropriate wavelength.  
Oligothiophenes are widely used in organic electronic devices and fluorescent probes 
because oligothiophene shows high absorbance values and large Stokes shifts.16  Time-
resolved experiments confirmed their fluorescent lifetimes are in the order of nanoseconds 
and it has been found that they can reach high quantum yields in solution as well as in the 
solid state.17  Additionally their photoluminescence frequencies can be tuned from the visible 
range to near-IR by changing the oligomer size and the position of substituents.18,19 
Oligothiophenes are soluble in both organic solvents and even in water after particular 
functionalization. Oligothiophenes have shown highly varying characteristics as a suitable 
fluorescent probes for detecting biomolecules. Oligothiophenes have been used as probes for 
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targeting and identification of intra- or extra-cellular protein aggregates which exist in a wide 
range of neurodegenerative conditions including prion, Parkinson’s, Huntington’s, and 
Alzheimer’s diseases.20   
 Fluorescence imaging studies on fluorescent carbon nanotubes have thus far focused 
primarily on the measurement of the steady state spatial changes in emission intensity or 
wavelength.21-36 The use of fluorescence lifetime imaging microscopy (FLIM) in 
combination with multi-photon excitation and near infrared37 femtosecond laser pulses is 
widely used in the study of small molecule fluorophores.38-41  To date FLIM has been used 
primarily on endogenous molecules such as tryptophan and common fluorescent dye-tagged 
proteins and fluorescein-based derivatives), with recent work exploring lifetime imaging of 
fluorescent platinum complexes permitting for the first time microsecond resolved emission 
imaging microscopy.42-44  Prior to this work and to the best of our knowledge so far there are 
no reports of using FLIM for studying the fluorescent behaviors of fluorescent carbon 
nanotube complexes after entering into cells. Due to the defined nature of the emission 
lifetime and the sensitivity of lifetime measurements, excited state lifetime measurement 
could provide a powerful mean to probe interaction between fluorescent carbon nanotubes 
with components in cells.  
 Recently, our collaborator Dr Peter Van Rijn  in Delft have reported the synthesis of 
new amphiphilic conjugated thiophenes45, which in water can self-assemble into micelles, 
and can create an energy transfer (ET) system by incorporation of suitable hydrophobic 
acceptor molecules into the hydrophobic micelle interior.46 No attempts to study their 
interactions with carbon materials have been made prior to this thesis and a discussion of this 
collaborative project carried out at Bath is given here (vide infra). 
In this chapter, a fluorescent conjugated dodecathiophene (denoted T12) oligomer 
(Figure 4.1) provided by Dr Peter Van Rijn at the University of Delft was successfully 
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utilised for helically non-covalent wrapping of SWNTs aiming for the generation of 
individual and stable SWNTs in the dispersed phase.   
The amphipathic conjugated oligothiophene T12 shows excellent dispersant abilities for 
de-bundling SWNTs in organic solvents as demonstrated by these experiments. The 
backbone structure of T12 can adapt to the curvature of SWNTs very well.  The highest 
debundling of carbon nanotubes in solution was achieved by wrapping SWNTs with T12.  
T12 also acts as a fluorescent coating on the surface of carbon nanotubes for tracking their 
trajectory in vivo and in vitro.  Investigation of the properties of T12@SWNT complex has 
been carried out by Raman, UV-vis-NIR and fluorescence spectroscopy and also by AFM, 
TEM and SEM.  The biocompatibility of T12 and T12@SWNTs in mammalian cells were 
evaluated by MTT assay to investigate the effect of coating on carbon nanotubes’ 
cytotoxicity. The cellular translocation behavior and intracellular fluorescent properties of 
the resulting T12@SWNT complex were investigated by a combination of fluorescence 
microscopy techniques of fluorescence lifetime imaging and confocal laser scanning 
microscopy.  The aim of this work is to develop a luminescent conjugated polythiophene 
functionalized CNT probe for cell imaging.  
 
Figure 4.1. Molecular structure of T12 provided by Dr Peter Van Rijn at the University of 
Delft 
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4.2 Results and Discussion 
4.2.1 Synthesis and characterizations of T12@SWNT dispersions 
 A typical procedure for preparing T12@SWNT dispersion is as follows: a mixture of 
SWNTs (0.1 mg) and the T12 polymer (0.1 mg) in CHCl3 (4 mL) was sonicated for 20 min 
and stirred for 2 days. After centrifugation (10000 rpm) of the resultant yellow-brown 
suspension for 30 min, the supernatant was taken and filtrated and washing with CHCl3 three 
times. The black complex on PTFE filter membrane was collected and dried in the oven at 
60 °C overnight.  The T12@SWNT composite can be dissolved again in CHCl3 and DMSO 
easily. As shown in Figure 4.2, transparent solution of T12@SWCNT system was observed, 
which remains stable for 3 months. 
4.2.1.1 Absorption spectroscopy and fluorescence spectroscopy 
 
Figure 4.2. Images of T12 solutions in CHCl3 (b) and T12@SWNT dispersions in CHCl3 
(SWNT~0.05 mg/mL) (a), SWNT (~1 mg/mL) (c) in CHCl3. 
 
 Figure 4.3 c depicts the fluorescence emission spectra of free T12 oligomer in a 
CHCl3 solution (70 µg/mL) compared to the spectra of T12@SWNT before 
([SWNT]i=70µg/mL, [T12]i=70µg/mL) and after ( [SWNT]i=70µg/mL, [T12]i=46µg/mL) 
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filtration. The maxima emission of T12 in CHCl3 is at 560 nm. After mixing and interaction 
of T12 and SWNTs, it shows that the binding of the T12 in the solution results in a 
broadening of emission at 560 nm. The new emission peak around 436 nm arises from T12 
bound on the SWNT surface. Disappearance of free T12 emission indicates that excess T12 
was removed after 3 filtration/dispersion cycle treatments. This blue-shift of 124 nm is due 
to the conformation change of T12 after its helical wrapping on the surface of SWNT.  The 
well resolved peaks of SWNTs (Figure 4.3 d) in the NIR range originate from electronic 
transitions between the first (S11) or second (S22) van Hove singularities of the nanotubes. 
The well-defined peaks also suggest that SWNTs are debundled very well without a 
significant amount of large aggregated SWNTs in the final dispersion. During the 
experiment, the solution phase was removed by 3 cycles of dispersion/filtration treatment.   
 
 
Figure 4.3. (a) UV-Vis spectroscopy of T12 and T12@SWNT (7.5 nM) in DMSO. (b) 
UV-Vis spectroscopy of T12 and T12@SWNT (7.5 nM) in CHCl3. (c) Typical fluorescence 
emission spectra showing the T12 fluorescence quenching and significant blue shift after 
interaction with SWNT. (d) UV-Vis-NIR spectroscopy of T12@SWNT composite (7.5 nM 
or 27.3 μg/mL T12, 70 μg/mL SWNT in CHCl3). 
(a) (b) 
(c) (d) 




Figure 4.4 shows the contour plot fluorescence spectrum of free T12 and T12@SWNT.  
It shows that free T12 has emission maxima around 560 nm, this peak also appeared in 
T12@SWNT complex solution before 3 cycles’ washing/filtration (Figure 4.4 b). 
The washing/filtration cycle significantly reduce the emission intensity of T12 while 
most of T12 was washed away and adsorbed onto the SWNTs, whereas the broad peaks with 
emission maxima between 420 nm and 470 nm originate from T12 adsorbed onto the 
SWNTs. The blue-shift due to the decreasing planarity of the polymer backbone after helical 
wrapping on the surface of SWNTs is about 90 nm in the emission spectra which 
corresponds to the distance from the highest energy emission peaks of free T12 to the peak 
maxima of the adsorbed T12 molecules.  
 
 
Figure 4.4.  Contour plots (linear color gradient) of the fluorescence spectra of (a) the 
T12 CHCl3 solution (19.2 nM or 70 μg/mL), (b) the T12@SWNT CHCl3 solution before 
filtrate (70 μg/mL T12, 70 μg/mL SWNT), (c) the T12@SWNT CHCl3 solution after filtrate 
(7.5 nM or 27.3 μg/mL T12, 70 μg/mL SWNT), (d) the SWCNT dispersion in CHCl3 (70 
μg/mL SWNT). 
 
 The idealised structure of the regioregular polymer should be planar and has the 
conjugation of π electrons distributed along the whole polymer backbone. We propose here 
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that the strong aromatic interaction between the thiophene oligomer and the aromatic surface 
of carbon nanotubes increases the twisting distortion of the polymer backbone. This type of 
conformational defect decreases the planarity and length of the conjugated system, leading to 
a blue shift of the emission maximum, analogous in its effect to the thermo-chromism effect, 
in which increasing temperature enhances the conformational defects, causing a blue shift in 
the UV-Vis spectra.   
4.2.1.2 Raman Spectroscopy investigation  
 The Raman spectra (excitation 830 nm) of both the T12@SWNT composite and 
steam purified SWNT are shown in Figure 4.5. Both  showed the expected G band at ca. 
1590 cm-1, a disordered D band at ca. 1300 cm-1 (consistent with the occurrence of defects in 
the tube post-functionalization), radial breathing modes (RBM) at ca. 265 cm-1 and G’ band 
at 2600 cm-1. The D (ID) band is attributed to a disordered graphite structure of the nanotubes, 
whereas the G (IG) band corresponds to a splitting of the E2g stretching mode of graphite, 
which reflects the structural intensity of the sp2-hybridized carbon atoms. The intensity of the 
D-band of T12@SWNT decreases compared to the starting material, indicating that the 
defects present in the starting material were removed during the functionalisation process.  
The increase in the band intensity ratio (ID/IG) of T12@SWNT (0.12) compared to free 
SWNTs (0.09) in the solid state reflects the relative degree of functionalisation of SWNTs. 
4.2.1.3 Surface analysis of T12@SWNTs complex 
 Before the washing/filtration treatment of the T12@SWNT composite dispersion, the 
AFM imaging shows that excess T12 formed a film and most T12@SWNTs were trapped 
beneath this film (Appendix Figure 8.12). After 3 washing/filtration treatment cycles, most 
of the free unbound T12 was removed successfully leaving the tubular T12@SWNT exposed 
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(Figure 4.6 a). The AFM height profiles show that the single layer coating of carbon 
nanotubes with a height of 3.5 - 5 nm (Figure 4.6 c, profile 1, 2) and a multilayer coating 
carbon nanotube with a height 10-12 nm (Figure 4.6 c, profile 3). It also reveals that polymer 
coats the surface of SWNTs evenly with an average repeat distance of thiophene units every 
8.3 nm (Figure 4.6d). T12 acts as a highly efficient dispersing agent capable of debundling 
SWNTs strands.  Some T12 crystals were attached to the tip of SWNTs even after 3 cycles 
of filtration/dispersion in CHCl3, which can increase fluorescence emission. A chart 
representation of T12@SWNT length distribution shows that 65% of tubes range from 200 
to 650 nm due to the sonication breaking SWNTs into fragments (Figure 8.10 in Appendix). 
 
Figure 4.5. Raman spectroscopy of steaming purified SWNT and T12@SWNT after 
washing (λex=830 nm, laser power at the sample 220 mW spot size 100 μm. (a) Full spectra 
for materials deposited silica wafer from CHCl3, 2 mg/mL; (b) Expanded Raman spectra 
showing D and G bands of SWNT and T12@SWNT. (c) RBM of SWNT upon T12 
complexation. Spectra of solid materials were recorded three times from different areas of 
the nanomaterial solid and the average spectra reported. 
 
The HRTEM images give the morphology of T12 functionalized SWNTs prepared in 
CHCl3 solvent (Figure 4.8). The worm-like materials attached onto the surface of SWNTs 
are presumably the T12 polymers which interact with aromatic carbon surface through 
(a) (b)
(c)
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aromatic interactions. Due to the presence of its two neighbouring hydrophilic and 
hydrophobic-functionalised thiophene groups, T12 seems to adopt a cis-conformation in 
aqueous environments resulting in a curved shape of oliogothiophene. This curved 
oliogothiophene would self-assemble to a “rod-like” structure as hydrophilic interaction 
(Figure 4.7 b).45,46  
 
Figure 4.6. (a) AFM imaging of T12@SWNT after 3 cycles’ filtration/dispersion 
treatment which shows most of free T12 was removed compared with the T12@SWNT 
solution before treatment. (b) typical imaging of  single T12@SWNT, (c) Line profile along 
the lines No 1, 2 and 3 respectively. (d) Line profile along the line No 4. 




                                                          （a） 
 
                                                                  (b) 
Figure 4.7. Schematic presentation of T12 polythiophene chain stacking on the surface of 
SWNTs (a). T12 which is amphiphilic in nature folds into “rod-like” structure in aqueous 
solvents with the curvature obtained from the trans to cis reorientation of the thiophene (b).  




















Figure 4.8. Typical HRTEM images of sample T12@SWNTs (dispersed in EtOH) (a-c). 
(a) global view; (b),(c) single SWNTs wrapped by T12 conjugated polymer, (d) EDS 
spectrum of SWNT control and (e) EDS spectrum of T12@SWNT.  
 
In weakly polar solvents (CHCl3), T12 is believed to adopt well-ordered, linearly 









                             Chapter 4 Synthesis of individual polythiophene-functionalised SWNTs  
 
 133
aromatic interactions (Figure 4.7 a). This also indicates that repeated sonication-
centrifugation methods enable isolation of T12@SWNTs in CHCl3 through strong interaction 
between polythiophene with carbon nanotubes.  
4.2.1.4 Confocal fluorescence microscopy imaging 
Confocal fluorescence microscopy images show that both T12@SWNT and T12 
were internalized by HeLa cells after 20 mins of incubation at 37 °C (Figure 4.9). The dye 
mainly localizes in the cytoplasm without entering into the nucleus. The arrows in Figure 
8.18 (see Appendix) clearly show that the black carbon nanotubes aggregate inside cells, 
confirming that the carbon nanotube can successfully translocate into the cell membrane. 
The level of the green fluorescence channel decreased in both T12@SWNT and T12 
incubation. The red fluorescence channel can maintain a similar level of illumination when 
exciting at 405 nm, 488 nm and 543 nm for the T12@SWNT and T12 incubation, while 
there is a significant decrease of the green fluorescence channel (see Appendix Figure 8.14 
and 8.16). The total fluorescence intensity profiles of crossing-line in HeLa cells show that 
both T12 and T12@SWNT have the maximum total fluorescence intensity using the laser 
excitation channel 405 nm in comparison to 488 nm and 543 nm (see Appendix Figure 8.14 
and 8.16). The fluorescence spectroscopy concluded that T12 gives maximum emission 
when exciting at 488 nm. However, cell images show both T12@SWNT and T12 have the 
strongest emission when exciting at 405 nm in HeLa cells, in which it is a blue-shift of the 
maximum excitation. T12 does not enter the nucleus of HeLa cells after 20 minute 
incubation, however the T12’s diffusion into the nucleus can be observed after 1.5 h 
incubation, as highlighted in in Figure 4.10.     





Figure 4.9. Single Photon Laser scanning confocal imaging of  cancerous (HeLa) cells 
incubated at 37 oC for 20 min where λex = 488 nm with: (a-d) T12 (1.92 nM or 7 μg/mL in 5: 
95 % DMSO:  EMEM), showing DIC (a), green channel (b), red channel (605-675 nm) (c) 
and DIC-green-red channel overlay (d). (e-h) T12@SWNT composite dispersion (in 5:95 % 
DMSO: EMEM) containing 7 μg/mL T12 anchored onto 18 μg/mL SWNT: DIC (e), green 
channel (515-530 nm) (f), red channel (605-675 nm) (g) and DIC-green-red channels overlay 
(h), Scalebar 5 μm.  
 
 Figure 4.11 shows that T12 in PC-3 cell has nearly zero emission in the red 
fluorescence channel compared to in HeLa cells. Additionally it is difficult to detect 
emission when exciting at 543 nm (Figure 8.19, see Appendix). Both T12 and T12@SWNT 
show that the dye mainly distributes in the cytoplasm not in the nucleus after 20 minute 
incubation (Figure 4.11).  The red channel (605-675 nm) emission can not be detected in PC-
3 cells incubated with T12 alone while T12@SWNT gives significant red emission at the 
same condition. The mechanism why T12 alone in PC-3 cells not gives red emission is still 
investigated (Figure 8.19 and 8.21, see Appendix).  
(a)                              (b)                           (c)                          (d) 
(e)                                  (f)                            (g)                               (h)




Figure 4.10. Single Photon Laser scanning confocal imaging of  cancerous (HeLa) cells 
incubated at 37 oC where λex = 488 nm with: (a-d) T12 for 20 min (1.92 nM or 7 μg/mL in 5: 
95% DMSO:  EMEM), showing DIC (a), green channel (b), red channel (605-675 nm) (c, 
very weak emission in red channel) and DIC-green-red channel overlay (d). (e-h) T12 for 1.5 
h (1.92 nM or 7 μg/mL in 5: 95% DMSO:  EMEM), showing DIC (e), green channel (515-
530 nm) (f), red channel (605-675 nm) (g) and DIC-green-red channels overlay (h), Scalebar 
5 μm.  
 
 
Figure 4.11. Single Photon Laser scanning confocal imaging of  human prostate cancer 
cells(PC-3) incubated at 37 oC for 20 min where λex = 488 nm with: (a-d) T12 (1.92 nM or 7 
μg/mL in 5: 95% DMSO:  EMEM), showing DIC (a), green channel (b), red channel (605-675 
nm) (c) and DIC-green-red channel overlay (d). (e-h) T12@SWNT composite dispersion (in 
5:99% DMSO: EMEM) containing 7 μg/mL T12 anchored onto 18 μg/mL SWNT: DIC (e), 
green channel (515-530 nm) (f), red channel (605-675 nm) (g) and DIC-green-red channels 
overlay (h), Scalebar 5 μm.    
(a)                              (b)                    (c)                          (d) 
(e)                              (f)                      (g)                               (h) 
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4.2.1.5 In vitro and in solution FLIM studies 
 In this work, Fluorescence lifetime imaging microscopy (FLIM) technique 
was used to visualize T12 and T12@SWNT taken up by cervical cancer cells (HeLa) and 
human prostate cancer cells (PC-3). FLIM was performed by using a confocal microscope 
(LSM 510, Carl Zeiss). A femtosecond mode locked Mira Ti:sapphire laser (Coherent Lasers 
Ltd) was tuned at 910 nm to generate two-photon luminescence from T12 and T12@SWNT. 
The laser pulse has a repetition rate of 75 MHz and duration of less than 180 fs.  The 
intensity image shows that T12 and T12@SWNT were localised around nuclei of both PC-3 
cells and HeLa cells imaged.  
FLIM provides contrast according to the fluorescence decay time of each pixel 
compared to the traditional imaging methods based on fluorescence intensity. The 
fluorescence intensity distribution may have no differences in two environmentally distinct 
regions, but fluorescence lifetime distribution can reveal such regional differences.  As well 
as being able to distinguish spectrally overlapping fluorophores,49 imaging of the 
fluorescence lifetime can also be used to investigate the surroundings and dynamic processes 
of  the fluorophore.50,51  
 FLIM images are showed under the intensity images are from the same samples with 
different coded colors representing different lifetime scales. The lifetime of each pixel is 
obtained by applying a single or multi-exponential fit; in this case a single exponential model 
was used. In PC-3 cells, the lifetime distributions of all the pixels are shown in Figure 4.12 e 
(T12) and Figure 4.12f (T12@SWNT). The main lifetime component of T12 is around 1713 
ps. There are two lifetime components of T12@SWNT in PC3, one is 0.8±0.3 ns and another 
is 2.0±0.75 ns which indicate there are at least two types of T12@SWNTs with different 
lifetimes. In HeLa cells, T12 presents two lifetime components, one is 0.11±0.08 ns and 
another is 1.663±0.66 ns (major component) (Figure 4.12e). The most likely possibility is 
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that T12 binds to cell components (for example proteins) forming a complex, which then 
changes the lifetime of T12. Surprisingly, T12@SWNT (Figure 4.13f) shows only one 
lifetime component (around 0.77 ns) in HeLa cell. The lifetime distribution profiles of T12 
and T12@SWNT show that both fluorophores have different interactions with the local 
environment in PC-3 cells and in HeLa cells: further investigations by the biophysicists at 
the Research Complex at Harwell would be needed, beyond the scope of this thesis to 
understand the different behavior of both fluorophores in a wider range of cells.    
 To probe the fluorescent nature of T12 and T12@SWNT in solution, fluorescence 
lifetime measurements were recorded for both compounds in DMSO using time-correlated 
single photon counting, with a 2-photon excitation wavelength of 910 nm. Two-photon 
emission lifetime decay spectra were recorded by time-correlated single photon counting 
using pulsed laser excitation (λex = 910 nm in DMSO). DMSO was chosen as both T12 and 
T12@SWNT showed very good solubility and dispersibility in this solvent and also due to 
its low volatility. Both compounds exhibited only one lifetime component. The lifetime for 
T12 measured in DMSO is ca. 1.6 ns (χ2=1.75), 1.2 ns for T12@SWNT (χ2=1.78) (Figure 
8.12, see Appendix). The faster fluorescent decay of T12 after stacking on the surface of 
SWNT (in DMSO) confirmed the fluorescence quenching by the SWNT surface (Figure 
4.14).  




Figure 4.12. Two-photon laser confocal fluorescence (λex = 910 nm):(a,c,e) Typical 
micrograph of PC-3 cells incubated for 20 min at 37 oC with T12 (1.92 nM or 7 μg/mL in 5: 
95% DMSO:  EMEM showing T12 mainly stay in cytoplasm surrounding nucleus, lifetime 
mapping and scalebar (a), intensity image (c), and corresponding lifetime distribution curve 
(e); (b,d,f) Typical micrographs of PC-3 cells incubated for 20 min at 37 oC with 
T12@SWNT composite dispersion (in 5: 95% DMSO: EMEM contained 7 μg/mL T12 (1.92 
nM) ‘anchored’ onto 18 μg/mL SWNT. Intensity image (d), lifetime mapping and scalebar 









Figure 4.13. Two-photon laser confocal fluorescence (λex= 910 nm):(a,c,e) Typical 
micrograph of HeLa cells incubated for 20 min at 37 oC with T12 (1.92 nM or 7 μg/mL in 5: 
95% DMSO: EMEM showing T12 localizes in both cytoplasm and cell nucleus, lifetime 
mapping and scalebar (a), intensity image (c), and corresponding lifetime distribution curve 
(e); (b,d,f) Typical micrographs of HeLa cells incubated for 20 min at 37 oC with 
T12@SWNT composite dispersion (in 5: 95% DMSO : EMEM contained 7 μg/mL T12 (1.92 
nM) ‘anchored’ onto 18 μg/mL SWNT. Intensity image (d), lifetime mapping and scalebar 











Figure 4.14. Two-photon fluorescence spectroscopy: fluorescence decay traces for the 
lifetime determinations (λex= 910 nm, T12 concentration: 7.5 nM or 27.3 μg/mL in pure 
DMSO, T12@SWNT composite dispersion containing 27.3 μg/mL or 7.5 nM T12 anchored 
onto 70 μg/mL SWNT).   
4.2.1.6 Diffusion-ordered 2D NMR (DOSY) as a tool for analysis of functionalisation of 
SWNTs 
1H NMR spectra of T12 in T12@SWNT (see Appendix Figure 8.22) composite 
material in CDCl3 showed that the peaks corresponding to protons of ethylene glycol chain 
(3.55 ppm), alkyl chain (1.25-1.27 ppm) and thiophene (7.31 ppm) all become smaller 
compared with that of free polymer, indicating aromatic stacking interactions between T12 
and SWNTs. As mentioned above, the majority of free, unbound, T12 was believed to be 
removed by three cycles of filtration/dispersion treatment. The tumbling motions of T12 are 
reduced strongly once conjugated to carbon nanotubes, which will have different magnetic-
field environments. 
Diffusion-ordered 2D NMR (DOSY) experiments have been used for analysis of the 
diffusive behaviour of mixtures,52 as well as for characterization of aggregates.53,54 A typical 
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DOSY experiment consists of a diffusion delay, flanked by two pulse field gradients. In the 
case of large and slowly moving molecules, the spin remains stationary during the time of 
these two pulses, the NMR signal is independent of the strength and length of the gradient 
pulse. But for small and fast moving molecules, the NMR signal will be affected. So, the 
NMR signal of rapidly moving, small molecule will be strongly attenuated, while the NMR 
signal of slowly moving, big molecule will be less attenuated. Therefore, DOSY technique 
can distinguish compounds according to their size.55   
After 48 h of stirring at room temperature, the solution mix was subjected to 
centrifugation cycles at 10000 rpm, giving a black suspension. The black suspension was 
filtrated and dispersed in CHCl3 3 times. The resulting black complex was obtained by 
evaporating the solvent. A proton-detected DOSY of T12@SWNT CDCl3 solution (1.54 mM) 
has been performed (see Figure 4.15).  
The 1H NMR spectrum of the conjugated T12 is shown in the horizontal axis: all 
signals are well resolved and consistent with the expected formula.  
Figure 4.15 shows the signal intensity decays of the conjugated T12 after removing 
excess T12 through filtration, as a function of the increasing field gradient strength. We can 
calculate the diffusion coefficient of each proton signal by least-squares fitting of these 
decay plots. Subsequently the data can be presented in a 2D contour mode plot with NMR 
chemical shifts on the horizontal axis and diffusion coefficients on the vertical axis.  
The numbers for the diffusion coefficients seem very small and further studies are 
necessary to elucidate the reasons for the rapid diffusion in solution: in the DOSY NMR of 
the T12@SWNT solution, three cross peaks were detected: the bottom one correspond to 
solvent/H2O and other very small molecules, coming at about 2.46×10-9 m2/s. The media 
peak may correspond to free, unbound T12 (D=8.2×10-10 m2/s) present in dispersion. The top 
peak corresponds to T12 conjugated to very short functionalised carbon nanotubes 
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(T12=5.8×10-10 m2/s).  It clearly shows that T12 dot and T12@SWNT dot are very close 
with each other still can see the difference once zoom in.  The precise size of the species was 
not estimated with precision as the behavior of this system is clearly very complex in the wet 
solvents used. 
 
(a)                                                                                (b) 
m2/s













Figure 4.15. Signal intensity decay obtained with the 2D-DOSY analysis of the 
T12@SWNT in CDCl3 after purification (a). 2D-DOSY contour mode plots (b-c), where the 
shift-resolved discrimination of the diffusion constant can be visualised, are reported for the 
same fractions (top and bottom right, F1axis=m2/S×10-9).  
 
                             Chapter 4 Synthesis of individual polythiophene-functionalised SWNTs  
 
 143
4.3 Conclusions for Chapter 4 
    In summary, a novel amphiphilic conjugated thiophene was used for noncovalent 
functionalisation of SWNTs. The interactions between the polythiophene and the SWNTs 
were studied by various characterization methods and the application of using this 
supramolecular structure as new molecular imaging probe was explored in this chapter. The 
non-covalent interactions (aromatic stacking, hydrophobic interactions) between SWNT and 
conjugated thiophene T12 are studied by UV-vis-NIR, fluorescence, Raman spectroscopic 
studies as well as surface analysis (AFM and TEM) study. The well resolved peaks of 
SWNTs in the NIR range suggest that SWNTs are de-bundled very well after interaction 
with T12 without large aggregated SWNTs in the solution, which was removed by the 3 
cycles of dispersion/filtration treatment.  The 90 nm blue-shift of maxima emission peak 
after complex with SWNTs which can be seen from 2D fluorescent contour plotting is due to 
the decreasing planarity of the conjugate T12 backbone after helical wrapping on the surface 
of SWNTs. The TEM and AFM studies show a good dispersibility of T12@SWNTs in 
organic solvents (CHCl3), also the possibility of using T12@SWNTs for fabricating 
functional SWNTs films.    
In order to investigate the intracellular imaging behavior of T12@SWNTs, we 
incubate cancer cells (HeLa and PC-3 cells) with T12@SWNTs DMSO solution and then 
image their intracellular localization and imaging by confocal laser scanning microscopy and 
also two-photon lifetime imaging microcopy. Lifetime imaging method provides the cellular 
information of T12@SWNTs and also free T12 based on fluorescent lifetime mapping and 
intensity imaging. Cellular imaging results show that the T12@SWNT complex acts as a 
very good potential candidate for molecular imaging nanoprobes. 
                             Chapter 4 Synthesis of individual polythiophene-functionalised SWNTs  
 
 144
4.4 Reference for Chapter 4 
(1) Baker, M. Nat. Methods 2010, 7, 957. 
(2) Kam, N. W. S.; Liu, Z. A.; Dai, H. J. Angew. Chem.-Int. Edit. 2006, 45, 577. 
(3) Kam, N. W. S.; O'Connell, M.; Wisdom, J. A.; Dai, H. J. Proc. Natl. Acad. Sci. U. S. 
A. 2005, 102, 11600. 
(4) Liu, Z.; Robinson, J. T.; Sun, X. M.; Dai, H. J. J. Am. Chem. Soc. 2008, 130, 10876. 
(5) Prato, M.; Kostarelos, K.; Bianco, A. Accounts Chem. Res. 2008, 41, 60. 
(6) De La Zerda, A.; Zavaleta, C.; Keren, S.; Vaithilingam, S.; Bodapati, S.; Liu, Z.; Levi, 
J.; Smith, B. R.; Ma, T. J.; Oralkan, O.; Cheng, Z.; Chen, X. Y.; Dai, H. J.; Khuri-Yakub, B. 
T.; Gambhir, S. S. Nat. Nanotech. 2008, 3, 557. 
(7) Tasis, D.; Tagmatarchis, N.; Bianco, A.; Prato, M. Chem. Rev. 2006, 106, 1105. 
(8) Carrillo, A.; Swartz, J. A.; Gamba, J. M.; Kane, R. S.; Chakrapani, N.; Wei, B. Q.; 
Ajayan, P. M. Nano Lett. 2003, 3, 1437. 
(9) Petrov, P.; Stassin, F.; Pagnoulle, C.; Jerome, R. Chem. Commun. 2003, 2904. 
(10) Wang, H.; Zhou, W.; Ho, D. L.; Winey, K. I.; Fischer, J. E.; Glinka, C. J.; Hobbie, E. 
K. Nano Lett. 2004, 4, 1789. 
(11) Chen, J.; Liu, H. Y.; Weimer, W. A.; Halls, M. D.; Waldeck, D. H.; Walker, G. C. J. 
Am. Chem. Soc. 2002, 124, 9034. 
(12) Welsher, K.; Sherlock, S. P.; Dai, H. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 8943. 
(13) Yang, S.-T.; Cao, L.; Luo, P. G.; Lu, F.; Wang, X.; Wang, H.; Meziani, M. J.; Liu, Y.; 
Qi, G.; Sun, Y.-P. J. Am. Chem. Soc. 2009, 131, 11308. 
(14) Ray, S. C.; Saha, A.; Jana, N. R.; Sarkar, R. J. Phys. Chem. C 2009, 113, 18546. 
(15) Yang, S.-T.; Wang, X.; Wang, H.; Lu, F.; Luo, P. G.; Cao, L.; Meziani, M. J.; Liu, J.-
H.; Liu, Y.; Chen, M.; Huang, Y.; Sun, Y.-P. J. Phys. Chem. C 2009, 113, 18110. 
(16) Wong, B. M.; Ye, S. H. Phys.Rev. B 2011, 84. 
(17) Ramakrishna, G.; Bhaskar, A.; Bauerle, P.; Goodson, T., III J. Phys. Chem. A 2008, 
112, 2018. 
(18) Barbarella, G.; Zambianchi, M.; Pudova, O.; Paladini, V.; Ventola, A.; Cipriani, F.; 
Gigli, G.; Cingolani, R.; Citro, G. J. Am. Chem. Soc. 2001, 123, 11600. 
(19) Gao, J.; Blondeau, P.; Salice, P.; Menna, E.; Bartova, B.; Hebert, C.; Leschner, J.; 
Kaiser, U.; Milko, M.; Ambrosch-Draxl, C.; Loi, M. A. Small 2011, 7, 1807. 
                             Chapter 4 Synthesis of individual polythiophene-functionalised SWNTs  
 
 145
(20) Aslund, A.; Sigurdson, C. J.; Klingstedt, T.; Grathwohl, S.; Bolmont, T.; Dickstein, D. 
L.; Glimsdal, E.; Prokop, S.; Lindgren, M.; Konradsson, P.; Holtzman, D. M.; Hof, P. R.; 
Heppner, F. L.; Gandy, S.; Jucker, M.; Aguzzi, A.; Hammarstrom, P.; Nilsson, K. P. R. ACS 
Chemical Biology 2009, 4, 673. 
(21) Ali-Boucetta, H.; Al-Jamal, K. T.; McCarthy, D.; Prato, M.; Bianco, A.; Kostarelos, 
K. Chem. Commun. 2008, 459. 
(22) Arnold, M. S.; Guler, M. O.; Hersam, M. C.; Stupp, S. I. Langmuir 2005, 21, 4705. 
(23) Balasubramanian, K.; Friedrich, M.; Jiang, C. Y.; Fan, Y. W.; Mews, A.; Burghard, 
M.; Kern, K. Adv. Mat. 2003, 15, 1515. 
(24) Bayazit, M. K.; Coleman, K. S. J. Am. Chem. Soc. 2009, 131, 10670. 
(25) Bianco, A.; Kostarelos, K.; Prato, M. Expert Opin. Drug Deliv. 2008, 5, 331. 
(26) Bottini, M.; Bruckner, S.; Nika, K.; Bottini, N.; Bellucci, S.; Magrini, A.; 
Bergamaschi, A.; Mustelin, T. Toxicol. Lett. 2006, 160, 121. 
(27) Bottini, M.; Cerignoli, F.; Dawson, M. I.; Magrini, A.; Rosato, N.; Mustelin, T. 
Biomacromolecules. 2006, 7, 2259. 
(28) Chen, J. Y.; Collier, C. P. J. Phys. Chem. B 2005, 109, 7605. 
(29) Cherukuri, P.; Gannon, C. J.; Leeuw, T. K.; Schmidt, H. K.; Smalley, R. E.; Curley, S. 
A.; Weisman, R. B. Proc. Nat. Acad. Sci. U.S.A. 2006, 103, 18882. 
(30) Cui, D. X.; Tian, F. R.; Ozkan, C. S.; Wang, M.; Gao, H. J. Toxicol. Lett. 2005, 155, 
73. 
(31) Didenko, V. V.; Moore, V. C.; Baskin, D. S.; Smalley, R. E. Nano Lett. 2005, 5, 1563. 
(32) Kubat, P.; Lang, K.; Janda, P.; Frank, O.; Matulkova, I.; Sykora, J.; Civis, S.; Hof, M.; 
Kavan, L. J. Nanosci. Nanotech. 2009, 9, 5795. 
(33) Lee, Y.; Geckeler, K. E. Adv. Mater. 2010, 22, 4076. 
(34) Lin, S. J.; Keskar, G.; Wu, Y. N.; Wang, X.; Mount, A. S.; Klaine, S. J.; Moore, J. M.; 
Rao, A. M.; Ke, P. C. Appl. Phys. Lett. 2006, 89. 
(35) Pascu, S. I.; Kuganathan, N.; Tong, L. H.; Jacobs, R. M. J.; Barnard, P. J.; Chu, B. T.; 
Huh, Y.; Tobias, G.; Salzmann, C. G.; Sanders, J. K. M.; Green, M. L. H.; Green, J. C. J. 
Mater. Chem. 2008, 18, 2781. 
(36) Porter, A. E.; Gass, M.; Muller, K.; Skepper, J. N.; Midgley, P. A.; Welland, M. Nat. 
Nanotech. 2007, 2, 713. 
(37) Worle-Knirsch, J. M.; Pulskamp, K.; Krug, H. F. Nano Lett 2006, 6, 1261. 
(38) Konig, K. J. Microsc. 2000, 200, 83. 
(39) Suhling, K.; French, P. M.; Phillips, D. Photochem. Photobiol. Sci. 2005, 4, 13. 
                             Chapter 4 Synthesis of individual polythiophene-functionalised SWNTs  
 
 146
(40) Stutzmann, G. E.; Parker, I. Physiology (Bethesda) 2005, 20, 15. 
(41) Oheim, M.; Michael, D. J.; Geisbauer, M.; Madsen, D.; Chow, R. H. Adv. Drug. 
Deliv. Rev. 2006, 58, 788. 
(42) Bisby, R. H.; Crisostomo, A. G.; Botchway, S. W.; Parker, A. W. Photochem. 
Photobiol. 2009, 85, 353. 
(43) Botchway, S. W.; Parker, A. W.; Bisby, R. H.; Crisostomo, A. G. Microsc. Res. Tech. 
2008, 71, 267. 
(44) Treanor, B.; Lanigan, P. M.; Suhling, K.; Schreiber, T.; Munro, I.; Neil, M. A.; 
Phillips, D.; Davis, D. M.; French, P. M. J. Microsc. 2005, 217, 36. 
(45) van Rijn, P.; Savenije, T. J.; Stuart, M. C. A.; van Esch, J. H. Chem. Commun. 2009, 
2163. 
(46) van Rijn, P.; Janeliunas, D.; Brizard, A. M. A.; Stuart, M. C. A.; Eelkema, R.; van 
Esch, J. H. Chem.-Eur. J. 2010, 16, 13417. 
(47) Tolosa, L.; Gryczynski, I.; Eichhorn, L. R.; Dattelbaum, J. D.; Castellano, F. N.; Rao, 
G.; Lakowicz, J. R. Anal. Biochem. 1999, 267, 114. 
(48) Bastiaens, P. I. H.; Squire, A. Trends Cell Biol. 1999, 9, 48. 
(49) Brismar, H.; Trepte, O.; Ulfhake, B. J. Histochem. Cytochem. 1995, 43, 699. 
(50) Ng, T.; Squire, A.; Hansra, G.; Bornancin, F.; Prevostel, C.; Hanby, A.; Harris, W.; 
Barnes, D.; Schmidt, S.; Mellor, H.; Bastiaens, P. I. H.; Parker, P. J. Science 1999, 283, 2085. 
(51) Peter, M.; Ameer-Beg, S. M. Biol. Cell 2004, 96, 231. 
(52) Van Lokeren, L.; Maheut, G.; Ribot, F.; Escax, V.; Verbruggen, I.; Sanchez, C.; 
Martins, J. C.; Biesemans, M.; Willem, R. Chem.-Eur. J. 2007, 13, 6957. 
(53) Keresztes, I.; Williard, P. G. J. Am. Chem. Soc. 2000, 122, 10228. 
(54) Jang, H. B.; Rho, H. S.; Oh, J. S.; Nam, E. H.; Park, S. E.; Bae, H. Y.; Song, C. E. 
Org. Biomol. Chem. 2010, 8, 3918. 
(55) Viel, S.; Mannina, L.; Segre, A. Tetrahedron Lett. 2002, 43, 2515. 
 
 
Chapter 5 Radio-metal filled fluorescent SWNTs as synthetic platforms for multimodal imaging systems   
 
 147
Chapter 5 Radio-metal filled and fluorescent SWNTs as 
synthetic platforms for multimodal imaging systems   
5.1 Introduction 
There is increased interest in improving our understanding of the interactions 
between nanomaterials and living systems, with regard to both the underlying chemistry and 
the physics of effects on the nanoscale. Imaging and therapeutic metallodrugs, including 
radioisotopes such as, for example, 64Cu (positron emission tomography, PET, radiotracer t1/2 
= 2.7 h), 89Zr (PET radiotracer, 78.4 h) or 186Re (radiotherapy, t1/2 =3.72 days). These 
building blocks when encased within inert carriers by rapid and simple chemistry based on 
non-covalent interactions, may lead to the construction of future nanomedicines.1 Increased 
attention has also been drawn recently to new methods of drug delivery emerging from the 
new, interdisciplinary field of nanotechnology. To date, no single molecular imaging 
modality is sufficient to gain all the necessary information need for both in vitro and in vivo. 
Positron emission tomography (PET) has very high sensitivity but poor resolution although 
this continues to improve as image processing methods advance.2,3 Both positron emission 
tomography and magnetic resonance imaging (MRI) require the imaging agents to 
accumulate in tumors without loss of the active species en route to target. The combination 
of multiple molecular imaging techniques can offer synergistic advantages over single 
modality imaging techniques (optical or PET alone).2,3  
Design protocols leading to the 'smart' nano-theranostics of the future rely on 
synthetic advantages offered by molecular recognition principles as well as high resolution 
transmission electron microscopy (TEM) and surface analysis techniques such as atomic 
force microscopy (AFM) and molecular imaging on the nano- and micro-scale. Our recent 
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work in decorating carbon nanomaterials with biocompatible materials such as 
naphthyldiimides and porphyrin oligomers constituted a proof-of-principle study on how 
understanding and design at the molecular level could help develop research new diagnostics 
or therapeutics.4  
Functionalisation methods for carbon nanomaterials(CNTs) have received huge 
attention over the past 5 years in the quest to clarify their role in biomedical applications. 
There are very few examples of radiolabeled nanotubes to date, and only one other study 
showing the entrapping or radioisotopes within carbon nanotubes. High-yield filling of 
single-walled carbon nanotubes (SWNTs) with inorganic compounds under harsh conditions 
(above 300 oC) leading to continuous crystalline filling has been demonstrated.5-7 In typical 
endohedral filling methods via a molten salt route, the end of the nanotubes normally close 
under the reaction conditions used, which involve thermal annealing of the SWNTs under 
harsh conditions, e.g. as samples are heated at temperatures at least 20 oC above the melting 
point of the filling material.5 
Designing nano-probes whereby PET imaging agents are anchored onto (or 
encapsulated within) nano-size carriers has become a topical issue.8 This requires rapid 
radiolabelling methods under mild conditions suitable to work under the confines of most 
radiopharmacies or radiochemistry laboratories.8 Combination of ‘smart’ fluorescent probes 
for cellular tracking with high resolution in vivo imaging methods such as PET coupled MRI 
constitutes an exciting prospect for future ‘all-in-one’ multimodality imaging applications. 
An additional current aim of our work is to design methods for the delivery of multiple 
molecules of an imaging reagent (encapsulated within a carrier) to a target while keeping the 
administered dose of the overall nanoprobe extremely small.  
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SWNTs have attracted growing interest due to their potential applications in the 
fields of cancer diagnosis and therapy.9-13 To trace and diagnose the effects of the treatment 
in single cells or tissues, SWNTs have been derivatised with fluorescent tags.14,15 
Intrinsically, carbon nanotubes also exhibit weak near-infrared emissions, but to date, these 
are not considered intense enough in practice to be useful in functional in vivo imaging and 
diagnosis.16 It is believed that appropriately functionalised SWNTs can efficiently reach 
tumor tissues in mice with limited or no apparent toxicity. The simultaneous radiolabeling 
(with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-anchored 64Cu) and 
fluorescence studies, coupled with biodistribution in vivo and in vitro has only been reported 
in two studies,17,18 both involving the covalent functionalisation and hence the disruption of 
aromatic network. Under certain conditions, water-dispersed, functionalised carbon 
nanotubes have been shown to be non-toxic when taken up by cells. 19 These studies have 
been complemented by the recent PET imaging of water-soluble 86Y-labeled carbon 
nanotubes in vivo20, to explore the potential usefulness of carbon nanocarriers as scaffolds 
for drug delivery. Recent challenges in achieving the controlled translocation of carbon 
nanotubes in living cells and organisms have been reviewed recently.21  
Covalent functionalisation with fluorophores attached directly onto the carbon 
nanotube surface may be problematic due to the strong quenching qualities of the electron 
rich SWNTs. The supramolecular tagging of the carbon nanotubes with fluorescent dyes 
attached via a continuous polymeric coating or via a very long linker (rather than directly 
onto the SWNTs) allows the separation of the fluorophore and the SWNT surface and was 
reported to be  advantageous in minimising the  fluorescence quenching.22,23  
Dai et al. demonstrated the non-covalent functionalisation of SWNTs by fluorescein-
polyethylene glycol (Fluor-PEG).18,24 Water-soluble nanotube conjugates (Fluor-
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PEG/SWNT), simultaneously attached to fluorescent labels have been developed. The same 
study showed that fluorescein, a widely used fluorophore, can strongly adsorb onto the 
sidewall of the SWNTs, likely by aromatic stacking, and the hydrophilic PEG chain imparts 
high aqueous solubility.25 To date only a relatively small number of in vitro and in vivo 
studies have been carried out to determine the influence on cell toxicity mechanisms of the 
functionalities incorporated in these imaging probes, and a toolkit aiding their rational design 
has not yet been devised.26 In this chapter aimed to validate our design principles for the 
assembly of the SWNTs-based imaging probes and hypothesise that bioimaging probes 
which rely exclusively on non-covalent interactions and molecular recognition methods can 
be synthesized and image in vivo and in vitro.  
Our synthetic protocol reported hereby involves the following steps:  
(a) Provision of single walled carbon nanotubes (SWNT) with open ends and a 
hollow cavity for the stable containment to prevent radionuclide loss en route to target, with 
lengths not exceeding 500 nm, and diameters up to 2 nm.  
(b) Encapsulation of a PET metallic radioimaging agent within the SWNT cavity 
under mild conditions in aqueous media. A stopper molecule with a compatible outer 
diameter (C70) is encapsulated within the inner cavity of the tubes simultaneously with the 
radiotracer to minimise the leaking of the payload in aqueous media.  
(c) Rendering the entire surface of carbon nanotubes biocompatible via 
supramolecular wrapping which allows further (rapid and reversible) surface derivatisation 
with optical imaging agents, chemotherapeutic payloads and/or targeting units in water.  
We are using a naturally occurring polysaccharide,  β-D-glucan, known for its cancer 
therapeutic effect in traditional Chinese medicine,27  as a dispersing agent having the ability 
to supramolecularly wrap the single strands of SWNts in water, having the potential to act 
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simultaneously as a biological targeting molecule and dispersing agent. A recent study by 
James and Shinkai showed that it is possible to attach small molecules to polysaccharide-
coated SWNTs using boronic acids.13 Here, diol groups act both as solubilising groups and 
as recognition units suitable for further synthetic modifications, by dynamic covalent 
chemistry involving boronic acids: attaching  fluorescent tags as an additional assembly step 
or intrinsic to the supramolecular/covalent wrapping was also employed, such that the 
resulting fluorescent and biocompatible hybrid can be used for tracking in cells. To facilitate 
the cellular imaging of the targeted delivery probe, a fluorescein derivative incorporating 
aliphatic linkers and an additional cellular targeting agent (biotin, a well-known system used 
as a recognition motif for streptavidin) was used as a building block in our design protocol.  
Systematic studies leading to the devising of hierarchical protocols that range from design 
and synthesis to observing molecular imaging probes in vivo and in vivo are described. 
Surface analysis determinations such as AFM/SEM/HRTEM narrowed down the search for 
most stable imaging probe in vitro and help rationalise the mechanisms of interaction with 
cells and organelles, thus providing feedback to inform probe design. Furthermore, the long-
term fate of nanomaterials in the body remains unknown and their biocompatibility and 
cytotoxicity (particularly for carbon nanotubes) is still much debated.28 We also report 
hereby our observations for the in vivo (by PET imaging) and in vitro (by confocal 
fluorescence imaging) of the new functional materials for molecular imaging applications 
based on high purity single walled carbon nanotubes assembled using the steps (a)-(c) listed 
above.  
An integrated methodology to build new biocompatible materials via a rational 
design and to elucidate their interactions with living cells via fluorescence imaging 
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techniques and ready for in vivo testing by Positron Emission Tomography, in future studies, 
was designed and is described below. 
5.2 Results and discussions 
5.2.1  Supramolecular nanoprobe scaffold C70@ M@SWNT synthesis 
 The main factor in nanotube toxicity remains the metal catalyst particles from 
particle manufacture, (Fe, Ni, Y, Co etc.) which are typically ca.10 % by weight in most 
commercial samples. Removal of impurities from as-made SWNTs is crucial for the next 
step of biomedical applications. Amorphous carbon layers were also known to be present on 
the surface of as-made SWNTs and believe to shield the surface of nanotubes from further 
functionalisation. Popular purification methods (such as nitric acid, hydrogen peroxide, 
hydrogen29,30) can cause extensive damage of the SWNT tubular structure, thus rendering 
them potentially less suitable for small molecule encapsulation techniques, and form more 
amorphous carbon by oxidising whole SWNT structure.  Here, the steam method was used 
for the purification and opening of single walled nanotubes (Elicarb©, Thomas Swann) 
following a method which was first reported by the research group of Professor Malcolm 
Green, University of Oxford with Thomas Swann Ltd. Steam acts as a mild oxidising agent 
to eliminate the graphitic coating without introducing defects and functional groups ready for 
biomedical applications.31,32 The purification of as-made SWNTs (Thomas Swann, Elicarb) 
can be achieved by introducing steam carried by an argon flow through the reactor. (Scheme 
5.1). SWNTs (500 mg -1 g) were introduced in a quartz reactor (9 mm diameter) placed 
inside of the quartz tube (5 cm diameter) and within the alumina lining of a furnace tube, 
which was flushed with argon at least 1 h prior to the experiment to minimise the presence of 
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air. Argon-degassed steam was introduced by bubbling argon through boiling water. The 
furnace temperature was gradually increased to 900 oC over ca. 30 min, and the reaction was 
maintained for at least 20 min and no longer than 2 h depending on the sample size. The 
resulting sample was refluxed in 16% HCl overnight, which removes most of the metal 
catalyst, and washed with NaOH and double distilled water on a 2 μm membrane filter until 
the filtrate was neutral pH. We introduced a further toluene washing/filtration step which 
allowed only the highest purity SWNTs samples to be recobered after filtration. We found 
that the overall yield of the purification procedure is lower than 20% so this method does not 
seem easily amenable to scale-up in commercial activities at present. However, the advanced 
purity of the samples used here was confirmed by exhaustive Raman and HRTEM/EDS 
analysis; this clearly shows that amorphous carbon and some graphitic particles entangling 
the as-made SWNTs were successfully removed leaving behind pristine SWNT surfaces 
(Figure 5.1b). HRTEM analysis and Raman spectroscopy indicated that the sample 
characteristics are consistent to those previously reported. This method gives rise to highly 
purified, opened carbon nanotubes, containing only SWNTs (when arc-made Carbolex-
quality samples are used) but also SWNTs mixed with several traces of double walled CNTs 
(when CVD-made Elicarb Thomas Swann Ltd samples are used as a starting material) with 
dimensions ranging between 50-500 nm and diameters between 0.9 and 2 nm.  
 
Scheme 5.1. Schematic drawing of the steam purification method of SWNTs by bubbling 
argon through boiling double-distilled H20, A: SWNTs solid sample.  





          (a)                                     (b)                                                
Figure 5.1. HRTEM pictures of (a) as-made SWNTs, (b) steam purified SWNTs  
                     (900 °C, 2 h) 
  
Although the filling of SWNTs with metal species is well established through the 
pioneering work of the Oxford Nanotube Group,33-35 so far the encapsulation of 64Cu2+ ions 
within SWNTs from aqueous solution, under the rapid and mild conditions applicable for 
tracer preparation for PET radioimaging was not demonstrated, particularly when working at 
the low concentrations (10-9 M) and time constrains (e.g. t1/2 12.7 h for 64Cu) required for 
most radioisotope work. In our work SWNTs containing open ends prepared as above31 have 
been exposed to aqueous solutions of simple metal salts, such as CuX2, (X = Br−, Cl− or 
OAc-) and their radiolabeled analogues (64CuX2), neat or using NaOAc as the filling support. 
The use of NaOAs in carrier-added experiments is known to be standard in PET tracer 
preparation and deemed not to hinder the in vivo imaging methods, as the pH is normally 
adjusted to 8 in the final tracer formulation, to simulate as closely as possible the conditions 
necessary prior to any in vivo work. The filling yield for 64Cu(OAc)2 (supported by saturated 
solutions NaOAc) was estimated by radiochemistry to be in the range of 60 % over ca 4 h 
experiment time. For ‘cold’ Cu2+@SWNT composites, obtained by filling with neat 
Cu(OAc)2, the HRTEM analysis of showed encapsulation in the form of short crystals visible 
inside the SWNTs (Figure 5.2c). For a comparison, we also performed filling experiments of 
SWNTs with CuBr2 via a molten salt route, and a similar yield (estimated by HRTEM) was 
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obtained only after ca. 8 h heating at 400 oC in accordance with literature reports.35-37 (Figure 
5.2 b) We thus found that the molten salt route is inadequate for radiochemistry work when 
this is performed under the confined environment of most clinical radiopharmacies, due to 
limitations in safe handling of radioactivity at high temperatures and the risk of potential 
release of radioactive vapours in the atmosphere.  
To explore the generality of the solution filling method in this work, the Zr4+ filling 
experiment was also performed from aqueous solutions using Zr(OAc)4 as the precursor, as a 
model for the PET radioisotope filling with 89Zr. The zirconium filling experiments in 
aqueous solution showed that the successful filling can only be achieved when the pH was 
adjusted to 2 by adding small amount H2SO4 according to HRTEM/EDS imaging. However, 
the precise nature of the Zr clusters encapsulated is difficult to predict due to the complex 
aqueous chemistry of Zr(IV) (Figure 5.3 a). The Zr4+@SWNT structures were analysed 
using High Resolution TEM. By lowering the accelerating voltage, the knock-on damage of 
the carbon nanomaterials can be minimised.  From HRTEM observations, crystal-filled 
carbon nanotubes were only found in sample A (C70@Zr4+@SWNT saturated with NaOAc, 
see Chapter 7 experimental description) which means that make the solution saturated with 
OAc- is a key fact for Zr filling. Zirconium clusters were formed after the hydrolysis of 
precursor Zr(OAc)4 in acetic acid and the condensation of partially hydrolysed species after 
48 h is likely to form a three-dimensional gel network.  The zirconium complex structure is 
likely to change after addition of sulfuric acid at pH 2.4: the stoichiometry of Zr(IV) to   the 
oxo-ions present in solutions are known to be strongly dependent on the pH. It is likely that 
the sulfate SO42- ions bind to Zr4+ and this counterion is expected to replace the AcO- ions, 
but the precise nature of the zirconium clusers present in this aqueous mixture could not be 
determined. Zirconium sulfate-based oxo-clusters are likely to be present in solution and 
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may be introduced into the open-ended SWNTs by solution filling. The filling experiment at 
low pH value seems to help convert the zirconium-aqueous gel-like material into more 
discrete species which in turn contributed to the successful filling SWNTs with Zr(IV) by 
solution method.    
Interestingly, a rather high filling yield, ca. 60% (estimated by HRTEM, Figure 5.3 c) 
from aqueous media was obtained with KReO4 (‘cold’ chemistry, as a model for 186/188ReO4- 
or 99mTcO4- therapeutic or SPECT diagnostic radiotracers). HRTEM reveals the presence of 
heavy atoms inside of carbon nanotubes with the high contrast compared with the un-filling 
SWNTs on the left side, which is corresponding to the Re compound (Figure 5.3 c, d). Also 
the HR-TEM revealed the absence of bulk ReO4- external to the SWNTs. The EDS analysis 
indicated the presence of Re in the sample as expected, a lower intensity of Re peaks was 
observed due to the removal of the external material by double-distilled H2O washing.  
The use of functionalised C60 was already shown to allow the removal of the excess 
free salts in water.38  In our hands we found that the leaking of the encapsulated metallic 
species from open SWNTs may be prevented by the simultaneous encapsulation of C70 
molecules (maximum van der Waals radii ca. 1.1 nm) rather than C60 (maximum external 
diameter = 0.7 nm) which remain stuck at the ends of SWNTs. Several C70  molecules act as 
stoppers of ideal size match for the SWNTs carriers used hereby: HRTEM images show that 
the open ends of SWNTs are filled by several C70 molecules by standard endohedral 
encapsulation methods.38 We found that any free, un-bond C70 decorating the outside of the 
tubes can be removed via a simple toluene washing step followed by the 
filtration/redispersion steps. The inter-fullerene spacing (HRTEM, Figure 5.2 a) of 
C70@SWNT is 10.4± 0.9 Å with the mean diameter of C70 encapsulated in tubes 7.4±0.5 Å. 
After fullerene encapsulation the mixtures containing M@C70@SWNTs were then filtered 
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and the solid residue was washed several times with distilled water to remove the metal ions 
external to the SWNTs (M = Cu(II), Zr(IV) and Re(V). The water and toluene washing steps 
allowed the removal of most free C70 adhering to the walls of the SWNTs also the removal 
of any other of the bulk materials from filling step, external to the SWNTs cavity.  
 
Figure 5.2. Typical HRTEM images of (a) C70@SWNT observed in metal-filled and 
simultaneously corked samples, (b) molten salt CuBr2@SWNT and (c) 
Cu(OAc)2@SWNT(from neat Cu(OAc)2 filling experiment. Samples were imaged on a 
lacey copper based grid. 
 
Raman spectroscopy studies showed that both sample A and B (Sample A: C70@ 
Zr4+@SWNTs saturated with NaOAc; Sample B: C70@ Zr4+@SWNTs without NaOAc, see 
Chapter 7 Experimental Description) exhibit characteristic radial breathing mode (RBM), G 
band and D band. (Figure 5.4) For both sample A and B, D-band intensities decrease with 
respect to those of purified SWNTs, indicating that functionalisation occurred. The ID/IG 
ratio of purified SWNTs, sample A and sample B are 0.121, 0.076 and 0.046, respectively. It 
shows that there is a decrease of the band intensity ratio after filling with zirconium.  
 
 
(a) (b) (c) 




Figure 5.3. (a) HRTEM of Zr4+encapsulated inside steam purified SWNTs.. (b) The EDS 
spectrum of Zr4+@SWNT. (c) HRTEM of KReO4@SWNT. (d)The EDS spectrum of 
KReO4@SWNT. Samples were imaged on a lacey copper based grid. 
 
 
(a)           (b) 
Figure 5.4. Solid state Raman spectrum of C70@Zr4+@SWNT when filling was achieved in 
the presence or absence of NaOAc (λex=830 nm) showing the intensity of G and D bands vs 
Raman shift (cm-1) (a) RBM frequency modes (b). Further Raman spectra are given in 
Appendix material.  
. 
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5.2.2 Supramolecular wrapping of the filled carbon nanotubes surface:  
M@C70@SWNT@glucan  synthesis 
The supramolecular wrapping of the tubular structure using polymers, polynuclear 
aromatic compounds, surfactants and biomolecules has become an important method to 
prepare well-dispersed SWNTs.25,28  Polysaccharides such as β-D-glucans have been used in 
traditional Chinese and Japanese medicine from ancient time to enhance the immune 
system.39-41 Numerous studies have demonstrated that β-D-glucan exhibit antitumor and 
antimicrobial activities in in vivo experiments.42,43 Mechanistic studies reveal that β-D-
glucan can activate macrophages, neutrophils, and natural killer cells to kill sensitive tumor 
cells44 and that T cell responses to cellular antigens were potentiated.45. Here, stable 
dispersions (in aqueous PBS or cellular medium DMEM) of empty, pristine and filled 
SWNTs have been achieved using β-1,3-1,4-D-glucan (from barley, Aldrich, denote as β-D-
glucan in this chapter) as a supramolecular coating.  The hypothesis here was that the 
wrapping with β-D-glucan will further mediate the biomedical and clinical functions of 
metal-filled SWNTs. The wrapping procedure exploits the combination of hydrogen-bonding 
formation (in DMSO) and solvophobic interactions (in H2O or NaOAc saturated aqueous 
solutions) which are known as the two main types of driving forces for β-D-glucan self-
organisation into helical structures. Shinkai et al.46 showed that these compounds exhibit 
hydrophobic cavities (acting as hosts) of shapes and dimensions perfectly adjustable to fit the 
SWNTs strands (acting as hydrophobic guests).  
  In this work the glucan@SWNT complex was prepared by mixing a solution of β-
1,3-1,4-D-glucan from barley, dissolved in DMSO with an aqueous dispersion of the carbon 
nanotube and incubating the mixture at 40 oC with stirring, shaking or mild periodic 
sonication (ca. 5 min) alternating with standing periods, over 1 h. After removal of excess 
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glucan by a washing/filtration repeated procedure, and filtration over a 0.2 µm membrane 
filter the resulting composite (denoted glucan@SWNT) showed excellent stability over 
minimum 24 h, at 0.5 mg/mL concentrations, without precipitation in various aqueous 
phases (water and PBS). The non-covalent interaction between SWNTs and the coating 
material is based mainly on hydrophobic interactions in water, thus the supramolecular 
wrapping method allows the modification of the entire surface of SWNTs, without affecting 
the electronic network of the tubes.11,12  
A simple molecular mechanics (MM+ Forcite)13  optimisation model was carried out 
by Sofia Pascu and this suggests that these glucan strands are able to fit around SWNTs of 
appropriate diameters. The morphology of this glucan-functionalised SWNT composite was 
analysed by HRTEM, SEM and AFM. These studies showed that SWNT are entirely coated 
by β-D-glucan as the entire one-dimensional structure of the SWNTs strand is encapsulated 











                  
  (a)                                                 (b)                                             (c) 
Figure 5.5. (a) HRTEM of Glucan@SWNT (b) HRTEM of glucan@Cu2+@SWNT (c), 
AFM of Glucan@SWNT. 
 
Figure 5.5 and Figure 5.6  show that single stands of SWNTs are uniformly coated by 
a soft layer or organic material, presumably β-D-glucan as imaged by tapping mode AFM 
(TM AFM). Solid samples were redispersed at 0.5 mg/mL concentration in EtOH and 
deposited on the relevant support needed for imaging: holey copper grids for HRTEM, mica 
Chapter 5 Radio-metal filled fluorescent SWNTs as synthetic platforms for multimodal imaging systems   
 
 161
for TM AFM and HOPG (highly ordered pyrolitic graphite support) for SEM. The β-D-
glucan@SWNTs hybrid strand determined by AFM images is ca. 15 nm overall indicating 
the formation of very small bundle on the mica substrates, comparable to the diameter of 
complexes observed by SEM images. The thickness of the coating is estimated to be ca. 5 
nm. It was also found by HRTEM that β-D-glucan can seal the opening ends of SWNTs 
without the filling of the nanotube cavity. In DMSO or EtOH dispersions β-D-glucan 
wrapped SWNTs can still adhere to each other to form small bundles via the hydrogen 
bonding of OH groups. Raman spectroscopy in solution showed that these aggregates are 
significantly more dispersible in H2O than pristine SWNTs.  
 
                                         (a)                                                (b) 
 
Figure 5.6. SEM images of β-D-glucan@SWNT (a) and representation of the β-D-
glucan@SWNT complex (MM+ Forcite) (b). Calculations were performed by using the 
Materials Studio software. 
 
Raman spectra shown in Figure 5.7 were recorded in solution and in the solid phase 
for dispersed samples deposited from double-distilled H2O onto an aluminium sample holder 
using λex = 830 nm. The G band (which corresponds to a splitting of the E2g stretching mode 
of graphite and reflects the structural intensity of the sp2-hybridised carbon atoms) at ~1590 
cm-1 and a disordered D band (generally attributed to the disordered graphite structure of the 
nanotubes) at ~1330 cm-1 were observed. For dried samples, a slight decrease in the ID/IG 
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band intensity ratio of the Cu2+@SWNT and β-D-glucan@ Cu2+@SWNT solid composite 
(9.1 % and 9.3 %) was observed compared to the ID/IG of free SWNTs and β-D-
glucan@SWNT  (12.1 % and 11.9 %). (Table 5.1) 
 
Figure 5.7. Raman spectrum of solid β-D-glucan@SWNT, Cu2+@SWNT and β-D-
glucan@ Cu2+@SWNT (λex=830 nm) showing the intensity of RBM frequency modes, G 
and D bands vs Raman shift (cm-1). Solution spectrum of SWNT@glucan and of free glucan 
in H2O. 
 
Table 5.1. Raman data and ID/IG   intensity ratio calculations 
 
5.2.3 Biocompatibility and proliferation effects of β-D-glucan and β-D-
glucan@SWNTs towards fibroblast cells  
Cytotoxicity investigations of β-D-glucan and β-D-glucan@SWNTs in a healthy cell 
line, Fek-4, fibroblast cells, were investigated. Figure 5.8 shows the cytotoxicity of β-D-
glucan to fibroblast Fek-4 cell line after incubation for 24 h. No significant cytotoxic effect 
Compound D band absorbance G band absorbance ID/IG 
 
Purified SWNT 2547 (1302 nm) 21041 (1591 nm)  0.121 
β-D-glucan@SWNT 
 
468.74 (1336 nm) 3918.55 (1584 nm) 0.119 
Cu2+@SWNT 
 
365.40 (1330 nm) 4011.90 (1582 nm) 0.091 
β-D-glucan@Cu2+@SWNT 
 
438.52 (1325 nm)  4713.43 (1582 nm)  0.093 
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to Fek-4 cells can be seen after exposure to β-D-glucan with a limit concentration of 1 
mg/mL in cell medium (precipitate can be seen if >1 mg/mL) (Figure 5.8 a).  It also indicates 
that β-D-glucan can act as a stimulating agent to enhance the proliferation of Fek-4 cells 
compared to that of the non-treated control (Figure 5.8 b). Also the proliferation enhanced 
effect after exposure to β-1,3-1,4-D-glucan form barley used throughout was dose and time 
dependently. This phenomenon can be explained  by that the normal human fibroblasts 
express pattern recognition receptors for β-1,3-D-Glucans in general.38 It is known that 
highly purified, well characterised glucan stimulates the pro-collagen gene expression and 
collagen biosynthesis of fibroblasts.47 Clinical report also shows that pediatric burns could be 
effectively and simply treated with glucan–collagen mixtures which can significantly 
decreased post-injury pain through stimulating fibroblast cells proliferation.48  
In this work, MTT assay results of Fek-4 cells after exposure to β-D-glucan@SWNTs 
complex clearly showed that glucan can improve the biocompatibility of SWNTs in 
comparison with SWNTs alone,49,50 which can be explained that glucan acts as an ideal 
material for covering the most of surface of SWNTs compared with other polymer 
functionalisation method. In our experiment, the upper concentration limit of β-D-
glucan@SWNTs used for testing in cell medium was 100 µg/mL. Even at this limit 
concentration, Fek-4 cells still show considerable cell viability with more than 70 %. This 
experiment shows the biocompatibility of β-D-glucan@SWNTs to healthy cells within this 
concentration limit. 
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(a) 
              
  (b) 
              
   (c) 
Figure 5.8. The cytotoxicity of β-D-glucan(a) and β-D-glucan@SWNTs(c) to fibroblast 
cell Fek-4 line, and also the proliferation effect of β-D-glucan to Fek-4 cells(b). The results 
are reported as a mean ± standard deviation (n = 3). The data was analysed by Student t-tests, 
and the values marked with asterisks are significantly (p < 0.05) different from the non-
treated control.  
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5.2.4 Reversible covalent chemistry for the attachment of targeting units or 
fluorophors: Hierarchical nanoprobes flurophor@glucan@M@SWNT synthesis 
   The procedure for attaching fluorophore to the glucan coating was derived from the 
pioneering work of Prof Tony James at Bath University, where boronic acid fluorophores are 
bound to glucose or fructose under basic pH control.51-54 The reaction mechanism is 
described in Scheme 5.1. Compounds 11, 12 and 15 were synthesized as described in 
Chapter 7, coumarin-derivative (Compound 16) was a generous loan from Professor Tony 
James and used for comparison purposes with 11, 12 and 15 which were synthesized hereby.  
All fluorophor-tagged boronic acids showed fluorescent quenching upon addition of 














































































Scheme 5.1. Chemical structures of 4 boronic acid fluorophores (11: FBA; 12: porphyrin-
boronic acid. 15: FLAB; 16: coumarin) investigated in this chapter and the diagram of 
boronic acid fluorophore reversible binding with 1, 2-diol of glucan to form diol–
phenylboronate complex with five membered ring.  
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There was virtually no fluorescence in control samples: glucan, glucan@SWNT, 
SWNT and solvent. The sequence of quenching efficiency was: PBS Buffer>DMSO> H2O. 
(Figure 5.10, Table 5.2)  The final pH values of fluorophore@glucan@SWNT buffer, H2O 
and buffer solution were 9.47, 7.04 and 11.24 respectively. Previous studies have shown that 
the borate ions form covalently-bonded complexes with 1,2-diol and 1,3-diol groups of the 
glucan at about pH 8-9.5 (Scheme 5.1). The binding constant of glucan with FBA 
(Compound 11) was determined by fluorescence titrations as 4.53 ×103 M-1 while for 12, 
binding constant was 2.82 ×108 M-1. For compound 15, the binding constant was 1.97 ×104 
M-1 whereas for 16 the binding constant was 3.0 ×106 M-1 (Figure 5.9). 
 
Figure 5.9. Relative fluorescence intensity versus glucan concentration profile of (a): 11 
(25 μM, , λex = 460 nm, λem = 543 nm), (b) 12 (33.7 μM, λex = 490 nm, λem = 629 nm ), (c) 15 
(25 μM, λex = 488 nm, λem = 514 nm) and (d) 16 (0.1 μM, , λex = 350 nm, λem = 377 nm)in a 
pH 9.5 aqueous buffer.   
 






Figure 5.10. Overlay emission fluorescence spectra of free FBA and FBA@glucan@SWNT 
exciting at 450 nm, 460 nm and 480 nm in double-distilled H2O (pH 7.0) (a), DMSO (pH 








Table 5.2. Fluorescence intensity of FBA in FBA@glucan@SWNT solution and free FBA 
solution excite 450 nm, 460 nm and 480 nm 
Solvent H2O Buffer DMSO 
Ex(nm)  
 










6.7 7.5 9.4 6.8×10-3 7.7×10-3 7.6×10-3 1.3 1.5 1.1 
Residual 
fluorescence 
percentage   
(%) 
9.2 13.7 19.5 7.6 ×10-3 1.35×10-2 1.6×10-2 0.9 1 0.72 
*Each data point represents an average of three readings, errors were within 10% 
throughout. 
 
Confocal imaging results (described below) confirmed that boronic acid 
fluorophore@glucan@SWNT can give sufficient residual emission to observe their uptake in 
cells using confocal fluorescence microscopy.    
Multiphoton fluorescence imaging in solution and in vitro was used to characterise 
the resulting probe in vitro and in the solution phase. Interestingly, MCF-7 cells showed no 
uptake for both FBA@glucan and FBA@glucan@SWNT complexes: after rinsing the cells 
with PBS, any unbound FBA appeared to be just physically attached to the outer cell 
membrane. Imaging showed that FBA appears to stain the bottom glass of the commercial 
Petri dish (coated with polylysine) and seems to adhere strongly even after rinsing with PBS 
(see Appendix). Therefore, we replaced the fluorescent agent with the more hydrophobic 
systems FLAB, which incorporate a much longer alkyl chain. Simultaneously, this molecule 
was also designed to include a biotin tag for further cellular targeting possibilities.55-59 Cell 
imaging shows the successful uptake of all probes in MCF-7 cells after incubation with 
FLAB, FLAB@glucan, and FLAB@glucan@SWNT (Figure 5.11). Bright-field imaging 
showed that black composites can be observed around the nucleus of MCF-7 cells for 
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FLAB@glucan@SWNT after 20 min incubation. This confirmed that the translocation of the 
composite into MCF-7 cells occured. Confocal fluorescence imaging of FLAB@glucan, and 
FLAB@glucan@SWNT showed that the glucan coating significantly enhances the cell 
membrane translocation of SWNTs. Presumably the glucan can efficiently attach to the cell 
membrane and lead to intracellular localization by recognising the cell membranes 
polysaccharides. The cellular uptake may be further mediated through the involvement of the 
biotin tag.60 
  
Figure 5.11. Fluorescent images of control (a-c), FLAB (d-f), FLAB tagged glucan (g-i), 
FLAB@SWNTs@glucan (j-l) in MCF7 cancer cells, (a) column represents a merged images 
of fluorescent images and non-fluorescent images, (b) column shows the fluorescent images 




(d) (e) (f) 
(g) (h) (i) 
(j) (k) (l) 
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To explore the nano-hybrid integrity in cells we also used fluorescence-lifetime 
imaging microscopy (FLIM) using two photon excitation techniques. This allowed us to 
visualise FLAB, FLAB@glucan and FLAB@glucan@SWNT inside cells after uptake and 
probe their biodistribution. FLIM was performed using a confocal microscope (LSM 510, 
Carl Zeiss). A femtosecond mode locked Mira Ti:sapphire laser (Coherent Lasers Ltd) was 
tuned at 910 nm to generate two-photon luminescence from FLAB. The laser pulse has a 
repetition rate of 75 MHz and duration of less than 180 fs.    
FLIM images are showed under the intensity images are from the same samples with 
different coded colors representing different lifetime scales. The lifetime of each pixel is 
obtained by applying a single or multiexponential fit; in this case a single exponential model 
was used. Figure 5.12 shows the lifetime emission maps for FLAB, FLAB@glucan and 
FLAB@glucan@SWNT in MCF-7 cells. Images are presented together with 2-photon 
intensity maps showing the spatial variations in fluorescence emission, the lifetime imaging 
maps and corresponding distribution plots for the predominant lifetime component (τ1) and 
minor lifetime component (τ2).  Only one lifetime component of FLAB was found in cells 
after single exponential fitting, i.e. 2.24±0.64 ns, which is as expected for a fluorescein-
derivative. Both FLAB@glucan and FLAB@glucan@SWNT showed two component 
lifetime in MCF-7 cells and the fitting proved significantly more complex. The major 
lifetime components for FLAB @glucan and FLAB@glucan@SWNT are much shorter, 
0.697±0.14 ns (79.2%) and 0.567±0.16 ns (84.1%), as expected for a nanoparticle-bound 
fluorescein. The minor components for FLAB@glucan and FLAB@glucan@SWNT are 
2.328±1.05 ns (20.8%) and 2.478±1.23 ns (15.9%) respectively, indicative of some minor 
dissociation of the fluorophor in cells. 




Figure 5.12. Two-photon laser confocal fluorescence (λex = 910 nm):(a-c) Typical 
micrograph of MCF-7 cells incubated for 1 h at 37 oC with FLAB (26 μM or 21 μg/mL in 1: 
99% DMSO EMEM) showing 2 just adhering onto the cell membrane but not entering into the 
cell, lifetime mapping(a), intensity image (b) and corresponding lifetime distribution curve 
(c); (d-f) Typical micrographs of MCF-7 cells incubated for 1 h at 37 oC with FLAB@glucan 
complex (dispersions in 1: 99% DMSO : EMEM contained 21 μg/mL NDI (26 μM) 
‘anchored’ onto 35 μg/mL SWNT. lifetime mapping and scalebar (d), Intensity image (e) 
and corresponding lifetime distribution curve (f). Bright spots in cytoplasm region indicate 
that fluorescent FLAB@glucan complex translocated into cells as intact objects. (g-i) 
Typical micrographs of MCF-7 cells incubated for 1 h at 37 oC with FLAB@glucan@SWNT 
composite were recorded for dispersions in 1: 99% DMSO: EMEM. These contained 21 
μg/mL NDI (26 μM) ‘anchored’ onto 35 μg/mL SWNT. Images show lifetime mapping and 
scalebar (g), intensity image (h) and corresponding lifetime distribution curve (i). The 
intensity image clearly shows that FLAB@glucan@SWNTs mainly concentrate in the 
cytoplasm region without nuclear uptake.   
 
This data indicate there are at least two types of FLAB molecules present in 
cells, but that more than 80% of FLAB remains still bound to the glucan or glucan@SWNT 
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FLAB@glucan@SWNTs with cellular local environments still need further investigation.  
There are several differences between the lifetime decay spectra profiles of free FLAB, 
FLAB@glucan and FLAB@glucan@SWNT and these were compared with the behaviour in 
solution. Figure 5.13 shows the fluorescence lifetime decay traces in PBS buffer: the long 
lifetime component decreased from 3.02 ns (71.6% weighting) in free FLAB in solution to 
2.98 ns (77.9% weighting) in FLAB@glucan and to 2.65 ns (66.7% weighting) in 
FLAB@glucan@SWNTs, characteristic to the presence of fluorescein. But it was found that 
the short component lifetime increased from 6.08 ns (28.4% weighting) in free FLAB to 8.13 
ns (22.1% weighting) in FLAB@glucan and 7.0 ns (33.3 % weighting) in 
FLAB@glucan@SWNTs. The decrease in fluorescence lifetime of FLAB confirmed the 
fluorescence quenching by glucan and glucan@SWNTs and also the successful binding of 
FLAB with glucan and glucan@SWNTs.  It also indicates that glucan@SWNT has more 
quenching effect to FLAB than glucan alone. .  
                
Figure 5.13. Two-photon fluorescence spectroscopy: fluorescence decay traces for the 
lifetime determinations (λex = 910 nm, FLAB  26 μM, pH 8.2 buffer, FLAB@glucan complex 
dispersion containing 21 μg/mL FLAB (26 μM) anchored onto 35 μg/mL SWNT in pH 8.2 
buffer, FLAB@glucan@SWNT complex dispersion containing 21 μg/mL FLAB (26 μM) 
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5.2.5 PET Imaging tracer preparation by radioisotope filling using 64Cu radioactivity 
encapsulation  
The reactions described in Chapter 7 Experimental section using radioactive Cu in 
water were performed in order to determine the optimum protocol for encapsulation and 
glucan wrapping in order to formulate a radiotracer suitable for in vivo investigations.38    
The procedure of preparation 5 samples ready for in vivo testing based on the 
sequence of addition glucan,  radioactive 64Cu2+ aqueous solutions (anchored onto NaOAc) 



















Scheme 5.2. Reaction diagram drawing of preparation of sample a-b, the conditions: 
glucan: 2 mg/mL in DMSO;   SWNT: 0.5 mg/mL in H2O; 64Cu(OAc)2 (50 µL,  about 10-9 M 
copper);   NaOAc (10 mg);   C70 (0.667 mg) suspended in 1 mL H2O for each sample. 
 
 
Table 5.3. Decay-corrected 64Cu incorporation into glucan@SWNT complex using the 
encapsulation reaction routes (a)-(e), A = A0× e-kt; k = ln2/ 12.7 h = 0.0546 (in h) 












5.54 6.30   6.70   5.00   6.16   
solid 2.93   3.54   2.53   2.97   3.59   Filtration 
step: solution 0.8   1.6   - - 0.1  
solid 2.00   3.47   1.4   2.82   3.26   Toluene 
and H2O 
wash: 
solution 0.4   0.1   0.2   0.13   0.1   
Estimated % 64Cu 
associated with 
tubes at end of 
experiment 
43 % 69 % 28% 77% 79% 
*Each data point represents an average of three readings. Estimated errors are within 15%.  
*One Bq is defined as one transformation (or decay) per second. 
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The order of 64Cu radio-labelling efficiency was Sample e > Sample d > Sample b > 
Sample a > Sample c (Table 5.3). For Samples b and d, we performed the filling of SWNT 
with 64Cu2+ aqueous solution first and adding β-D-glucan/DMSO for encapsulating with the 
64Cu radiolabeled SWNTs. The difference between samples b and d is that a slight variation 
in the C70 capping procedure was used for sample d. This induces a little increase of labelling 
efficiency compared with Sample 2 without C70 capping after glucan wrapping.  
Sample a and c showed a lower radiolabelling efficiency than sample d and b. This 
could be due to encapsulating the SWNT with glucan before 64Cu filling take place: glucan 
blocking both ends of the SWNT and reducing the filling efficiency. This result is in 
agreement with HRTEM experiments on glucan@SWNT in which a layer of glucan was 
clearly observed to coat an open end of a SWNT strand.  (Figure 5.5 a) The results reveal 
that only 20 min interaction between SWNT and β-D-glucan can lead to more than 50% 
radioactivity retention even after the washing of the un-loaded radioisotope, and the highest 
radiochemical filling yield obtained can even reach 79%.  
5.3 Conclusion to Chapter 5 
We demonstrated the successful filling of SWNTs with Cu2+ (radiochemistry 
methods, using “hot” 64Cu ions anchored onto NaOAc and also a “cold” optimised procedure 
for Cu(OAc)2. Filling with other metal ions were also tested, for example KReO4 (the ‘cold’ 
chemistry, as a model for 186/188Re(V) radiotracers, of importance for radiotherapy and /or 
SPECT imaging or as a synthetic model for 99mTcO4- for SPECT  tracers encapsulation). The 
filling experiments with Zr(OAc)4 in solution did not prove successful at normal pH but 
results were promising when pH was adjusted to ca. 2  using H2SO4.  The filling efficiency 
of Cu2+ from a solution as the concentration of the metal salt is reduced to nano-molar 
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concentrations (by using ‘hot’ chemistry) and the radiochemistry yield has been optimised to 
above 70 %.  Any significant leakage of metal ions from open SWNTs seems to be avoided 
by simultaneous encapsulation of C70 molecules at the ends of SWNTs. We also explore the 
functionalisation of SWNTs by the supramolecular wrapping the surface of SWNTs in 
aqueous media without affecting the electronic network with a naturally occurring glucan (β-
1,3-1,4-D-glucan). The corresponding in vivo experiments by PET imaging are currently 
carried out at Wolfson Brain Imaging Center, Cambridge University by Dr. Franklin 
Aigbirhio. 
Several boronic acid fluorophores were successfully synthesized and tested for the 
labeling of glucan@SWNTs by molecular recognition between boronic acids and β-D-glucan. 
Their cellular translocation behaviour and fluorescence properties were investigated by 
confocal fluorescence imaging and fluorescence lifetime imaging (FLIM). Both methods 
show that localization in sub-cellular (MCF-7 cells) regions and that the glucan coating 
significantly enhances the cell membrane translocation of SWNTs. This is likely due to the 
fact that glucans can be efficiently attached to the cell membrane by recognising cell 
membranes polysaccharides. The glucan coating can greatly mediate SWNTs’ intracellular 
localization, and it appears to reduce the toxicity of carbon nanotubes. MTT assays showed 
that both β-D-glucan and β-D-glucan@SWNTs are biocompatible and have little cytotoxicity 
against fibroblast cells Fek-4.  
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Chapter 6 Synthesis of thermally reduced graphene 
oxide and of its amino acid naphthalene diimide 
complex  
6.1 Introduction 
Graphene is one of the most exciting materials in recent years and this new material 
was discovered by Andre Geim and co-workers at the University of Manchester using the 
‘scotch tape method’. This has already switched on the new revolution in physics, chemistry 
and material.1  
Graphene has a large theoretical specific surface area (2630 m2 g-1), high intrinsic 
mobility (200000 cm2/Vs), high thermal conductivity (5000 Wm−1K−1), electrical 
conductivity, high Young’s modulus (1.0 TPa) and also its advantageous optical 
transmittance (97.7%).2  
All these properties determine that graphene has become considered as the next-
generation material in the applications of nanoelectronic devices, transparent conductive 
films, fuel cells, electrical energy storage and also structural materials.  
The popular approaches for producing graphene on a synthetic scale include 
mechanical exfoliation, chemical vapour deposition (CVD) and chemical or thermal 
reduction of graphite oxide.3 The thermal reduction of graphite oxide method is considered 
not only the low-cost approach of mass-produced graphene but also the simple, non-
chemical conversion of GO powder or film to graphene powder or film, respectively.4  
Chemical reduction of GO, especially exposure to hydrazine in solution is the most 
widely used route to prepare reduced GO so far. However, the chemically reduced GO 
cannot reduce O atomic content efficiently.5 The resulting material is still functionalised with 
O-residual groups on its aromatic surface.6,7 Another disadvantage is hydrazine-treatment 
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forms nitrogen-functional groups with the toxicity of hydrazine.8,9 Removal of the O-residual 
groups and N-functional groups could be carried out by either low temperature heating post-
treatment (200-500 °C).10,11  In comparison, thermal annealing reduction at high temperatures 
(900–1000 °C) is found to be an efficient route of producing graphene-like films with a 
significantly high C/O ratio, with no introduction of any residual groups on surface and do 
not need any toxic reagents.12,13 However the thermal annealing treatment of GO is a very 
complex phenomenon because the thermal induced multi-step removal process of 
intercalated H2O molecules and oxide groups of –COOH (carboxyl group), –OH (hydroxyl 
group), and >O (epoxy group).14 Thermal reduced graphene produced in a wide range of 
organic solvent systems with the hydrazine derivatives can form very stable organic 
dispersions for at least 2 months.15 The strong dispersibility of thermal reduced graphene in 
various of organic solvent is extremely useful for complex with other organic compounds or 
material with advantageous properties and applications of fabrication of organic-based 
composites then thin films. Inspired by our recent publication of interaction between SWNTs 
with amino acid tagged naphthalene diimide through a rapid, highly controllable 
supramolecular chemistry wrapping method,16 we report here a novel and efficient approach 
of use thermal exfoliation and reduction of a graphite oxide (TRG) to complex with amino 
acid tagged naphthalene diimide through aromatic interactions. 
6.2 Results and Discussion 
In this work, graphene oxide (GO) was prepared using a modification of Hummers’ 
method.17 in a highly oxidising mixture of KMnO4 /H2SO4 /KNO3, oxygen functionalities 
such as hydroxyl, epoxide, carboxyl and other carbonyl groups were introduced on the edge 
and in the plane of the graphene sheet, resulting in good solubility of the GO in H2O (Figure 
6.1d). Digital photos of GO and steam thermal reduced graphene at 900 °C for 1 h clearly 
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showed that the colour of the GO suspension changed from yellow-brown in H2O  to black in 
CHCl3 suggesting that the reduction of GO to graphene nanosheets has occurred.  
 
Figure 6.1. TEM images of (a) monolayer of graphene stacked with smaller flakes, image, 
scale bar =200 nm, the inset is SAED of GO; (b) annealing thermal treatment of GO in 
CHCl3;  (c) NDI@TRG after complex, several layer of TRG stacked with each other after 
complex with NDI;  (d) digital photos of GO in H2O(A), TRG in CHCl3(B), NDI@TRG in 
CHCl3 (C) and NDI in CHCl3 (D); (e) SEM image of NDI@TRG in CHCl3.  
 
The thermal reducing of the GO was achieved by steam treatment at high 
temperatures (900 °C) generates graphene-like sheets (Scheme 6.1 and Figure 6.1b). Typical 
TEM images show that both GO and TRG are mono-layered or few-layered. TEM image of 
GO along with selected area electron diffraction (SAED) is shown in Figure 6.1a. The 
typical GO sheets can spread over a macroscopic region, and the SAED pattern indicates a 
crystalline structure, suggesting that the GO before reduction are not randomly oriented with 
respect to one another, and the interlayer coherence is not destroyed. The enormous 
differences between TRG and NDI@TRG in CHCl3 are shown in Figure 6.1c and Figure 
(a) (c)(b)
(e)(d) 
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6.1b, in which clearly shows that after complex with NDI, TRG are less isolated and also 
form multi-layer NDI@TRG aggregate. Also the EDS measurements indicate that NDI 
successfully anchored on the graphene nanosheets compared with EDS spectrum of TRG.  
 
 
Scheme 6.1. Schematic diagram of the thermal reduce treatment of GO and TRG complex 
with NDI  
 
 
The Raman spectra of graphite, GO and TRG are characterised by two prominent 
features (Figure 6.2) ：a) the Brillouin zone-centered LO-phonon around 1590 cm-1, named 
the G or graphite peak; b) the phonon peak around 1300 cm-1, which corresponds to the 
double-resonance excitation of phonons close to the K point in the Brillouin zone, named the 
D or defect-induced peak.  
The peak for GO (1591 cm-1) at the G-band was up-shifted compared with that of 
graphite (1588 cm-1). This was attributed to the presence of isolated double bonds that 
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resonate at frequencies higher than that of the G-band of the graphite. The G-band of TRG 
returned back to1588 cm-1, which corresponds to the recovery of the hexagonal network of 
carbon atoms with defects. After thermal reduction, the Raman ID/IG intensity ratio of 
reduced GO is usually higher than the as-made GO, indicating an increase in the number of 
smaller graphene domains. In contrast, when our GO materials was reduced under 900 °C, 
the TRG showed an average ID/IG intensity ratio lower than that of the as-made GO (Table 
6.1).  
Since the Raman ID/IG intensity ratio is proportional to the average size of the sp2 
domains, the high temperature annealing actually increased the average size of the crystalline 
graphene domains in our GO. 
 
Figure 6.2.    Raman characteristics of graphite, as-made GO and thermal reduced graphene 
(TRG).  
 
Table 6.1. The percentage values of ID/IG ratios obtained by Raman spectroscopy 
Samples D band (cm-1) G band (cm-1) ID/IG  
Graphite 1298 1588 3.31 
As-made GO 1315 1591 3.05 
TRG 1303 1588 2.78 
 
FT-IR spectroscopic investigations confirmed the successful preparation of GO. 
Figure 6.3 shows the typical FT-IR spectrum obtained for three graphite materials. For GO, 
the broad, intense band at 3193 cm-1, which corresponds to the O-H stretching vibrations 
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mode of intercalated water, the bands at 1717 cm-1 are due to C=O stretching vibrations from 
carbonyl and carboxylic groups, 1588 cm-1 corresponds to C=C skeletal vibrations from un-
oxidised graphitic domains，1162 cm-1  corresponds to C-OH stretching vibrations and 1042 
cm-1  corresponds to alkoxy groups. Thus, FT-IR spectroscopy provided evidence of the 
presence of abundant different types of oxygen functional on the graphite oxide material. 
The stretching vibrations of different types of oxygen functionalities in GO were 
significantly reduced (leaving a small peak at 2981 cm-1 corresponds C-H in aromatic ring) 
due to deoxygenation after thermal annealing treatment. The disappearance of characteristic 
peaks of oxygen functionalities groups in TRG indicates that such graphene oxides have 
been fully reduced to the graphene.  
The FT-IR spectrum of NDI@TRG exhibits typical NDI absorption features, such as 
C=C-C of aromatic ring stretch(1450 cm-1, 1484 cm-1, 1580 cm-1), C-N binding with 
aromatic ring (1335 cm-1, 1246 cm-1), C=O (1705 cm-1), aromatic C-H out of plane bend 
(768 cm-1,881 cm-1,1006 cm-1,1177 cm-1, 1246 cm-1).  These features confirm that the NDI 
has non-covalently been grafted with TRG sheet successfully. 
 
 
Figure 6.3.  FTIR spectra of the graphite, GO, TRG, free NDI and NDI@TRG solids. 
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We have also examined the thermal stability of the prepared hybrids and compared it 
with that of pristine graphite and GO using thermogravimetric analysis (TGA). As shown in 
Figure 6.4 (blue line), the GO exhibits about 5.8 wt % loss below 100 °C and more than 70 
wt % loss at 218 °C, resulting from the removal of the labile oxygen-containing functional 
groups such as CO, CO2, and H2O vapour. In contrast, the removal of the thermally labile 
oxygen functional groups by chemical reduction increased the thermal stability of graphene. 
It was shown a 30 wt % loss in a nitrogen atmosphere at 200 °C for the TRG (Figure 6.4 red 
line), which was much lower than that of the GO, indicating a decreased amount of 
oxygenated functional groups of TRG after thermal annealing treatment.  
 
Figure 6.4. TGA curves of graphite (black), TRG (red) and GO (blue). 
 
Fluorescence spectra of NDI show significant changes on the addition of TRG. The 
intensity of the fluorescence bands decrease markedly and the shape of peaks become 
broader with the increase in TRG concentration as illustrated in the Figure 6.5a. Such strong 
quenching of fluorescence of NDI by graphene can only be due to an excited state 
phenomenon since we do not observe ground state charge-transfer.   
  Chapter 6 Synthesis of a thermally reduced graphene oxide-amino acid naphthalene diimide complex 
 189
 
             (a)                                                                          (b) 
Figure 6.5. (a) Fluorescence spectra of NDI recorded after the sequential addition of 
concentrated TRG  accompanied by sonication 5 s and leave it 5 min for complete complex 
(molar fractions are given in the graph). (b)  relative fluorescence intensity versus graphene 
concentration profile of NDI (1 μM, λex = 488 nm, λem = 522 nm) in a CHCl3 (1 mg/mL conc) 
 
Two-dimensional fluorescence contour plotting for free NDI (Figure 6.6 a) and 
NDI@TRG (Figure 6.6 b, c) were recorded, respectively (excitation from 200 nm to 800 nm, 
emission from 200 nm to 800 nm) to investigate the excitation and emission behaviour 
differences of NDI before and after complex with TRG.  Apart from the fluorescence peak of 
NDI, a strong Rayleigh scattering line is also observed from NDI 2D fluorescence contour 
plot (Figure 6.6 a), arising from the NDI dispersed in CHCl3. After complexation of TRG 
with NDI in CHCl3, it clearly shows that nearly most of free NDI was absorbed onto TRG, in 
which that free NDI peaks was disappeared in NDI@TRG contour plot. Also it shows that 
both the excitation wavelength and the emission wavelength of the peak maximum, 
experience a significant red-shift (excitation maximum wavelength moves from 250-350 nm 
to 400-450 nm, emission peak maximum wavelength moves from 350-450 nm to 450-550 
nm). The plots also indicate that the intensity of NDI was severely quenched after complex 
with TRG. We postulate that these red-shifts and quenching of fluorescence occur as 
consequences of the adsorptive interaction between NDI with TRG through aromatic 
stacking. 




                                
           (b)                                                                  (c) 
Figure 6.6. Two-dimensional fluorescence contour plots of (a) free NDI; (b) NDI@TRG; 
(c) Expansion of the NDI@TRG 2D fluorescence plot (Spectra recorded in CHCl3). 
 
 
Binding studies between TRG (“guest”) with NDI (“host”) were carried out by 
adding TRG stock solution in toluene (0.123 M, assuming that Mw of TRG is 1.48 mg/mL) 
to 2 ml NDI solution in fluorescent spectroscopy cuvette and leaving 5 minuets for the 
binding between “guest” and “host” completely then same volume of mixture was removed 
maintaining the total volume unchanged after each titration. Fluorescent spectra were 
recorded (λex= 400 nm, λem= 522 nm) after each titration.  The observed stability constants 
(K) with coefficient of determination (r2) were calculated by the fitting of emission intensity 
at a single wavelength versus TRG concentration using custom written non-linear 
(Levenberg-Marquardt algorithm) curve fitting using Origin 8.0 software. Stability constants 
(K) determined by fitting a 1:1 binding model to I/I0. The stability constant between TRG 
and NDI were calculated using equation (1) (see below). The curve from which the constant 
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was calculated is shown in Figure 6.5 b. TRG shows the fluorescence quenching effect to 
NDI with binding constant of K = 1.47×105 M-1.  
])[1/(])[( maxmin guestKguestKIII FFF ×+××−=                                             (1) 
   In Equation (1), IF max is the initial (maximum) fluorescence intensity, IF min is the 
final (minimum) fluorescence intensity, IF is the fluorescence intensity for a particular guest 
concentration and K is the stability constant of the receptor with the guest. 
6.3 Conclusion for Chapter 6  
We studied the solution complexation of thermally reduced graphene with a 
naphthalene diimide to form a stable nanohybrid complex. Our observations and 
spectroscopic analysis confirm that making reduced graphene by thermal annealing is an 
important step leaving a more planar and clean aromatic surface for aromatic compound NDI 
stacking on. The efficient fluorescence quenching and significant red-shift of fluorescence of 
NDI was induced by the presence of the graphene-type material. The new complex was 
characterised by surface analysis (TEM and SEM), Raman spectroscopy, FT-IR and 
fluorescence microscopy. This complex will be useful for applications such as printable 
electronics, solar cells or future fuel lubricants. 
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 Chapter 7 Experimental details 
7.1 Instrumentation 
7.1.1 Raman spectroscopy 
Raman spectroscopy was performed at STFC CLF Facility in the Research Complex 
at Harwell using a Renishaw upright microscope using 830 nm for excitation, LWD 
objective 2 cm, operated at 50 × magnifications. Laser power magnification at the sample 
was 220 mW and spot size 100 micrometers. 
7.1.2 Transmission electron microscopy (TEM) with energy dispersive X-ray (EDS) 
analysis 
High resolution transmission electron microscopy (HR TEM) images were taken on a 
high resolution microscope JEOL 3000F coupled with EDS (point resolution, 0.16 nm) or a 
Jeol 4000F. Samples for HR TEM observation were ground and dispersed in EtOH and 
placed drop-wise onto a holey carbon support grid. A JEOL JSM-6500F instrument 
operating at 5 kV was used for scanning electron microscopic (SEM) measurements. 
7.1.3 Ultrasonication 
Ultrawave U-500 30 kHz or Agar Scientific S0080 Sonomatic 30 kHz, 80 W 
ultrasonic baths were used. It is recommended that the SWNTs used are sonnicated for no 
longer than 5 minutes followed by resting at the room temperature to avoid extensive 
fragmentation and tube damage. 
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7.1.4 Scanning electron microscopy (SEM)  
All scanning electron microscopy (SEM) images and energy dispersive X-ray (EDS) 
spectra were obtained using a JEOL JSM-6500F field-emission SEM equipped with a JEOL 
EX-23000 BU EDS system. 
7.1.5 Fluorescence lifetime imaging microscopy (FLIM)  
Fluorescence lifetime experiments were carried out at the Rutherford Appleton 
Laboratory. Laser light at a wavelength of 580-630 nm was obtained from an optical 
parametric oscillator pumped by a mode locked Mira titanium sapphire laser (Coherent 
Lasers Ltd) producing 180 fs pulses at 75 MHz. this laser was pumped by solid state 
continuous wave 532 nm laser (Verdi V18, Coherent Laser Ltd). The oscillator fundamental 
output of 910 ± 2 was also used. The laser beam was focused to a diffraction limited spot 
through a water immersion ultraviolet corrected objective (Nikon VC ×60, NA1.2) and 
specimens illuminated at the microscope stage of a modified Nikon TE2000-U with UV 
transmitting optics. The focused laser spot was raster scanned using an X-Y galvanometer 
(GSI Lumonics). Fluorescence emission was collected without de-scanning, bypassing the 
scanning system and passed through a coloured glass (BG39) filter. The scan was operated in 
normal mode and line, frame and pixel clock signals were generated and synchronized with 
an external fast micro-channel plate photomultiplier tube used as the detector (R3809-U, 
Hamamatsu, Japan). These were linked via a Time-Correlated Single Photon Counting 
(TCSPC) PC module SPC830. Lifetime measurements were recorded using time correlated 
single photon counting with an excitation wavelength of 910 nm and measuring the emission 
at 360-580 nm.   
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Emission spectral detection was carried out using an Acton Research Component 275 
spectrograph and an Andor iDus 740-BU CCD camera. The data included for each 
measurement the goodness of fit of the decay curves given by χ2, the lifetime of each 
component and their respective weighting if more then one component was present. The χ2 
value of 1.0 indicates an optimal single exponential fit, whilst χ2 value of more than 1.3 
indicates an incomplete single exponential fit. As such, curves were subsequently fitted to 
two components.  Lifetimes calculations were obtained using Becker and Hickl SPCImage 
analysis software. 
7.1.6  Atomic Force Microscopy (AFM) 
     A Digital Instruments Multimode atomic force microscope (AFM) was used with 
a Nanoscope IIIa controller, operating in tapping mode with an ‘E' scanner, having a lateral 
range of 12 μm and a vertical range of 3.5 μm. Silicon probes (Nascatec GmbH model NST-
NCHFR), with resonant frequencies of approximately 320 kHz were used. X, Y, and Z 
calibration of the AFM was accomplished by scanning a 10 μm pitch 200 nm 3D reference 
from Digital instruments. The sample is dropped onto freshly cleaved mica surfaces using a 
Laurell Technologies WS-400 spin-coater (3000 rpm). The mica substrate was rinsed briefly 
with water, blow dry with air, and used for AFM imaging under the supervision of Dr Robert 
Jacobs (at Oxford University ) and Dr John Mitchels (at Bath University). 
7.1.7 UV/vis spectroscopy 
Electronic absorption spectroscopy (UV/vis) was performed using a Perkin-Elmer 
Lambda 19 spectrometer, running UV Winlab software. Spectra were measured using 1.00 
cm quartz cuvettes.  
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7.1.8  NMR spectroscopy 
  The NMR spectra were referenced to solvent and the spectroscopic solvents were 
purchased from Euriso-Top (C. E. Saclay). 1H NMR data (300 MHz, 298K) are reported as 
follows: chemical shift in ppm on the δ scale, integration, multiplicity (s: singlet, d: doublet, t: 
triplet, q: quartet, dd: doublet of doublets, bs: broad singlet, bt: broad triplet), coupling 
constants (Hz) and assignment. TLC analyses were carried out using Merck silica gel 60 Å 
TLC plates.  Column chromatography was performed on Breckland Scientific Supplies silica 
gel 60 Å (0.040-0.063 mm) for column chromatography. 
7.2 Materials 
Unless otherwise detailed, all chemicals and materials of the highest quality available 
were obtained from Aldrich or Agar. Carbon nanotubes (Elicarb) were provided by Thomas 
Swann Ltd (courtesy of Dr Marcello Motta) and further purified by standard stem 
purification methods.  
7.2.1 Chemicals 
Gases of the highest available purity were supplied by Air Products or BOC.  High 
purity water was collected from a USF Elga water system with an output resistivity of 18.2 
MΩcm.  Otherwise, deionized water was obtained from the Inorganic Chemistry Laboratory 
(ICL) supply. 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, Fluka 03449) was 
stored at -18 ºC. Triethylamine (Et3N, Sigma 471283) was dried with KOH.    




Glassware was cleaned by soaking in concentrated sodium hydroxide dissolved in 
isopropyl alcohol, then immersing in a dilute solution of hydrochloric acid, with water rinses 
after each soak.  Finally, glassware was rinsed with acetone (lab grade) and allowed to dry. 
Glassware used with solutions of 18.2 MΩcm water was cleaned with Decon® 90 
surfactant and then washed extensively with 18.2 MΩcm water to remove surfactant.  If 
drying was required, glassware was washed further with AR grade ethanol and blown dry 
with argon or nitrogen.  Sterile containers (Sterilin), syringes, needles, and 0.20 μm syringe 
filters were also used with 18.2 MΩcm water. 
7.3 Methods 
7.3.1 TEM sample preparation 
TEM samples were prepared by sonicating 0.1 mg of dried sample in 1-2 mL of 
EtOH and then depositing 3 drops of suspension onto copper grids (Agar) coated with holey 
carbon films.  
7.3.2 Preparation of amino acid-tagged Naphthalenediimide  functionalised Single 
Walled Carbon Nanotubes 
7.3.2.1 Synthesis of NDI ((2S,2'S)-2,2'-(1,3,6,8-
tetraoxobenzo[lmn][3,8]phenanthroline-2,7(1H,3H,6H,8H)-diyl)bis(3-(4-
iodophenyl)propanoic acid))  (1)  (Scheme 7.1) 
1,4,5,8-Naphthalenetetracarboxylic dianhydride (200 mg, 0.746 mmol) and 4-
iodophenylalanine (4.34 mg, 1.492 mmol) were suspended in 6 mL DMF in a pressure tight 
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8 mL microwave vial.  To this suspension 0.2 mL dry Et3N were added.  The suspension was 
sonicated until the mixture became homogenous.  The reaction mixture was heated for 5 min 
at 140 °C under microwave irradiation using a dedicated microwave reactor (CEM Discover).  
The solvent was removed under reduced pressure. The dark brown residue was taken up into 
CH3CN (4 mL).  This solution was added under stirring to 100 mL of 1M HCl.  The resulting 
suspension was allowed to settle for 1 hour and then filtered using a Büchner funnel.  The 
solid was then washed with 150 mL deionized water and dried in vacuo.  The product was 
obtained in the form of a pale yellow solid in 87% yield.  
1H NMR (400 MHz, 1:1 CDCl3:CD3OD) δ(ppm): 8.63 (s, 4H, NDI-CH), 7.40 (d, J = 8.3, 
4H, Ph-CH), 5.95 (dd, J1 = 10.4, J2 = 5.5, 2H, CαH), 3.61 (dd, J1 = 14.4, J2 = 5.5, 2H, CβH), 
3.45 (dd, J1 = 14.4, J2 = 10.4, 2H, CβH); 13C {1H}NMR  (100.61 MHz, DMSO-d6) δ(ppm): 
171.5, 163.1, 137.9, 137.4, 131.8, 131.6, 127.3, 126.8, 92.5, 55.0, 34.8. Mass spectrometry: 
Negative mode ES: M/z calcd: C32H20I2N2O8 813.9309 found: 813.9251 [M-]. 
 
 
 Scheme 7.1. Synthesis of iodine-derivatised NDI  
 
7.3.2.2 Crystal structure determination  
Single crystal X-ray diffraction data was obtained for NDI (Compound 1) and 
tryptophan-derived NDI (Compound 9). In both cases, crystals suitable for analysis were 
grown from THF layered with pentane (for Compound 1) or from DMSO:H2O (for 
Compound 9). In each case a typical crystal was mounted using the oil drop technique, in 
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perfluoropolyether oil at 150(2) K with a Cryostream N2 open-flow cooling device. Single 
crystal X-ray diffraction data were collected using graphite monochromated Mo-Kα 
radiation (λ= 0.71073 Å) on a Nonius KappaCCD diffractometer.1,2 The structures were 
solved by direct methods by using the program SHELXL97.3 The refinement (on F2) and 
graphical calculations were performed with the SHELXL97.4 In general, coordinates and 
anisotropic displacement parameters of all non-hydrogen atoms were refined except where 
this was not possible due to the presence of disorder.  Abbreviated crystal data and structure 
refinement parameters are included in below.  
Compound 1: NDI •2THF: C40H36I2N2O10: M = 814.319, Z = 2, monoclinic P21 space 
group a =  12.7594(4)Å, b =  9.2119(3)Å, c =  16.3278(6)Å, β = 103.4340(10)º, U =  
1866.63(11)Å3, T = 150 (2) K, µ =   1.747 mm–1, λ =  0.71073 Å. Of   28017 reflections 
measured, 8439 were independent (Rint = 0.0953). Final R = 0.0486 (6146 reflections with I 
> 2σ (I)) and wR = 0.0812.  
Crystallographic data (excluding structure factors) for the structure reported in this 
paper have been deposited with the Cambridge Crystallographic Data Centre as 
supplementary publication no. CCDC.736937. Data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/cgi-bin/catreq.cgi.  
Compound 9: Try-NDI •3H2O•3DMSO: C36H24N4O8, 3(C2H6OS), 3H2O:  
M = 911.02, Z = 4, orthorhombic P 21 21 21  space group, a =  8.6884(8) Å, b =  
19.6749(18) Å, c =  25.149(2) Å, α=β=γ = 90º, U =  4299.06 Å3, T = 150 (2) K, µ =    0.243 
mm–1, λ =  0.71073 Å. Of  35763 reflections measured, 6841 were independent (Rint = 
0.065). Final R = 0.0529 (4973 reflections with I > 3σ (I)) and wR = 0.0569.  
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7.3.2.3  Computational methods  
First-principles computational studies using density functional theory (DFT) were 
performed on a naphthalene diimide (NDI) molecule anchored onto a model single strand of 
a [10. 10] SWNT by Dr Navaratnarajah Kuganathan (UCL). All calculations were performed 
using the SIESTA code,5 which solves the standard Kohn–Sham (KS) equations using 
numerical atomic orbitals (NAO) basis sets. The exchange–correlation term was modeled 
using the local density approximation (LDA) parameterized by Ceperley and Alder.6 
Standard norm conserving Troullier–Martins pseudopotentials were used to model the core 
electrons of carbon, nitrogen, oxygen, iodine and hydrogen.7-10 The reference electronic 
configuration, cut-off radius and partial core cut-off radius for all pseudopotentials employed 
here are listed in Table 7.1. For nitrogen and iodine, a partial core correction was necessary 
to account for nonlinearity of the exchange and correlation potential between core and 
valence charge densities. The iodine pseudopotential was generated with scalar relativistic 
effects. To test the quality of the pseudopotential, comparisons were made with the 
eigenvalues and excitation energies of all-electron calculations on the same series of atomic 
configurations. The cross-excitation energies for both carbon and nitrogen pseudopotentials 
were not more than 0.09 eV, for oxygen and iodine were 0.06 eV and for hydrogen were 
0.04 eV, indicating the excellent transferability of these pseudopotentials. The one electron 
Kohn–Sham eigenstates were expanded in a basis of strictly localized numerical atomic 
orbitals.9 For carbon, nitrogen and oxygen, a double ζ basis set for the 2s and 2p valence 
states and a single ζ basis set for the 3d state were used. For iodine, a double ζ basis set for 
the 5s, 5p and 6p and a single ζ basis set for 5d and 6s orbitals were used. For hydrogen a 
double ζ basis set for 1s and a single ζ basis set for the 2p orbitals were used. Structure 
optimizations were performed using a conjugate gradient algorithm and the forces on the 
atoms were obtained from the Hellman–Feynmann theorem including Pulay corrections. For 
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all optimized geometries, the forces on the atoms were smaller than 0.06 eV Å−1 and the 
stress tensor was less than 0.02 GPa. To represent the charge density a cut-off of 200 Ry for 
the real space grid integration was used in all calculations. We have used super cells with 25 
Å and 45 Å vacuum spaces along the x, y and z directions for a NDI interacting with a model 
SWNT. A single k-point (Γ) was used for all calculations. 
This modeling approach has been successful in earlier studies modeling the charge 
transfer in the gas phase for the interaction between porphyrins and C60 molecules and within 
the supramolecular structure of porphyrin@SWNT nanohybrids, whereby SWNTs acted as 
an acceptor molecule. Previously, a close agreement was obtained using this method between 
the experimental structure and the optimised geometry of the complex formed between C60 
and a porphyrin host whereby the shortest C–C distances between porphyrin unit and C60 
ranged between 3.27 and 3.71 Å compared with a range of experimental values of 3.35 to 
3.67 Å.11 
The binding energy between the NDI and the C60 or SWNT guest would be ideally 
described by the difference between the total energy of the C60 or SWNT@NDI composite 
and the total energies calculated for an isolated C60/SWNT unit and an isolated NDI unit. 
Subtraction of the energy quantities of both C60/SWNT and NDI unit from the composite 
with localized basis sets gives an uncorrected binding energy, Eb(unc),  defined by equation 
(1) 
SWNTCNDINDISWNTCuncb
EEEE /_/)( 6060 −−=           (1) 
where NDISWNTCE _/60  is the total energy of C60 or SWNT complexed by the NDI and 
60C
E  and NDIE  are the total energies of C60 (or SWNT) and an isolated NDI respectively. The 
error in binding energy due to basis set superposition errors (BSSE) can be high and must be 
corrected in DFT calculations employing localized basis sets. The true binding energy can be 
determined by the counterpoise correction (CP) method of Boys and Bernardi 12 using 
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‘‘ghost’’ atoms. The ‘‘ghost’’ molecule corresponds to additional basis wave functions 
centred at the atomic positions of C60, SWNT or the NDI, but without any atomic potential. 
NDISWNTghostCNDIghostSWNTCNDISWNTCCPb
EEEE ++ −−= //_/)( 606060   (2) 
 
 
7.3.2.4 Cell culture (FEK-4, MCF-7 and HeLa) and fluorescence imaging 
   Cells were cultured at 37 °C in a humidified atmosphere of 5% CO2 in air and split once 
confluence had been reached, using EMEM medium (Eagle’s Modified Essential Medium) 
with foetal calf serum (FCS) (10% for HeLa and MCF-7 and 15% for FEK-4, 200 U mL-1 L-
glutamine and 100 U mL-1 penicillin. The medium contained no fluorescent indicator dyes 
such as phenol red and was therefore suitable for use in fluorescence imaging studies. 
Samples for fluorescence imaging were prepared in the following way: surplus supernatant 
after culturing (containing dead cell matter and excess proteins) was discarded. The live 
adherent cells were then washed with two 5 mL aliquots of phosphate buffer saline solution 
 
Table 7.1. Reference configuration and cut-off radii (a.u.) of the pseudopotentials used in this 
study. 
 
Atom  C N O I H 
Reference  2s22p23d04f0 2s22p33d04f0 2s22p43d04f0 5s25p55d04f0 1s22p03d04f 0 
Core radius 
(a.u.) 
s 1.25 1.25 1.15 1.80 1.25 
 p 1.25 1.25 1.15 1.90 1.25 
 d 1.25 1.25 1.15 3.00 1.25 
 f 1.25 1.25 1.15 2.10 1.25 
Core cutoff 
(a.u.) 
 0.00 1.37 0.00 2.50 0.00 
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to remove any remaining medium containing FCS since this contains protease inhibitors 
which inactivate trypsin, thus inhibiting the resuspension of the cells. For re-suspension in 
solution, the cells were incubated in 3 mL of trypsin–EDTA (500 mg L-1 trypsin, 200 mg L-1 
EDTA) solution for 5 min at 37 °C. After trypsinizing, fresh EMEM (15% FCS) was added 
to the suspended cells to give a sufficient concentration of cells (ca. 50000 cells/mL). The 
concentration of cells required varied slightly between cell lines and is chosen to be optimal 
for achieving sufficient coverage on the Petri dish for optimal imaging (between 40-60% 
coverage). The cells were plated in a Petri dish with a glass cover slip (Mattek) and left for 
24 h to adhere before fluorescence imaging measurements were made.  Final concentrations 
on cell plates used, in 1: 99 DMSO: EMEM, were: a) 21 μg/mL (26 μM) NDI; b) 
NDI@SWNT composite dispersion containing 21 μg/mL NDI (26 μM solution used to 
‘anchor’ NDI onto 35 μg /mL SWNT); c) 35 μg /mL dispersion of free SWNT. Cells were 
incubated for maximum 2 h followed by washing prior to imaging. Cell viability prior to the 
experiment was tested by optical microscopy and MTT assays. The uptake of the 
NDI@SWNT composite was imaged by laser-scanning confocal microscopy (LSM 510 
META, Zeiss) of live cells, as well as in fixed cells, using the 488 nm line of an argon ion 
laser for excitation. The emission was long pass filtered (515 nm) and detected with a 
photomultiplier tube (PMT). The intensity of the laser was modified to reduce the possibility 
of photo-bleaching of the fluorophore over time and the PMT voltage adjusted to be just 
above the auto-fluorescence limit of the starting conditions (for imaging of living cells) thus 
recording a background image before addition of compound, whilst maximizing sensitivity 
and ensuring optimal focusing. A similar standard procedure was used for imaging fixed 
cells, and for these an additional background image was collected (using fixed, but untreated 
cells) at the end of experiment. The confocal imaging of the cells using λex=405 nm did not 
show significant fluorescence emission for either free NDI or NDI@SWNTs thus allowing 
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colocalization tests with nuclear staining dyes such as Hoechst or DAPI (Invitrogen). A 
strong fluorescence emission was observed in the green (515-530 nm) and red (605-675 nm) 
channels upon single-photon laser confocal microscopy using excitation with a green laser 
(488 nm). Upon incubation with the NDI@SWNT probe, formation of endosomes of ca. 0.5-
1 μm seems to be suggested by both bright field and fluorescence imaging inside the cells’ 
cytoplasm. The largest of NDI@SWNT aggregates (ca. 4 μm) did not appear to cross the 
outer membrane and remained attached to the outside membrane of the cell. After exposure 
to NDI@SWNT the cell membrane did not show any significant disruption or changes in 
morphology within 1 h incubation time at 37 °C. In contrast, when the experiment was 
repeated using either free NDI or pristine SWNT imaging showed that these distributed 
rapidly both inside the cells throughout the cytoplasm and in the nucleus and visibly altered 
the cell membrane morphology within 1 h of incubation.  
7.3.2.5 Cell viability tests in FEK-4 and MCF-7 cell lines by MTT assays 
Cell viability studies were carried out under conditions closely comparable with the 
imaging experiments. Stock solutions were prepared as follows: samples containing 42 µg 
NDI, 42 µg NDI anchored onto 70 μg SWNT (mass ratio NDI: SWNT = 0.6) and 70 μg 
purified SWNT were each treated with 2 mL CHCl3: EtOH (4:1) and sonicated for ca 20 min. 
After sonication, the solvent was completely removed and 100 µL DMSO was added to each 
of the residues, followed by further sonication for ca 20 min. Aliquots from each of the stock 
solutions were added to EMEM and immediately added to the wells containing cells ready for 
treatment such that the final DMSO content in EMEM was 1%. The final concentration of the 
probes added to each well was: a) 42 μg free NDI, b) NDI@SWNT composite, formed by 
anchoring 42 μg NDI onto 70 μg SWNT and c) 70 μg SWNT, each dispersed in 100 μL 
solvent (1: 99 DMSO : EMEM). Two control groups were used consisting of 100 μL 
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solvent/well, i.e 1%: 99% EMEM, as well as 100% EMEM. FEK-4 and MCF-7 cell lines 
(cultured using standard procedures13) were incubated at 37 °C with the samples prepared as 
above for 1 h, 3 h, 6 h and 24 h.  After incubation, wells were aspirated and solvents replaced 
by 100 μL of 0.5 mg/mL MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) in EMEM:PBS 9:1, followed by a further incubation (at 37 oC) for 2 h.14 The MTT 
solution was then aspirated and 100 μL of DMSO was added. Absorbance of resulting 
samples (directly proportional to cell viability) was measured at 570 nm using a plate reader. 
Cell viability (%) was estimated as [experiment group OD value] ×100 /[ control group OD 
value].  
7.3.2.6  Epifluorescence Microscopy  
    FEK-4 cells and MCF cells cultured in glass bottom dishes (0.1 million cells/dish) 
were incubated with NDI (42μg), SWNT(35μg) or NDI@SWNT(42μg@35μg).Fluorescence 
spectra were measured in a fluorescence spectrophotometer equipped with a xenon lamp 
(Nikon XB0 100, Tokyo, Japan) and a CCD camera Cool SNAP fx photometrics 193 (20 
MHz, 1300 × 1030 pixels). The fluorescence ratio was recorded every 0.1 s using Lambda 
10-2 Sutter Instrument (Nikon CO. Tokyo, Japan) and Fluorescence Analysis was performed 
with the Software Metafluor® 5.0. 
7.3.2.7  MTT assays for MI50 determinations 
The MI50 (24 h) of NDI, NDI@SWNT and SWNT was assessed following an 
adaptations of literature methods. Briefly, suspensions of 5 ×104 cells/mL Fek-4 or MCF-7 
cells were aliquotted into 96-well plates and incubated in triplicate with NDI (in 
concentrations ranging from 1×10-3 to 1 μmol/mL), NDI@SWNT prepared as above (in 
concentrations containing from 1×10-3 to 1 μmol/mL NDI keeping the mass proportion of 
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NDI and SWNT constant RNDI/SWNT= 0.6) and SWNT (in concentrations ranging from 1 to 
1000 μg/mL) for 48 h and analyzed using a 3-(4,5-dimethylthiazole-2-yl)-2-5-diphenyl 
tetrazolium bromide (MTT) assay. Three independent experiments were performed and MI50 
was calculated. Software Origin 8.0 version was used to calculate the MI50 value. The 
mathematical model used for nonlinear curve fitting was a logistic fit.  
Equation used: )))^/(1/()( 0212 pXXAAAy +−+=                        (3) 
 
7.3.2.8 Calculate Fluorescence Quantum Yields of NDI 
   A comparative method to that Williams et al. was used for the determination of 
quantum yield (Φ),15 It is based on the ratio of five experimentally determined values and 
characterised standard samples with known ΦF values are well characterised. It is an un-
direct measurement. The standard sample should have the same excitation wavelength as the 
test sample to ensure standard sample absorb after excitation. If possible, standard sample 
emit in the same region to the test sample. Standard 10 mm path length fluorescence cuvettes 
were used for running the fluorescence measurements. Use [Ru(bpy)3][PF6]2 (ruthenium trs-
bipy) dionised solution as a reference sample. This compound has a quantum yield of 0.042. 
[Ru(bpy)3][PF6]2 solution and samples must be measured on the same day otherwise it is not 
possible to compare the estimated Qys. UV/vis absorbance of Rubpy is below 0.06 for a 
standard.  
   The quantum yield (the ratio of photons emitted to photons absorbed) is calculated 















D ××××Φ=Φ                                             (4) 
 
 Φ = quantum yield           
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 D = integrated area under emission peak (on fluorimeter) 
 s = sample                    
A = absorbance of solution at excitation wavelength 
 r = reference                     
 n = refractive index of (pure) solvent 
 I = maximum intensity of emission peak 
    [Ru(bipy)3][PF6]2 water solution was used as the reference material, where Φr = 
0.042. Absorbance is calculated according to the Beer Lambert Law with A=εcl where ε= 
molar absorptivity of sample (Lmol-1cm-1 – from UV-Vis spectra, c= concentration (molL-1) 
and l= path length (cm – cuvette dimension). 
7.3.2.9  Staining for nuclear co-localisation studies 
Cells were cultured using standard protocols, as described above, in EMEM. Prior to 
addition of the commercial co-localisation dye, cells were washed 5 times with PBS. 
Protocols adapted from Invitrogen were used throughout. Hoechst A stock solution of 100 μg 
mL-1 Hoechst 33342 (Invitrogen) was prepared in sterile MilliQ water. To 10 μL of the stock 
solution, a volume of 990 μL was added giving a final concentration of 1 μg mL-1.  After 
cells were incubated with this solution for 30 min a further 5 washings with PBS were 
carried out, before the addition of 2 mL of serum free medium (SFM).  Subsequently, a small 
volume of SFM was removed (e.g. 10 μL) and compound in DMSO was added in equal 
volume to what was removed, to obtain a final volume of 1 mL and the desired concentration 
and 1% DMSO).  After 2 h incubation with the compound cells were washed 3 times with 
PBS and fresh serum free medium was added (1 mL) and images were recorded immediately. 
A similar method was used for the DAPI staining, and cells were fixed prior to imaging 
using standard protocols and images were recorded immediately. 




7.3.3 Synthesis of Bombesin-Naphthalenediimide conjugate functionalised Single 
Walled Carbon Nanotubes 
7.3.3.1 Reagents  
 HPLC-grade water (Millipore); acetonitrile (ACN) (Sigma; cat. no. 34967-1L); 
HPLC-grade formic acid (Sigma; cat. no. 27001-500ML-R);  
7.3.3.2  Equipment 
250-μL HPLC vial (Dionex; cat. no. 6820.0029); Ultimate 3000 nano HPLC system 
(Dionex); Chromelon 6.7 software (Dionex); C18 PepMap100 solid-phase extraction  
μ-Precolumn cartridge (particle size 5 μm, pore size 100 Å, 300 μm inner diameter) (Dionex; 
cat. no. 160454); Nano-column PepMap C18 reversed-phase material (particle size 3 μm, 
pore size 100 Å, 75 μm inner diameter) (Dionex; cat. no. 160321);  
7.3.3.3  Reagent setup 
Solution A 0.01% formic acid (wt/vol) in water; Solution B 0.01% formic acid 
(wt/vol) in CH3CN 
7.3.3.4 Semi-preparative HPLC system  
HPLC system Chromatographic system: UltiMate 3000 LC system was used for 
separate sample. Injection system: FAMOS μ−autosampler equipped with a 500 μL sample 
loop, a user-defined injection method was used. HPLC detection system: UltiMate UV 
Detector, 3 μL flow cell, 214-nm detection wavelength. Separation column: PepMap C18, 
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75 μm ID ×150 mm length, 3 μm particle size, 100 Å pore size. Mobile phase for column: 
95 % 0.01% water; 5 % CH3CN. Loading solvent for HPLC is DMSO. RP-column flow rate: 
0.300 μL min- 1. Load sample to a Pepmap C18 Precolumn from 0 min to 30 min, switch on 
the collector from 8 min to 18 min.  
7.3.3.5 Flow gradient for semi-preparative HPLC 
The initial proportion of B was kept at 5 % (v/v). (Figure 7.1) The B was 
successively increased up to 95 % (v/v) from 0 to 7.5 min. The B proportion was kept at 95 
% (v/v) for 9 min (from 7.5 min to 16.5 min) in order to appropriately separate compounds 5 
and 11. After that, the proportion B was successively decreased back to 5 % (v/v) from 16.5 
min to 30.0 min. During the whole procedure, the flow rate was maintained 2 mL/min.  
 
 
Figure 7.1.   Detail of elution and flow-rate gradient. 
 
7.3.3.6 Synthesis of bombesin [7-13] peptide (2) (Scheme 7.2)  
   The bombesin (Gln-Trp-Ala-Val-Gly-His-Leu-NH2) [7-13] peptide sequence was 
made by SPPS (Solid Phase Peptide Synthesis), involving the coupling of coupled 
fluorenylmethoxycarbonyl (Fmoc) amino acids onto Rink Amide Resin. Leucine, glycine, 
alanine and valine were used unprotected, Fmoc-Leu-OH, Fmoc-Gly-OH, Fmoc-Ala-OH and 
Fmoc-Val-OH.  The side chain functional group of histidine and glutamine were protected 
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by trityl and tert-butoxycarbonyl(Fmoc-His(Trt)-OH, Fmoc-Gln(Boc)-OH)and tryptophan 
protected by tert-Butyloxycarbonyl, Fmoc-Trp(Boc)-OH.  The first amino acid Fmoc-Leu-
OH coupling onto resin is normally the hardest to attach and hence as a precaution the 
HOBt/DIC coupling method was used. But for the next amino acids coupling, HBTU and 
DIPEA were used. Deprotection of the Fmoc group was achieved by 3×3 min treatment 
with 20% piperidine in DMF and then washed by 3× DCM and 3×DMF. A Kaiser-test 
was used for confirming the free amine after deprotection which the beads should turn 
blue.  After all amino acids were coupled to this sequence, peptide can be cleaved from 
resin and also amino acid protective groups can be deprotected by mixing resins with a 
cocktail of TFA/TIS/water 95:2.5:2.5 in a round-bottom flask stirring 3 h. The solution 
then was filtrated and filtration liquid was collected and evaporated. Dichloromethane 
was added to the product and extracted with double-distilled H2O 3 times. The aqueous 
layer is recovered and evaporated again. The product was then freeze-dried and stored in 
the fridge for further analysis.  The white powder after freeze-drying was analyzed by 
mass spectroscopy:  
ESI/MS: m/z 809.44 [M + H]+, 405.38 [M +2H]2+  
 HPLC Rt: 5.35 min. (flow gradient, see section 7.3.3.5) 
7.3.3.7  Swelling the resin 
The resin, Rink Amide MBHA, is swelled in the peptide vessel, using DCM, for 
20 min. 
7.3.3.8  Deprotection 
The deprotection was achieved by washing resin with a solution of 20% 
piperidine in DMF 4 × 4 min. Then the resin was washed by 4 ×DMF and 4 × DCM.  
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7.3.3.9 Kaiser-test  
The Kaiser test is a qualitative test for monitoring deprotection in solid phase peptide 
synthesis16. The test is based on reaction of Ninhydrin (2,2-Dihydroxyindane-1,3-dione) with 
primary amines can give a dark blue colour. A small amount of beads are taken and 
deposed in a small vial. Then several drops from ninhydrin (5%, w/v) in ethanol, phenol 
(4:1, w/v) in ethanol and potassium cyanide (2%, v/v, of a 1 mmole/liter aqueous 
solution) in pyridine are taken separately and added to vial. Then the vial was heated by 
heating gun. If the beads turn dark blue, then there is a free amine present, confirming 
deprotection was successful. If the beads are still colorless, then the deprotection failed 
and procedure needs to be repeated.  
7.3.3.10 Coupling  
A mixture of the amino-acid (3 eq), coupling reagent (3 eq) and the base (6 eq) in 
DMF was added to the resin. For the first amino acid Leucine was coupled to resin by 
standard HOBt/DIC coupling. For the next amino acids, HBTU and DIPEA were used.   
7.3.3.11 Loading efficiency of the fist amino acid to the resin  
   The loading efficiency of the fist amino acid to resin is very important to the last 
product field. We calculated the loading efficiency of the first amino acid based on the Beer-
Lambert law:  
                       lCA ε=                                                                                                                  (5) 
Where A is the absorbance, ε the absorption coefficient, which is 3800 for Fmoc-
H, C is the concentration and l the path length of UV cuvette, which is 1 cm.    
The concentration of Fmoc- first amino acid was calculated and compared to the 
theoretical loading.  





Scheme 7. 2: Procedure for the synthesis of bombesin[7-13]: Gln-Trp-Ala-Val-Gly-His-Leu-
NH2 
 




Figure 7.2. The ESI/MS spectrum of Bombesin[7-13] showing two peaks at m/z 809.44 
and 405.38 corresponding to[M]2+ and [M]+ . 
7.3.3.12 Synthesis of Naphthalene diimide-Bombesin Conjugates 
7.3.3.12.1 Method 1: The first route of synthesis of naphthalene diimide-Bombesin 
conjugates (mono-substituted naphthalene diimide-Bombesin) (3) (Scheme 7.3) 
 
INDI (11.4 mg, 0.014 mmol, 1 eq) was dissolved in DMF (100 µL), and the solution 
was cooled to 4 in ice bath. EDC·HCl(N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride) (6.71 mg, 0.035 mmol, 3 eq) and HOBt·H2O(1-hydroxybenzotriazole 
hydrate)(6.62 mg, 0.049 mmol) was added sequentially  to NDI solution and allowed to stir 
for 40 min in ice bath and to this solution was added bombesin peptide (34 mg, 0.042 mmol, 
3 eq). The pH value of solution was adjusted to 9 with DIPEA.  Then the ice bath was 
removed and the solution was stirred at room temperature for one night. After reaction, the 
solvent was removed under reduced pressure, leaving behind a pale white residue. The 
residue was dissolved in CHCl3 (125 mL), washed with H2O (2×20 mL) and saturated 
aqueous Na2CO3 Solution (2 ×20 mL). The organic layer was dried over anhydrous MgSO4, 
and evaporated to dryness under reduced pressure and yellow powder was obtained (18 mg, 
53.7% yield).  
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Mono-substituted NDIBBN Mass Spectrometry: Positive mode ES: m/z calcd for 
C70H74I2N14O15Na+:1627.35 [M+Na]+; found: 1627.0; calcd for C70H74I2N14O15K+ :1643.35 
[M+K]+ ; found: 1643.0).  
HPLC Rt: 8.31 (flow gradient, see section 7.3.3.5) 
 
 














Figure 7.3. The ESI/MS spectrum of mono-NDIBBN showing peaks at m/z 1628.0 and 
1643.0 corresponding to [M+Na]+ and [M+K]+  .  
 
7.3.3.12.2 Method 2: The second route of synthesis of naphthalene diimide-Bombesin 
conjugates (double-substituted naphthalene diimide-Bombesin) (5)   
 
7.3.3.12.2.1 Synthesis of NDI-OSu (4) (Scheme 7.4) 
 
    NDI and N-hydroxylsuccinimide was dissolved in DMF with stirring in ice bath 
for 15 min.  EDC・HCl was dissolved in DMF and then added to the solution which was 
stirring in ice bath for another 15 min. Then ice bath was removed and the solution was 
continually stirring at room temperature for 8 h. The DMF was removed by evaporating and 
a small amount of acetonitrile was added for dissolving the resulting product. Then the 
solution was added to stirring double-distilled H2O from which precipitate was formed. The 
precipitate was collected by filtration and fine powder was formed by adding pentane to 
precipitate in bottom flask and then dried in vacuum. Yield: 0.76 g, 88%. 1H NMR (500 
MHz, DMSO-d6, 300 K) δ(ppm): 8.76 (s, 4 H, NDI), 7.51 (d, J = 8.3, 4H, Ph-CH), 7.00 (d, J 
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= 8.28, 4H, Ph-CH),  6.37 (dd, J1 = 9.9, J2 = 5.9, 2H, CαH), 3.74 (dd, J1 = 14.4, J2 = 6.5, 2H, 
CβH), 3.61 (dd, J1 = 15.3, J2 = 10.2, 2H, CβH); 2.82 (s, 8 H, NC(O)CH2). 13C {1H}NMR  
(100.61 MHz, DMSO-d6) δ(ppm): 176.2, 169.1, 159.2, 139.8, 137.6, 129.5, 90.8, 25.8. 
(Positive mode ES: m/z calcd for C40H26I2N4O12Na+ : 1030.96 [M+Na]+.; found: 1030.95). 
HPLC Rt: 12.56 (flow gradient, see section 7.3.3.5) 
 
 
Scheme 7.4:  Synthesis of NDI-OSu (4). 
 
Figure 7.4. The ESI/MS spectrum of NDI-OSu showing peaks at m/z 1030.95 
corresponding to [M+Na]+ . 
 
7.3.3.12.2.2 Synthesis of naphthalene diimide-Bombesin conjugates by coupling of NDI-
OSu with bombesin[7-13] (5) (Scheme 7.5) 
 
    To a mixture of NDI-OSu (10 µmol, 10 mg) and bombesin (21µmol, 17 mg) in DMF was 
added Et3N (2.93 mg). The solution was stirred under N2 for 8 h at room temperature. 
Solvent was removed and acetone was added to the residue. The acetone mixture was added 
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dropwise to a vigorously stirred solution of 1 M HCl (200 mL). The precipitate was collected 
by filtration and dried. Mass spectroscopy and analytical HPLC methods were used for 
analyzing the resulting compound. Both methods confirm that there are two products, one is) 
and another is double-substituted. The product was purified by semipreparative HPLC 
(reverse phase).  
NDI-Bombesin (Positive mode ES: m/z calcd for C108H128I2N26O22K+: 2433.78 [M+K]+; 
found: 2433.47) (Figure 7.5). 
HPLC Rt: 8.71 (flow gradient, see section 7.3.3.5) 
 
Scheme 7.5. Synthesis of double substituted NDIBBN (5). 
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MSS 10282 [C108 H128 N26 O22 I2] 14-Feb-2012 13:54:42MALDI
m/z



































Figure 7.5. The MALDI spectrum of double substituted NDIBBN (5) showing peaks at 
m/z 2433.47 corresponding to [M+K]+. 
 
7.3.3.12.3 Isolation of mono-substituted NDI-Bombesin and double-substituted NDI-
Bombesin from impurities by semipreparative HPLC 
 
HPLC system Chromatographic system: UltiMate 3000 LC system was used for 
separate sample. Injection system: FAMOS  μ-autosampler equipped with a 500 μL sample 
loop, a user-defined injection method was used. HPLC detection system: UltiMate UV 
Detector, 3 μL flow cell, 214-nm detection wavelength. Separation column: PepMap C18,  
75 μm ID 150 mm length, 3 μm particle size, 100 Å pore size. Mobile phase for column: 
95% 0.01%water; 5% CAN. Procedure: (a) Loading solvent for HPLC: DMSO. RP-column 
flow rate: 0.300 μL min- 1. (b)Load sample to a Pepmap C18 Precolumn from 0 min to 30 
min, (c) Switch on the collector from 8 min to 18 min.  
7.3.3.13 Preparation of 5@SWNT complex, denoted as NDIBBN@SWNT 
The NDI-Bombesin@SWNT complex was prepared by mixing mono-substituted 
NDIBBN (3) water solution (2.4 mg, 1.5 μmol, 2 mL) with SWNT (0.25 mg, 2 mL) EtOH 
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dispersion, then sonicating 20 min, solution was stirring 2 days. Dialysis of NDI-Bombesin 
and SWNTs mixture against phosphate-buffered saline (PBS, 50 mM, pH 7.4) was carried 
out at 37 °C, which results in removal of unbound NDI-Bombesin. Centrifuge was 
performed to remove the aggregate which size is not suitable for biomedical application. The 
procedure results a very clear NDI-Bombesin@SWNT complex dispersion. (Figure 7.6 
b).The UV-Vis analysis concluded that 1.44 mg 5 (0.9 μmol) bind with 180 μg SWNTs.  
 
                  (a)                               (b)                             (c) 
Figure 7.6. a) Mono-NDIBBN H2O solution, 2.4 mg, 1.5 μmol, 2 mL b)mono-
NDIBBN@SWNT H2O solution obtained on a preparative scale after buffer dialysis, and 
redispersed at 0.1 mg/mL conc. (1.44 mg mono-NDIBBN (0.9 μmol) anchored onto 180 
μg SWNTs), c) 0.25 mg SWNT dispersed in H2O, 2 mL. 
7.3.3.14  Fluorescence imaging of NDI-Bombesin and NDI-Bombesin@SWNTs  
   Final concentrations of compounds added to PC-3 cell and Hela cell plates in 1: 99 
DMSO: EMEM, were: a) 3 μM NDI-Bombesin; b) 3 μM NDI-Bombesin@SWNT composite 
dispersion (3 μM solution used to ‘anchor’ 3μmol NDI-Bombesin onto 6 mg SWNT). Cells 
were incubated for maximum 2 h followed by washing prior to imaging. Cell viability prior 
to the experiment was tested by optical microscopy, standard trypan blue tests and MTT 
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assays. The uptake of the NDI-Bombesin@SWNT composite was imaged by laser-scanning 
confocal microscopy (LSM 510 META, Zeiss) of live cells, as well as in fixed cells, using 
the 405 nm, 488 nm and 543 nm line of an argon ion laser for excitation. The emission was 
detected with a photomultiplier tube (PMT). The intensity of the laser was modified to 
reduce the possibility of photobleaching of the fluorophore over time and the PMT voltage 
adjusted to be just above the auto-fluorescence limit of the starting conditions (for imaging 
of living cells) thus recording a background image before addition of compound, whilst 
maximizing sensitivity and ensuring optimal focusing. A similar standard procedure was 
used for imaging fixed cells, and for these an additional background image was collected 
(using fixed, but untreated cells) at the end of experiment. 
7.3.4 Synthesis RGDfK-Naphthalene diimide conjugate  
7.3.4.1 Synthesis of linear RGDfK(Arg(Pbf)-Gly-Asp(OtBu)-D-Phe-Lys(Boc)) (6) 
(Scheme 7.6) 
Loading of the resin was achieved by swelling 2-chlorotrityl polystyrene resin (1.0 g) 
for 20 min in DCM. After swelling, the resin was treated with a solution of Fmoc-Gly-OH (2 
eq, 3 mmol) and DIPEA (4 eq, 1 mL) in DCM (10 mL) by agitating for 90 min. The first 
amino acid attached resin was then washed with a solution of DCM / MeOH / DIPEA (10 
mL; 17: 2: 1 v/v/v) for 3 ×15 min and with DCM (3 × 10 mL), DMF (2 × 10 mL), and DCM 
(2 × 10 mL). The other amino acids coupling were performed using Fmoc-amino acid (2 eq, 
3 mmol), PyBOP (2 eq, 3 mmol), and DIPEA (4 eq, 6 mmol) in DCM (10 mL) for 90 min. 
Fmoc deprotection before next amino acid coupling was achieved by treatment with 
piperidine/DMF (1:4 v/v) for 4×3 min. The deprotection reaction was monitored by 
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ninhydrin test and chloranil test. Washing of the resin after coupling were deemed complete 
by DMF (2 × 8 mL), Et2O (2 × 8 mL) and DCM (2 × 8 mL). 
    Cleavage from the resin was achieved by treatment with TFA / DCM (7 mL; 1 : 99 
v/v) for 10 × 2 min. Before aspirating cleavage solution from vessel, the cleavage solution 
were neutralised by addition to pyridine / MeOH (10 mL; 1: 9 v/v). The mixture was 
concentrated in vacuum, dissolved in a minimum volume of MeOH, then the crude peptide 
was precipitated by adding Millipore water, collected by centrifugation, dissolved in DCM 
(100 mL), washed with water (100 mL). The DCM layer was collected and evaporated in 
vacuum to give 6 as a white solid (1.18 g; 85%). ESI-MS: m/z calcd for C49H74N9O13S 
1028.52 [M+H]+; found 1028.4936. 
HPLC Rt: 8.54 min (flow gradient, see section 7.3.3.5) 
 
                                                            (a) 
 
                                                             (b) 
Figure 7.7. Analytic HPLC trace(Rt: 8.58 min) (a) and ESI/MS spectrum(b) showing 
peaks at m/z 1028.49 corresponding to [M+H]+ of linear RGDfK 
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7.3.4.2 Cyclisation of protected RGDfK peptide (Cyclo(-RGDfK), 7)  
6 (139 mg; 0.13 mmol) and PyBOP (0.083 g; 0.161 mmol) were dissolved in DCM 
(135.5 mL) and the solution was adjusted to pH 8 by the addition of DIPEA (0.382 mL) and 
allowed to stir for 24 h. The reaction mixture was then concentrated in vacuum. The crude 
product was dissolved in DCM (20 mL) and washed with a saturated solution of NaHCO3 (4 
× 20 mL) and with brine (75 mL). The crude peptide was then precipitated in cold Et2O, 
and centrifuged to give 7 as a white solid (127 mg; 94%).  
HPLC Rt: 10.19 min (flow gradient, see section 7.3.3.5). 
ESI-MS : m/z calcd for C49H73N9O12SNH4+ 1029.51 [M+NH4]+; found 1030.53.  
 
Figure 7.8. ESI MS spectrum of cyclic protected RGDfK 7 showing peaks at m/z 1030.49 
corresponding to [M+NH4]+. 
7.3.4.3  Cyclic deprotected RGDfK peptide (8). 
Protected Cyclo(-RGDfK) 7 (0.2 g; 0.198 mmol) was dissolved in a TFA 
deprotection cocktail (TFA/CH2Cl2, 1: 1, 5 mL), and the solution was stirred for 2 h. The 
majority of the TFA can be removed by purging N2 gas. The crude peptide was precipitated 
in cold Et2O, then centrifuged to give the desired product as a light green solid (0.122 g; 
67%).  
HPLC Rt : 7.95 min (flow gradient, see section 7.3.3.5); 
ESI-MS: m/z calcd for C27H42N9O7: 604.31 [M+H]+; found 604.3910. 




Figure 7.9. ESI/MS spectrum of cyclic deprotected RGDfK showing peak at m/z 604.39 
corresponding to [M+H]+. 
 
Scheme 7.6. Synthesis of deprotected cyclic RGDfK peptide 8, (i):Fmoc-Gly-OH, 
DIPEA,CH2Cl2 (ii):20%(v/v) piperidine in DMF; (iii):Fmoc-Arg(Pbf)-OH, PyBop, 
DIPEA,CH2Cl2; (iv): Fmoc-Lys(Boc)-OH, PyBop, DIPEA, CH2Cl2; (v): Fmoc-D-Phe-OH  
PyBop, DIPEA,CH2Cl2; (vi):Fmoc-Asp(OtBu)-OH, PyBop, DIPEA,CH2Cl2; (vii):TFA/ 
DCM (10 mL; 1 : 99 v/v) for 10×2 min, pyridine/MeOH (10 mL ; 1 : 9 v/v); (viii): PyBOP, 
DIPEA, 72 h rt; (x):TFA/CH2Cl2 (1:1), rt, 2 h. 




7.3.4.4 Synthesis of tryptophan-NDI (TNDI) (9) (Scheme 7.7) 
1,4,5,8-Naphthalenetetracarboxylic dianhydride(200 mg, 0.746 mmol) and the  L-
Tryptophan (1.491 mmol, 304.5 mg) were suspended in 8 mL of DMF in a pressure-tight 15-
mL microwave vial. To this suspension was added 0.2 mL of dry Et3N. The suspension was 
sonicated until the mixture became homogeneous. The reaction mixture was heated for 5 min 
at 140°C under microwave irradiation using a dedicated microwave system. 
The solvent was removed under reduced pressure. The dark brown oil was taken up 
into MeOH (6 mL). This solution was added under stirring to 400 mL of 1M HCl. The 
resulting suspension was allowed to coagulate overnight and then filtered through a glass 
funnel. The solid was then washed with 100 mL deionized water and dried under reduced 
pressure. The product was obtained in the form of a brown solid in 88% yield. 
1H NMR (400 MHz, DMSO-d6) δ(ppm): 10.48(s, 2H), 8.54(s, 4H),  7.4(d, 2H, J=7.8),  
7.11(d,2H, J=8), 6.91(d,2H, J=2.2), 6.86(dd,2H, J=7.1), 6.74(dd,2H,J=8), 5.8(t, 2H),  3.64-
3.45( m, 4H) 13C NMR{1H } (100.61 MHz, DMSO-d6) δ(ppm): 169.2, 161.8, 137.2, 131.3, 
128.9, 128.1, 126.4, 125.9, 125.5, 54.2, 52.3, 34.0; ESI/MS calcd. for: C36H24N4O8K+ 
[M+K]+ (m/z): 679.16, found: 680.09. 
 
Scheme 7.7.  Synthesis of Compound 9. 
 




Figure 7.10. 1H NMR (400 MHz, DMSO-d6) spectrum of 9. 
 
MSSS 10285 [C36H24 N4 O8] 13-Feb-2012 11:11:40MALDI
m/z







































Figure 7.11. MALDI spectrum of TNDI showing peaks at m/z 680.09 corresponding to 
[M+K]+ . 
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7.3.4.5  Synthesis of tryptophan-NDI-OSu (TrypNDI-OSu) (10) (Scheme 7.8) 
Tryptophan-NDI (0.2 mmol, 128.12 mg) and N-hydroxysuccinimide (0.8 mmol, 92 
mg) were dissolved in DMF and stirred in ice bath for 15min.  EDC・HCl (0.8 mmol, 
153.36 mg) was dissolved in 20 mL DMF and then added to the solution which was stirred in 
ice bath for another 15 min. Then ice bath was removed and the solution was continually 
stirring at room temperature for 8 h. The DMF was removed by evaporating and a small 
amount of acetonitrile was added for dissolving the resulting product. Then the solution was 
added to stirring double-distilled H2O from which precipitate was formed. The precipitate 
was collected by filtration and fine powder was formed by adding pentane to precipitate in 
the bottom of the flask and then dried in vacuum.  
Yield: 160.2624 mg, 96%. 1H NMR (300 MHz, DMF-d1, 300 K) δ(ppm): 11.7 (s, 1 
H, NH), 8.7(s,4H, NDI), 7.54(d, 2H, J7.5), 7.1(d, 2H, J9.8),6.8(m, 6H), 5.3(t, 2H, J6.1 and 
4.1), 3.67(m, 4H), 2.76(s,1H), 2.64(s,1H). 13C {1H} NMR (100.61 MHz, DMF-d1) δ(ppm): 
162.91, 162.71, 162.13, 107.92, 67.15, 35.85, 34.47, 30.74, 29.91 and 24.18. 
Positive mode ESI MS: m/z calcd: C44H30N6O12Na+ 857.19 [M+Na]+; found: 857.45. 
calcd: C44H30N6O12K+ 873.19 [M+K]+; found: 873.46. (Figure 7.12) 
 
Scheme 7.8.  Synthesis of TrypNDI-OSu 10. 
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MSS 10286 [C44 H30 N6 O12] 14-Feb-2012 13:59:18MALDI
m/z












































Figure 7.12. MALDI spectrum of TNDI-OSu showing peaks at m/z 857.45 [M+Na]+, 
873.46 [M+K]+.  
 
7.3.4.6  Synthesis Trypotophan-tagged naphthalene diimide-RGDfK conjugates 11 
by coupling reaction (Scheme 7.9) 
To a mixture of 10 (10 µmol, 10 mg) and 8 (21 µmol, 17 mg) in DMF was added Et3N 
(2.93 mg). The solution was stirred under N2 for 8 h at room temperature. Solvent was 
removed and acetone was added to the residue. The acetone mixture was added dropwise to a 
vigorously stirred solution of 1 M HCl (200 mL). The precipitate was collected by filtration 
and dried (Scheme 8). Mass spectrometry and analytical HPLC methods were used for 
analyzing the resulting compound. MALDI and HPLC confirm that the product is double-
substituted NDI-RGDfK (11). The product was purified by semi-preparative HPLC. Positive 
mode ESI MS: m/z calcd: C90 H103 N22 O20+, 1811.76 [M+H]+; found: 1811.76 (Figure 10).   
 































































2eq RGDfK,N2, 8 h,room temperature
in peptide grade DMF
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Scheme 7.9.  Synthesis of TNDI-RGDfK 11 
MSS 10281 [C90 H102 N22 O20] 14-Feb-2012 13:51:40MALDI
m/z
































Figure 7.13. MALDI spectrum of 11 showing peaks at m/z 1811.76 [M+H]+ . 
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7.3.5 Functionalisation of SWNTs with a dodecathiophene (denoted T12)  
7.3.5.1 Materials 
    All solvents (HPLC grade) were used without further purification. All starting materials 
were purchased from Aldrich, Acros, or Fluka and used without further purification. T12 was 
synthesized by Patrick van Rijn from Delft University of Technology and used as provided.  
The purity and identity of this compound was confirmed by NMR and Mass spectroscopy at 
Bath.  
1H NMR (300 MHz, CDCl3): δ=0.80 (t, J=7.0 Hz, 12H), 1.09-1.26 (m, 104 H), 1.47–1.75 (m, 
8H), 3.22–3.33 (m, 24H), 3.40–3.49 (m, 16 H), 3.50–3.74 (m, 112 H),4.57 (s, 16H), 6.84 (s, 
1 H), 7.19 ppm (s, 11H), 7.53 (s, 2H) 13C NMR (75 MHz, CDCl3): δ=14.23 (CH3), 29.12 
(CH2), 29.68 (CH2), 29.88 (CH2), 31.08 (CH2), 76.59 (CH2), 77.01 (CH2), 77.22 (CH2), 
77.44 (CH2), 126–140 ppm (broad  overlapping signals corresponding to 14 CH and 34 C);  
ESI-TOF: m/z calculated for C192H314O40S12; 3643.92 (mono-isotopic) found: 1844.9081 
[M+2Na]2+,1237.6293 [M+3Na]3+. 
7.3.5.2 Preparation of T12@SWNT nanohybrid 
    A typical procedure for preparing T12@SWNT dispersions is as follows: a mixture of 
SWNTs (0.1 mg) and the T12 polymer (0.1 mg) in CHCl3 (4 mL) was sonicated for 20 min 
and stirred for 2 days. After centrifugation (10000 rpm) of the resultant yellow-brown 
suspension for 30 min, the supernatant was taken and filtrated and washing with CHCl3 three 
times. The black complex on PTFE filter membrane was collected and dried in oven 60 °C 
overnight. The T12@SWNT composite can be dissolved again in CHCl3, DCM and DMSO 
easily.  
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7.3.5.3 Cell culture and fluorescence imaging  
For microscopy, cells were seeded onto chambered coverglass slides and incubated for 12 h 
to ensure adhesion. Prior to imaging, the solution was replaced with 1 mL fresh EMEM. 
Background autofluorescence was measured by imaging the cells in 1 mL of EMEM 
medium only.  Final concentrations on cell plates used were: a) 7 μg/mL T12 (1.92 μM in 5: 
95% DMSO: EMEM); b) T12@SWNT composite dispersion (in 5: 95% DMSO: EMEM) 
containing 7 μg/mL T12 (1.92 μM T12 ‘anchored’ onto 18 μg/mL SWNT);  
7.3.6 Preparation of metal radiopharmaceuticals filling and biocompatible 
fluorescent material coating Carbon Nanotubes  
7.3.6.1 Buffer and Solvents 
The fluorescence titrations of boronic acid fluorophore with β-D-Glucan were carried 
out in in a pH 8.21 aqueous methanolic buffer. The buffer was prepared as Perrin and 
Dempsey method17: 52.1 wt% HPLC grade methanol in deionised water with KCl (10.0 
mM), KH2PO4 (2.75 mM), and Na2HPO4 (2.75 mM) and was stored in the dark in fridge 
when not in use. PBS buffer was made by dissolving each tablet of PBS with 100 mL of 
distilled water. This buffer contains 10 mM phosphate, 150 mM sodium chloride, pH 7.3 to 
7.5. 
7.3.6.2  Steaming purification of SWNTs (Figure 7.14) 
This method was based on literature method by Malcolm L H Green.18,19 250 mg arc-
discharge made SWNTs (CarboLex) was kept in a glove box fed with argon gas for two days 
to remove oxygen absorbed on surface of carbon nanotubes.  
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Distilled water was first flushed with argon to remove dissolved oxygen. SWNTs 
were placed in a silica tube (9 mm diameter) and immobilised with silica wool at both sides. 
The sample was then put in the middle of quartz furnace tubes. The sample was kept under 
argon for 30 min. The steam was introduced by bubbling argon through boiling water (98 
°C). After the whole system was purged by argon for 2 h, then the furnace was gradually 
then heated to 900 °C (15 °C/min). After 2 h steaming treatment, the steam was turned off, 
and the furnace was switched off, but argon flow was kept on until furnace decreased to 
room temperature to protect the sample from thermal oxidation. After steam treatment, 
sample was stirring in 16 % HCl overnight, and then the carbon nanotubes was filtered after 
the solution diluted with access distilled water, the solid was washed with access distilled 
water. Obtained carbon nanotubes solid was dried in oven at 60 °C overnight.  
 
Figure 7.14. (a) Equipment setup for SWNTs steaming purification. (b) Argon flow 
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7.3.6.3 “Cold” filling steam-purified SWNTs using the orecursors: Cu(AcO)2, KReO4 and 
Zr(OAc)4 
7.3.6.3.1     Filling with Copper Acetate      
 
In a typical procedure, 0.8 mg of steam purified open SWNTs were suspended into a 
saturated Cu(OAc)2 and NaOAc (1:10 ratio) solution and then sonicated for 30 min. The 
solution was kept stirring at 50 °C for 2 h. Then the Cu(AcO)2@SWNTs solution was 
evaporated  to remove the H2O. 0.66 mg C70 was sonicated in EtOH for 2 min. Cu(OAc)2 
@SWNTs precipitate was added to this solution and the mixture was sonicated for 1 min and 
left stirring for 30 min, to allow the C70  to enter the SWNTs, in a similar mechanism called 
“nano-extraction” method for the encapsulation of fullerenes. After “corking”, the solution 
was filtered, and washed several times with distilled water to remove the excess of copper 
acetate external to the SWNTs. The solid residue on the filter membrane was washed again 
with toluene (5 mL) to remove C70 sticking on the external surface of SWNTs. The solid 
residue was dying under reduced pressure. A very small amount of the sample (less than 1 
µL) was dropped on a copper grid for HRTEM.  
 
7.3.6.3.2 Filling with Zirconium Acetate Zr(OAc)4 
 
Open-ended SWNTs (1.6 mg) was added to 20 mL of ethanol and then ultrasonicated 
in a water bath for 20 min. SWNTs ethanol solution was splitted into 2 samples (A and B).  
23.4 mL of zirconium acetate solution (30 mg) was added to each vial. 10 mg of sodium 
acetate was added into B sample. Zr(OAc)4 formed gel in both samples after two days room 
temperature stirring.  H2SO4 was added into both samples in dropwise until the pH value was 
adjusted to 2.4 for avoiding the gel formation of Zr(OAc)4. Ethanol was removed by 
evaporation and then 10-15 mL double-distilled H2O was added into each sample without the 
gel forming by dropping H2SO4.  Samples were kept under constant stirring at 50 °C for 48 h.  
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The solution was filtered through a 0.2 μm polycarbonate membrane and washed with excess 
distilled water to remove the large excess of Zr(OAc)4 and sodium acetate. The sample was 
then dried under vacuum giving zirconium acetate filled SWNTs, designated as 
Zr(OAc)4@SWNTs.  Also the unwashed Zr(OAc)4@SWNTs  solution can be “corked” with 
C70. Prior to washing, C70 (0.4 mg) was added, stirred and heated at 50 oC overnight. After 
24 h, the solution was filtered, and washed several times with excess double-distilled H2O, 
followed by a toluene wash to remove the C70 left in solution.  
 
7.3.6.3.3 Filling with Potassium Perrhenate (KReO4) 
 
In a typical procedure, 0.8 mg of steam purified open SWNTs were suspended into a 
saturated KReO4 solution and then sonicated for 30 min. The solution was kept stirring at 70 
°C for 2 h. Then the KReO4@SWNTs solution was evaporated to remove the H2O. 0.5 mg 
C70 were sonicated in EtOH for 2 min. KReO4@SWNTs solid was added to this solution and 
the mixture was sonicated for 1 min and left stirring at 80 °C for 2 days. After “corking”, the 
solution was filtered, and washed several times with distilled water to remove the excess of 
KReO4 external to the SWNTs. The solid residue on the filter membrane was washed again 
with toluene (5 mL) to remove C70 sticking on the external surface of SWNTs. The solid 
residue was dying under reduced pressure. A very small amount of the sample (less than 1 
µL) was dropped on a copper grid (lacey carbon) for HRTEM imaging.  
7.3.6.4 Synthesis of fuorescein-5-[thioureidyl-(3-phenylboronic acid)] (FBA) (Scheme 
7.10)(12) 
Fluorescein isothiocyanate (130 mg, 0.33 mmol), m-aminophenylboronic acid (45.2 
mg, 0.33 mmol) were added into a methanol (12 mL) and distilled water (2 mL) mixture 
solvent. Triethylamine (1 mg) was dropped into this reaction. The solution was stirred for 1 h 
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at room temperature and then another 45.2 mg of m-aminophenylboronic acid was added. 
Stirring for another 1 h, the product was then purified by thin layer chromatography (eluent 
dichloromethane:methanol, 9:1). 1H NMR (300 MHz, MeOD d4+D2O) δ:  7.97 (1H, d, J 2.7), 
7.74 (1H, dd, J 8.5 and 2.7), 7.71 (1H, s), 7.6 (1H, d, J 8.5), 7.36 (1H, m), 7.19-7.15 (2H, m), 
6.63-6.59 (5H, m), 3.35 (2H, NH). 13C NMR (75 MHz, D2O) δ:   182.2, 179.9, 160.0, 159.9, 
141.9, 141.8, 139.7, 133.1, 132.9, 132.1, 131.7, 131.5, 129.7, 128.2, 127.1, 126.6, 123.6, 
123.4, 115.5, 114.9, 104.7, 104.5.  11B NMR (D2O, 96 MHz): 19.17. HRMS (ESI)- calcd for: 
C27H18BN2O7S-,525.10 [M-H]-; found: m/z 525.0946. 
  
Scheme 7.10. Synthesis of 12. 
7.3.6.5 Synthesis of porphyrin-boronic acid (Scheme 7.11) (13) 
2-(4-ethynylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (27.13 mg, 0.119 
mmol), 5-(3-iodophenyl)-15-phenylporphyrin(70 mg, 0.119 mmol), Pd2(dba)3 (13.5 mg, 
0.0148 mmol) and AsPh3 (36.4 mg, 0.119 mmol) were dissolved in toluene (8 mL) and Et3N 
(4 mL). The solution was saturated with argon (three freeze thaw cycles) and stirred at room 
temperature for 3 days, after which the solvent was removed under reduced pressure. The 
reaction mixture was purified by preparative TLC on silica gel eluted with Hexane/CH2Cl2 
(1/4) to yield 13 as black-red solid (71.29 mg, 87%). 1H NMR (500 MHz, CD3OD) 10.4 (2H, 
s, meso-CH), 9.50 (2H,d,J4.7, pyrrole-Hβ), 9.49 (2H,d, J4.7, pyrrole-Hβ), 9.15 (2H, d, J4.5, 
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pyrrole-Hβ), 9.14 (2H,d, J4.5, pyrrole-Hβ), 8.51 (1H, m), 8.31(2H, m), 8.06 (1H, d, J8.2), 
7.88 (6H, m), 7.79 (2H, d, J8.4 ), 7.63 (2H, d, J8.4), -3.3 (2H, br s,NH), 1.36 (12H, s, CH). 
MALDI-TOF MS (m/z) Calcd for: C46H37BN4O2Na+, 711.30 [M+Na]+, found 711.18; Calcd 
for: C46H41BN5O2K3+, 745.30 [M+NH4+K]3+; found: 745.17. (Figure 7.15). 
 
 
Scheme 7.11. Synthesis of porphyrin-boronic acid 13. 
MSS 10324 [C46 H37 B N4 O2] 27-Feb-2012 08:16:51MALDI
m/z




















































Figure 7.15.  MALDI spectrum of porphyrin-boronic acid showing peaks at m/z 711.18 
[M+Na]+, 745.17 [M+NH4+K]3+. 
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7.3.6.6  Synthesis of FLAB (16) (Scheme 7.12) 
 
 
Scheme 7.12. Synthesis of FLAB 16. 
Synthesis of intermediate Compound 14  
Biotin N-hydroxysuccinimide ester (500 mg) was mixed with excess hexamethylene 
diamine (5 g) in piperidine/H2O. The mixture was then stirred overnight. The precipitate thus 
formed was collected by filtration, washed with diethyl ether and a little dichloromethane, 
and dried in vacuo to give a white solid of 14 (quantitative yield, >90%).  
HRMS-ESI+: Calculated for C16H31N4O2S+, 343.21 [M+H]+, found: 343.2. 
Compound 15  
Dried, powdered molecular sieves (3 Å), DMF (10 mL) and compound 13 (490.5 mg, 
1.45 mmol) were added to a flask purged with nitrogen. To this flask, 4-formyl 
phenylboronic acid (217.4 mg, 1.45 mmol) and pinacol (171.35 mg, 1.45 mmol) were added. 
The mixture was next stirred under nitrogen for 16 h. Sodium triacetoxyborohydride (461 mg, 
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2.175 mmol) was then added, and then the mixture was stirring for another 24 h. Ethyl 
acetate was added to this solution for neutralizing and the solvents were evaporated under a 
high vacuum to give 342.5 mg of crude white solid of compound 15.  
HRMS-ESI+: Calculated for C29H48BN4O4S+: 559.34 [M + H]+; found: 559.3.   
Compound 16 
Fluorescein isothiocyanate (194.69 mg, 0.5 mmol) was dissolved in DMF (20 mL), to 
which 7 (236 mg, 0.5 mmol) was added, followed by triethylamine (2 mL). The mixture was 
stirring overnight under nitrogen while being protected from light. Subsequent drying in 
vacuo delivered desired compound 16 as a yellow solid. 
 1H {13C}NMR (300 MHz, D4-MeOD) δ:  8.09(1H, s, NH), 7.8(2H, d, J2.3), 7.77(1H, 
d, J2.2), 7.11(3H,d, J7.5), 6.8(1H,d,J9.2), 6.58(1H, d, J2.7), 6.49(1H,dd, J2.3 and 8.7), 
3.24(1H, s), 3.21(2H, m), 3.05(2H, q, J7.4 and 14.7), 1.83(2H, d, J1.4), 1.2(12H, s), 1.18(4H, 
d, J 14.5). 13C NMR (75 MHz, D4-MeOD) δ:   180.2, 169.1, 172.8, 160.3, 155.9, 145.1, 
135.7, 132.3, 129.6, 105.8, 56.9, 36.0, 32.5, 31.9, 30.1, 28.9, 24.6.   
11B NMR (d4-MeOD, 96 MHz): 160.46 ppm.  
MALDI-TOF MS (m/z) Cacld: C50H57BN5O9S2-, 947.38 [M-H]-, found 947. 
Cacld for: C50H58BN5O9S2Cl -, 982.38 [M+Cl]-, found 982. 
MSS 10283 [C50 H56 B N5 O9 S2] Negative 23-Feb-2012 09:54:15MALDI
m/z














































Figure 7.16. MALDI spectrum of 16 showing peaks at m/z 947[M-H]-, 982 [M+Cl]-. 
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7.3.6.7 Fluorescence Titrations of boronic acid fluorophors FLAB, FBA, Coumarin- 
and porphyrin-boronic acid and β-D-glucan  
Coumarin was provided by the Prof Tony James group and used as a comparison to 
prove the generality of the boronic acid-glucan tagging method.  
Stock solution of “receptor” (FLAB, FBA, Coumarin and porphyrin-boronic acid) 
with known molarity was made by dissolving fluorophores in pH 8.21 aqueous buffer. 50 
mL working solutions (25 μM FLAB, 25 μM FBA, 0.1 μM Coumarin and 33.7 μM 
porphyrin-boronic acid) were prepared by diluting stock solution with pH 8.21 aqueous 
methanolic buffer separately.  
β -D-Glucan was completely dissolved in pH 8.21 aqueous buffer by heating (50 °C) 
generated 0.031 mM “guest” solution. Increasing volumes of guest were transferred to 1 mL 
receptor solution in fluorescent spectroscopy cuvette and leaving 5 minuets for the binding 
between guest and receptor completely, then same volume of mixture was removed 
maintaining the total volume unchanged after each titration.  
Fluorescence emission spectra were recorded (FLAB (λex= 488 nm, λem= 514 nm), 
FBA (λex = 460 nm, λem= 543 nm), Coumarin (λex = 350 nm, λem = 377 nm) and porphyrin-
boronic acid (λex = 490 nm, λem = 629 nm) after each titration.   
7.3.6.8   Titration Data Analysis 
The observed stability constants (K) with coefficient of determination (r2) were 
calculated by the fitting of emission intensity at a single wavelength versus polysaccharide 
concentration using custom written non-linear curve fitting (equation 6) using Origin 8.0 
software.   Binding constant (K) was determined by fitting a 1:1 binding model to IF/IFmax.  
1 2 1(1 ) / (1 )y A A x A x= + ∗ ∗ + ∗                                                                   (6)                
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y:  IF/IFmax 
A1: K (binding constant of the receptor with the guest) 
A2:  IFmin/IFmax  
x : the concentration of glucan added to fluorophore  
    IFmin is the final (mimimum) fluorescence intensity; IFmax is the initial (maximum) 
fluorescence intensity; IF is the fluorescence intensity after addition of particular glucan 
(guest) concentration. 
7.3.6.9 Boronic acid fluorophore binding with β-D-glucan, β-D-glucan@SWNTs or β-D-
glucan@metalical atom@SWNT  
An aqueous solution containing boronic acid fluorophore was added to the aqueous 
solution containing glucan@SWNT composites at 7.0 pH and at 9.4 pH. As the borate ion 
forms covalently bonded complexes with 1, 2-diol and 1, 3-diol groups, it should also form 
complexes with the side-chain glucose in β-D-glucan from barley used. Scheme7.13 shows 
the procedure for preparing glucan@SWNT complex and the bonding the fluorescent 
boronic acid to glucan through the interaction between boronic acid and diol groups.  
 
Scheme. 7.13. Basic principle for preparing boronic acid 
fluorophore@glucan@SWNT, diagram adapted from paper20. 
 
1M boronic acid fluorophore solutions were prepared by dissolving  boronic acid 
fluorophores (FBA, FLAB, prophyrin boronic acid or coumarin) in pH 8.2 buffer. β-D-
glucan, β-D-glucan@SWNT or β-D-glucan@Mn+@SWNT composites were dispersed in pH 
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8.2 buffer. Boronic acid fluorophore buffer solutions were mixed with β-D-glucan, β-D-
glucan@SWNTs or β-D-glucan@Mn+@SWNT separately . Maintain the reaction stirring at 
the room temperature for 2 days.  Excess fluorophore was removed by filtrate boronic acid 
fluorophore@β-D-glucan@SWNTs and boronic acid fluorophore@β-D-
glucan@Mn+@SWNT solution through 2 µm membrane. The black solid on membrane was 
collected and dried in oven overnight (60 °C). 
7.3.6.10 Preparation of glucan-wrapped SWNTs and encapsulation of radio-metal ions 
from aqueous media 
All the “cold” (non-radioactive metal ions) and “hot” (radioactive isotopes of same 
metals) chemistries were performed in collaboration with the Radiopharmaceutical 
Chemistry Laboratory of Wolfson Brain Imaging Center (WBIC), University of Cambridge. 
The SWNTs dispersion before wrapping and filling was carried out in “cold” chemistry 
laboratory using a sonicator. The β-D-glucan DMSO solution (2 mg/mL) was prepared 
before radioisotope-filling experiments performed in “hot” cell.  
64Cu was produced at the WBIC by the irradiation of a thin layer of 64Ni electroplated 
on a solid gold internal target plate of the GE PETtrace cyclotron utilizing the nuclear 
reaction 64Ni(p,n)64Cu and separated from the target material as [64Cu]-CuCl2 by anion 
chromatography as previously described.21-24  
The radioactive 64CuCl2 was converted to 64Cu(OAc)2  a by diluting 0.2 mL 64CuCl2 
in 0.1 mol dm−3 HCl with 0.1 mol mL−3 sodium acetate (1.8 mL, pH 5.5).  
The radioisotope ions filling and C70 capping after filling were performed in standard 
lead lined “hot cells”. Each cell is provided with monitored air extract to protect against 
gaseous radio-activity leaks into the atmosphere. The radioactivity of radiolabelling samples 
was counted on a γ-counter (1480 Wizard 3, Perkin–Elmer, Boston, MA). Before 
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radiolabelling, 2.4 mg purified SWNTs were sonicated in 8 mL EtOH for 30 min and then 
split into 4 fractions.  Solvent was removed by evaporation.  
Sample a:  Sugar wrapping before radio-metal filling without C70 capping the ends of     
SWNTs. 
    0.8 mg SWNTs in one fraction were dispersed in 2 mL ddH2O through sonicating 
30 min. SWNTs solution was mixed with 2 mg/mL β-D-glucan DMSO solution and the 
mixed solution was sonicated for 20 min (mild sonication using a water bath). 50 µL of ~10-9 
M 64Cu (OAc)2 and 10 mg NaOAc were mixed with glucan@SWNTs solution. Leave 
radiolabelling reaction stirring at the room temperature for 2 h.  After reaction, the un-loaded 
radioisotope was removed by filtration through syringe 0.45µm membrane. The 
radioactivities of solid on membrane and filtrate solution were measured by γ- counting.  The 
radiolabelling solid on membrane was washed with excess double-distilled H2O. The 
radioactivities of solid on membrane and eluting solution were measured again by γ- 
counting.  Experiment steps above were repeted 4 times and an average measurement 
reported.  
Sample b: Sugar wrapping after radio-metal filling without C70 capping the ends of 
SWNTs 
    0.8 mg SWNTs in one fraction was dispersed in 2 mL double-distilled H2O 
through sonicating 30 min. 50 µL of ~10-9 M 64Cu (OAc) 2 and 10 mg NaOAc were added to 
SWNTs solution and the radio-reaction continued 2 h. Radiolabeled SWNTs solution was 
mixed with 2 mg/mL β-D-glucan DMSO solution and the mixed solution was sonicated for 
20 min (mild sonication using a water bath). The un-loaded radioisotope was removed by 
filtration through syringe 0.45µm membrane. The radioactivities of solid on membrane and 
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filtrate solution were measured by γ- counting.  The radiolabelling solid on membrane was 
washed with excess double-distilled H2O. The radioactivities of solid on membrane and 
eluting solution were measured again by γ- counting.  Experiment steps above were repeted 4 
times and an average measurement reported.  
Sample c: Sugar wrapping SWNTs before both radio-metal filling and C70 capping the 
ends of SWNTs 
 0.8 mg SWNTs in one fraction was dispersed in 2 mL double-distilled H2O through 
sonicating 30 min. 50 µL of ~10-9 M 64Cu(OAc) 2 and 10 mg NaOAc were added to SWNTs 
solution and the radio-reaction continued 2 h. Radiolabeled SWNTs solution was mixed with 
0.67 mg/mL C70 H2O dispersion and the mixed solution was sonicated for 5 min (mild 
sonication using a water bath) and leave it stirring another 1 h. The un-loaded radioisotope 
was removed by filtration through syringe 0.45µm membrane. The radioactivities of solid on 
membrane and filtrate solution were measured by γ- counting. The radiolabelling solid on 
membrane was washed with excess double-distilled H2O. The radioactivities of solid on 
membrane and eluting solution were measured again by γ- counting.  Experiment steps above 
were repeated 4 times and an average measurement reported.  
Sample d: Sugar wrapping SWNTs after radio-metal filling but before C70 capping the 
end of SWNTs 
0.8 mg SWNTs in one fraction was dispersed in 2 mL double-distilled H2O through 
sonicating 30 min. 50 µL of ~10-9 M 64Cu (OAc)2 and 10 mg NaOAc were added to SWNTs 
solution and the radio-reaction continued 2 h. Radiolabeled SWNTs solution was mixed with 
2 mg/mL β-D-glucan DMSO solution and the mixed solution was sonicated for 20 min (mild 
sonication using a water bath). 0.67 mg/mL C70 H2O dispersion was added to the above 
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radiolabeled glucan@SWNTs and sonicating for 5 min (mild sonication using a water bath) 
and leave it stirring another 1 h. The un-loaded radioisotope was removed by filtration 
through syringe 0.45µm membrane. The radioactivities of solid on membrane and filtrate 
solution were measured by γ-counting.  The radiolabelling solid on membrane was washed 
with excess ddH2O. The radioactivities of solid on membrane and eluting solution were 
measured again by γ- counting.  Experiment steps above were repeated 4 times and an 
average measurement reported.  
Sample e: Sugar wrapping SWNTs after both radio-metal filling and C70 capping the end 
of SWNTs 
0.8 mg SWNTs in one fraction was dispersed in 2 mL double-distilled H2O through 
sonicating 30 min. 50 µL of ~10-9 M 64Cu (OAc)2 and 10 mg NaOAc were added to SWNTs 
solution and the radio-reaction continued 2 h. Radiolabeled SWNTs solution was mixed with 
a 0.67 mg/mL C70/H2O dispersion and sonicated for 5 min (mild sonication using a water 
bath) . Mixture was left stirring another 1 h. The above radiolabeled C70@SWNTs solution 
was mixed with 2 mg/mL β-D-glucan DMSO solution and the mixed solution was sonicated 
for 20 min (mild sonication using a water bath). The un-loaded radioisotope was removed by 
filtration through syringe 0.45 µm membrane. The radioactivities of solid on membrane and 
filtrate solution were measured by γ-counting.  The radiolabelling solid on membrane was 
washed with excess double-distilled H2O. The radioactivities of solid on membrane and 
eluting solution were measured again by γ- counting.  Experiment steps above were repeated 
4 times and an average measurement reported.  
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7.3.6.11  Cells fluorescence imaging and In vitro fluorescence lifetime imaging (FLIM) of 
Fluorophores@glucan@SWNTs 
Cells (MCF-7 and HeLa cell lines) were seeded in a Petri dish with a glass cover slip 
(Mattek) and left for 24 h to adhere before fluorescence imaging measurements were made. 
Prior to imaging, the solution was replaced with 1 mL fresh medium. Fluorophore stock 
solutions were prepared for live cells fluorescence imaging. 5% v/v stock sample was added 
to dish.  Cell dish was incubated in a 5 % CO2  humidified atmosphere for 20 min. Surplus 
supernatant was removed after culturing (containing dead cell matter and excess proteins). 
Adherent cells were washed with two 5 mL aliquots of phosphate buffer saline solution to 
remove any remaining medium containing FCS. The uptake of the 
fluorophore@glucan@SWNTs and fluorophore@glucan by cells were imaged and 
monitored by using laser-scanning confocal microscopy (LSM 510 META, Zeiss) by tuning 
the argon ion laser excitation wavelength to 405 nm, 488 nm and 543 nm separately.  
        After confocal lasing imaging, cells in the same dish was scanned with an 
external fast microchannel plate photomultiplier tube as the detector.The multiphoton excited 
image of cell with the associated characteristic decay at each pixel position was generated by 
a time-correlated single-photon-counting PC module SPC830 (Becker and Hickl) These were 
linked via a time-correlated single-photon-counting PC module SPC830 (Becker and Hickl) 
to generate the multiphoton excited image with the associated characteristic decay at each 
pixel position. The scan was operated in normal mode and line, frame and pixel clock signals 
were 20 generated and synchronized with an external fast microchannel plate photomultiplier 
tube used as the detector. FLIM data can be analysed using the SPCImage analysis software 
(Becker and Hickl). 
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7.3.7 Synthesis of a thermal reduced graphene oxide-amino acid naphthalene 
diimide complex 
7.3.7.1 Graphene oxide (GO) synthesis, thermal exfoliation and reduction of GO to 
give TRG  
Graphite oxide is synthesized from graphite powder (SP-1 grade 325 mesh, Bay 
Carbon Inc.) by the modified Hummers method.25 Graphite oxide is synthesized from natural 
graphite powder (Fluka 50870) by the Hummers method using NaNO3, H2SO4, and KMnO4.   
10 g of powdered graphite and 5 g NaNO3 was added to concentrate H2SO4 (50 mL). The 
mix was cooled to 0 °C using an ice bath. 30 g of KMnO4 was added to the suspension 
slowly while maintaining the suspension vigorous agitation and controlling the temperature 
of suspension not exceeding 20 °C.  The temperature went up to 35 °C after remove ice-bath 
and keeping the stirring 30 min. After oxidation, 500 mL double-distilled H2O was added 
carefully and temperature was increased to near 100 °C. The color eventually turned to 
brown from dark.  After 15 min, the diluted suspension was continuing diluted to 1.5 L. Then 
the suspension was treated with 30% H2O2 for reducing the MnO4 and MnO2 to soluble 
manganese sulfate. The suspension was filtered 3 times with total 4.5 L double-distilled H2O. 
The filter flake was dispersed in double-distilled H2O again and dried in vacuum oven 
overnight. The dried product was diluted to make a 2% w/v dispersion that is put through 
dialysis for 2 weeks to remove any remaining salt. This product was dehydrated in at 40 °C 
over phosphorus pentoxide under vacuum. For the preparation of graphene oxide dispersions 
in H2O, the dried product was diluted with double-distilled H2O to make a 2 % w/v 
dispersion and sonicated in an ultrasound bath cleaner (J. P. Selecta Ultrasons system, 40 
kHz) for 1 h. The suspension was centrifuged at 3000 rpm 5 h. The supernatant was taken 
and left settling for 1 month after which the clear supernatant was used for next experiments. 
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2 mg of GO powder was made by freeze drying of GO suspension overnight. GO powder 
was then thermally exfoliated and reduced in a tubular furnace under N2 flow (300 mL min−1) 
to 900 °C (15 °C min−1), to obtain graphene-oxide annealed, labeled TRG.  
7.3.7.2 Synthesis of the complex NDI@TRG 
1 mg of TRG synthesized as above was dispersed in 5 mL toluene or CHCl3 through 
1 h ultrasonication treatment (50/60 Hz), and then the mixture was centrifuged with ×10000 
rpm speed to remove the aggregate leaving the supernatant for next use. 4 mg of NDI was 
added to this clear TRG suspension then sonicate for another 5 min and then leave it stirring 
for overnight. Then the solution was filtered through a 0.22 µm PTFE membrane which can 
be use to redisperse readily the deposited solid in organic solvents by ultrasonication.    
7.3.7.3 Thermogravimetric analyses (TGA) 
Thermogravimetric analyses (TGA) of sample was performed on a Pyris Diamond 
TG/DTA Thermogravimetric Analyzer (Perkin-Elmer Thermal Analysis). Sample was 
heated under nitrogen atmosphere (gas flow 20 mL/min) from 45 °C temperature to 600 °C 
at 5 °C min-1. 
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a                        b                    c                           d 
Figure 8.1. Materials studied as solutions (NDI) or dispersions in 2 mL CHCl3:EtOH 4:1. 
a) 0.7 mg SWNT; b) 42 μg NDI (26 μM); c) NDI@SWNT composite obtained on a 
preparative scale after 4 cycles of filtration, and redispersed at 0.2 mg/mL conc. d) 









Figure 8.2. High resolution transmission microscopy: a-c: Typical HR TEM images of 
the NDI@SWNT composite showing the uniform coating of SWNTs, including its tips 
(a and b),  and the presence of ‘dark dots’ assignable to the heavy element iodine (Z = 53) 












Figure 8.3.   Fluorescence titrations (CHCl3: EtOH) of NDI onto SWNTs dispersions (a) 
and of SWNTs  (total 35 μg/mL, added as 10 μl aliquots) onto a 26 μM solution of NDI 
(b). UV-Vis titrations of NDI onto SWNTs dispersions (35 μg/mL SWNT in CHCl3: 
EtOH 4:1) (c). Fluorescence spectroscopy showed a qualitatively full quenching of 
fluorescence was observed when a small amount of SWNT was added (b). This 
qualitative observation is indicative of close NDI–SWNTs contacts but the titration data 
did not allow reliable estimation of the association constant. Data was used to estimate a 
NDI: SWNT mass ratio which allowed complete coverage and minimum free (unbound) 
NDI in solution. The proposed ratio NDI: SWNT =0.6 was further verified by UV-Vis 





a                                                      b 
 
c                                                           d 
Figure 8.4. Circular Dichroism (top row, a and b) and UV-Vis (bottom row, c and d) 
spectroscopy for fresh solution (recorded within 20 min in solution) of free NDI, 26 μM 
in CHCl3: EtOH 4:1 and in pure CHCl3 solutions. 
 
8.1.2 Cell culture and fluorescence imaging for FEK-4, HeLa, HT801 and MCF-7 cell 
lines 
In general cells were cultured at 37 oC in a humidified atmosphere of 5% CO2 in air 
and split once confluence had been reached. Cells were cultured in EMEM medium (Eagle’s 
Modified Essential Medium) with foetal calf serum (FCS) (10% for HeLa and MCF-7 and 
15% for FEK-4, 200 U mL-1 L-glutamine and 100 U mL-1 penicillin. The medium contained 
no fluorescent indicator dyes such as phenol red and was therefore suitable for use in 
fluorescent studies.  
  V
Samples for live cells fluorescence imaging were prepared as described below. 
Surplus supernatant after culturing (containing dead cell matter and excess proteins) was 
discarded. The live adherent cells were then washed with two 5 mL aliquots of phosphate 
buffer saline solution to remove any remaining medium containing FCS (since this contains 
protease inhibitors which inactivate trypsin, thus inhibiting the resuspension of the cells). To 
re-suspend the cells in solution, they were incubated in 3 mL of trypsin–EDTA (500 mg L-1 
trypsin, 200 mg L-1 EDTA) solution for 5 min at 37 oC. After trypsinizing, fresh EMEM was 
added to the suspended cells to give a sufficient concentration of cells. The concentration of 
cells required varies between cell lines and is chosen to be optimal for achieving sufficient 
coverage and optimal imaging. Cells were maintained at 37 °C in a 5 % CO2  humidified 
atmosphere and grown to approximately 85 % confluence before being split using 0.25 % 
trypsin. For microscopy, cells were seeded onto chambered coverglass slides and incubated 
for 12 h to ensure adhesion. Prior to imaging, the solution was replaced with 1 mL fresh 
EMEM. Background autofluorescence was measured by imaging the cells in 1 mL of EMEM 
medium only.  Final concentrations on cell plates used: 
a) 21 μg/mL NDI (26 μM in 1: 99% DMSO:  EMEM);  
b) NDI@SWNT composite dispersion (in 1: 99% DMSO : EMEM) containing 21 
μg/mL NDI (26 μM  ‘anchored’ onto 35 μg/mL SWNT);  
c) 35 μg/mL free SWNT scaffold (dispersed in 1: 99% DMSO: EMEM).   
Fixed cell imaging: Cells cultured as above were plated in a Petri dish containing a 
glass cover slip. Before fluorescence imaging, the serum containing medium was replaced 
with SFM. After addition of compound, cells were fixed by inverting the coverslip placing it 
onto 50 μL of paraformaldehyde dissolved in PBS (4%). After 15 min, the coverslip was 
mounted to a slide using Vectashield®, hard set mounting medium with DAPI (Vector 
Laboratories, Inc.). A similar standard procedure to that described above was used for 
  VI
imaging fixed cells, and for this an additional background image was collected (using 
untreated cells) at the end of experiment.  
The uptake of the NDI@SWNT composite was imaged by single-photon laser-
scanning confocal microscopy (TCS NT, Leica), using the 488 nm line of an argon ion laser 
for excitation and the emission was long pass filtered (515 nm) and detected with a 
photomultiplier tube. The intensity of the laser was modified to reduce the possibility of 
photobleaching of the florophore over time and the PMT voltage adjusted to be just above 
the auto-fluorescence limit of the starting conditions (for imaging of living cells) effectively 
recording a background image before addition of compound, whilst maximizing sensitivity 















Figure 8.5. Epifluorescence imaging λex = 450-500 nm of healthy FEK-4 cells incubated 
for 2 h at 37 oC with an NDI@SWNT composite dispersion (in 1: 99% DMSO: EMEM) 
containing 21 μg/mL NDI (26 μM) ‘anchored’ onto 35 μg/mL SWNT. Scalebar = 100 
μm. Brightfield, fluorescence emission and overlaid micrograph 
 
 
For both live cells, or fixed cells, formation of endosomes of ca. 300-400 nm was 
evident by both brightfield and fluorescence imaging inside the cytoplasm, but the largest 
NDI@SWNT aggregates (ca 1 μm) did not appear to cross the outer membrane and remained 
attached to the outside of the cell. After exposure to NDI@SWNT the cell membrane did not 
show any significant disruption. The composites do not seem to cross the perinuclear 
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membrane within 24 h uptake. In contrast, when the experiment was repeated using free NDI, 
this distributed both inside the cytoplasm and cell nucleus and visibly altered the cell 
membrane morphology within 1 h. Notably, the confocal imaging of the same cells using λex 




















Figure 8.6.  DIC images of HeLa cells incubated for 2 h at 37 oC  in 1: 99% DMSO : 
serum free medium EMEM containing 0.35 μg/mL SWNT (left) and control experiment 
showing live HeLa cells prior to imaging, after incubation 37 oC in cells medium 





































Figure 8.7. Epifluorescence images showing brightfield, fluorescence emission and 
overlaid micrographs (λex = 450-500 nm) of FEK-4 cells incubated for 2 h at 4 oC with: a) 
21 μg/mL NDI (26 μM in 1: 99% DMSO : EMEM); b) NDI@SWNT composite 
dispersion (in 1: 99% DMSO : EMEM) containing 21 μg/mL NDI (26 μM) ‘anchored’ 
onto 35 μg /mL SWNT; c) 35 μg /mL free SWNT scaffold (dispersed in 1: 99% DMSO : 











































Figure 8.8.  Epifluorescence imaging showing brightfield, fluorescence emission and 
overlaid micrographs (λex = 450-500 nm) of MCF-7 cells incubated for 2 h at 37 oC with: 
a) 21 μg/mL NDI (26 μM in 1: 99% DMSO: EMEM); b) NDI@SWNT composite 
dispersion (in 1: 99% DMSO: EMEM) containing 21 μg/mL NDI (26 μM ‘anchored’ 
onto 35 μg/mL SWNT). Scalebar = 100 μm. Images show nuclear uptake for free NDI 
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Figure 8.9. MI50 determinations from MTT assays in healthy and in cancerous cells: a) 
NDI uptake in MCF-7 cells by MTT assays, b) NDI uptake in FEK-4 cells by MTT 
assays, c) NDI anchored onto SWNT (NDI@SWNT): uptake in MCF-7 cells by MTT 
assays (mass ratio was kept constant over the range of concentrations used, NDI:SWNT 
= 0.6),d) NDI anchored onto SWNT (NDI@SWNT): uptake in FEK-4 cells by MTT 
assays (mass ratio was kept constant over the range of concentrations used was 
NDI:SWNT = 0.6),e) SWNTs uptake in MCF-7 cells by MTT assays f) SWNTs uptake 
in MCF-7 cells by MTT assays  
b 
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8.2 Appendix for Chapter 3 
 
Figure 8.10. Distribution of T12@SWNT length in this AFM imaging.  
 
 
Figure 8.11. Fitted 2 photon excitation (λex= 910 nm) FLIM decay curves for T12@SWNT 
and T12 in DMSO. (T12: 7.5 nM or 27.3 μg/mL T12 in pure DMSO, T12@SWNT 
composite dispersion containing 27.3 μg/mL T12 (7.5 nM) anchored onto 70 μg/mL 




Figure 8.12. AFM imaging of T12@SWNT (a) original solution(mixture of SWNTs (0.1 
mg) and the T12 polymer (0.1 mg) in CHCl3 (4 mL), (b) after the first 
filtration/dispersion treatment, (c) after the second filtration/dispersion treatment and (d) 







Figure 8.13. Single Photon Laser scanning confocal imaging of  cancerous (HeLa) cells 
incubated at 37 oC for 20 min with T12 (1.92 nM or 7 μg/mL in 5: 95% DMSO:  EMEM), 
(a-d) λex = 405 nm, showing DIC (a), green channel (b), red channel (605-675 nm) (c) 
and DIC-green-red channel overlay (d). (e-h) λex= 488 nm, showing DIC (e), green 
channel (515-530 nm) (f), red channel (605-675 nm) (g) and DIC-green-red channels 
overlay (h). (i-l) λex = 543 nm, showing DIC (i), green channel (515-530 nm) (j), red 
channel (605-675 nm) (k) and DIC-green-red channels overlay (l), Scalebar 5 μm. 
 
 
Figure 8.14.   Fluorescent Intensity profile of HeLa cells (d) incubated at 37 oC for 20 min 
with T12 (1.92 nM or 7 μg/mL in 5: 95% DMSO:  EMEM) (a) λex = 405 nm, (b) λex = 
















a c b d 
  XIV
 
Figure 8.15. Single Photon Laser scanning confocal imaging of  cancerous (HeLa) cells 
incubated at 37 oC for 20 min with T12@SWNT composite dispersion (in 5:99 % 
DMSO:EMEM) containing 7 μg/mL T12 anchored onto 18 μg/mL SWNT, (a-d) λex = 
405 nm, showing DIC (a), green channel (b), red channel (605-675 nm) (c) and DIC-
green-red channel overlay (d). (e-h) λex = 488 nm, showing DIC (e), green channel (515-
530 nm) (f), red channel (605-675 nm) (g) and DIC-green-red channels overlay (h). (i-l) 
λex = 543 nm, showing DIC (i), green channel (515-530 nm) (j), red channel (605-675 





Figure 8.16. Fluorescent Intensity profile of HeLa cells (d) incubated at 37 oC for 20 min 
with with T12@SWNT composite dispersion (in 5:99% DMSO:EMEM) containing 7 
μg/mL T12 anchored onto 18 μg/mL SWNT, (a) λex = 405 nm, (b) λex = 488 nm and (c) 
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Figure 8.17. Single Photon Laser scanning confocal imaging of  PC-3 cells incubated at 37 
oC for 20 min with T12 (1.92 nM or 7 μg/mL in 5: 95% DMSO:  EMEM), (a-c) λex = 405 
nm, showing DIC (a), green channel (b) and DIC-green-red channel overlay (c). (d-f) λex 
= 488 nm, showing DIC (d), green channel (515-530 nm) (e) and DIC-green-red 
channels overlay (f). (g) λex = 543 nm, showing DIC-green-red channels overlay (g), 
Scalebar 5 μm. 
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Figure 8.18.   Fluorescent Intensity profile of PC-3 cells (c) incubated at 37 oC for 20 min 
with T12 (1.92 nM or 7 μg/mL in 5: 95% DMSO:  EMEM) (a) λex = 405 nm and (b) λex 





Figure 8.19. Single Photon Laser scanning confocal imaging of  PC-3 cells incubated at 37 
oC for 20 min with T12@SWNT composite dispersion (in 5:99% DMSO:EMEM) 
containing 7 μg/mL T12 anchored onto 18 μg/mL SWNT, (a-d) λex = 405 nm, showing 
DIC (a), green channel (b), red channel (605-675 nm) (c) and DIC-green-red channel 
overlay (d). (e-h) λex = 488 nm, showing DIC (e), green channel (515-530 nm) (f), red 
channel (605-675 nm) (g) and DIC-green-red channels overlay (h). (i-l) λex = 543 nm, 
showing DIC (i), green channel (515-530 nm) (j), red channel (605-675 nm) (k) and 

















Figure 8.20.   Fluorescent Intensity profile of PC-3 cells (d) incubated at 37 oC for 20 min 
with with T12@SWNT composite dispersion (in 5:99% DMSO:EMEM) containing 7 
μg/mL T12 anchored onto 18 μg/mL SWNT, (a) λex = 405 nm, (b) λex = 488 nm and (c) 
λex = 543 nm 
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Figure 8.21.    1H NMR spectroscopy of T12 and T12@SWNT in CDCl3 
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8.3  Appendix for Chapter 5 
 
Figure 8.22. 1H NMR spectroscopy of porphyrin-boronic acid  in CD3OD 
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